"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. . "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. eprosartan. this classification denotes an angiotensin ii receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2kh13z0s0y. european medicines agency schedules eprosartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06586mig. eprosartan generally arises in the molecular formula c23h24n2o4s. the term eprosartan is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35.) eprosartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eprosartan under hs 29349990 and sitc 51579. as of q4 2014, eprosartan remains the us fda preferred term for this commodity. eprosartan bears us nlm identifiers umls id c0287041 and nci concept code c61749. smiles: s1c(c/c(=c/c2n(c(nc2)cccc)cc2ccc(cc2)c(=o)o)c(=o)o)ccc1.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. aliskiren. this classification denotes an antihypertensive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 502fwn4q32. european medicines agency schedules aliskiren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21380. aliskiren generally arises in the molecular formula c30h53n3o6. the term aliskiren is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45.) most nations schedule aliskiren under hs 29242995 and sitc 51479. as of q4 2014, aliskiren remains the us fda preferred term for this commodity. aliskiren bears us nlm identifiers umls id c0915224 and nci concept code c65222. smiles: oc(c(n)cc(c(c)c)cc1cc(occcoc)c(oc)cc1)cc(c(c)c)c(=o)ncc(c)(c)c(=o)n.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. tirofiban. this classification denotes an antiplatelet agent with the molecular formula c22h36n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ggx234si5h, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)- but generally known as tirofiban, which bears us nih compound identifier 60947. european medicines agency schedules tirofiban in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11118mig. the term tirofiban is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules tirofiban in its anatomical therapeutic chemical (atc) classification. tirofiban is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tirofiban under hs 29350090 and sitc 51580. as of q4 2014, tirofiban remains the us fda preferred term for this commodity. tirofiban bears us nlm identifiers umls id c0247025 and nci concept code c76405. smiles: s(=o)(=o)(nc(cc1ccc(occccc2ccncc2)cc1)c(=o)o)cccc.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. arfalasin. this classification denotes an angiotensin ii receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7e6sp93i57. european medicines agency schedules arfalasin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05557mig. arfalasin generally arises in the molecular formula c48h67n13o11. the term arfalasin is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17.) arfalasin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule arfalasin under hs 29332990 and sitc 51573. as of q4 2014, arfalasin remains the us fda preferred term for this commodity. arfalasin bears us nlm identifiers umls id c0624820 and nci concept code c87430. smiles: o=c(n1c(ccc1)c(=o)nc(c1ccccc1)c(=o)o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)ccc(=o)n)ccc/n=c(/n)n)c(c)c)cc1ccc(o)cc1)c(c)c)cc1[nh]cnc1.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. aliskiren fumarate. this classification denotes an antihypertensive agent with the molecular formula 2c30h53n3o6.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c8a0p8g029. european medicines agency schedules aliskiren fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25393. the term aliskiren fumarate is a japanese accepted name designation. most nations, for tariff and trade purposes, schedule aliskiren fumarate under hs 29242995 and sitc 51479. smiles: cc(c)[c@@h](cc1ccc(c(c1)occcoc)oc)c[c@@h]([c@h](c[c@@h](c(c)c)c(=o)ncc(c)(c)c(=o)n)o)n.cc(c)[c@@h](cc1ccc(c(c1)occcoc)oc)c[c@@h]([c@h](c[c@@h](c(c)c)c(=o)ncc(c)(c)c(=o)n)o)n.c(=c/c(=o)o)\\c(=o)o.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. eprosartan mesilate or mesylate. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c23h24n2o4s.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8n2l1nx8s3, chemically known as (e)-2-butyl-1-(p-carboxybenzyl)-.alpha.-2-thenylimidazole-5-acrylic acid, monomethanesulfonate, but more generally known as eprosartan mesylate, which bears us nih compound identifier 5282474. european medicines agency schedules eprosartan mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06586mig. most nations, for tariff purposes, schedule eprosartan mesylate under hs 29349990. as of q4 2014, eprosartan mesylate remains us fdas preferred term for this commodity. eprosartan mesylate bears us nlm identifiers umls id c0772203 and nci concept code c47515. smiles: ccccc1ncc(n1cc2ccc(cc2)c(=o)o)/c=c(\\cc3cccs3)/c(=o)o.cs(=o)(=o)o.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. tirofiban hydrochloride. this classification denotes an antiplatelet agent with the molecular formula c22h36n2o5s.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6h925f8o5j, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, monohydrochloride, monohydrate but more generally known as tirofiban hydrochloride, which bears us nih compound identifier 60946. european medicines agency schedules tirofiban hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04887mig. most nations, for tariff and trade purposes, schedule tirofiban hydrochloride under hs 29350090 and sitc 51580. as of q4 2014, tirofiban hydrochloride remains us fdas preferred term for this commodity. tirofiban hydrochloride bears us nlm identifiers umls id c0795668 and nci concept code c47759. smiles: ccccs(=o)(=o)n[c@@h](cc1ccc(cc1)occccc2ccncc2)c(=o)o.o.cl.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. tirofiban hydrochloride anhydrous. this classification denotes an antiplatelet agent with the molecular formula c22h36n2o5s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ike1p4x57j, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, hydrochloride (1:1), but more generally known as tirofiban hydrochloride anhydrous, which bears us nih compound identifier 64781. european medicines agency schedules tirofiban hydrochloride anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11118mig. most nations, for tariff purposes, schedule tirofiban hydrochloride anhydrous under hs 29350090. smiles: ccccs(=o)(=o)n[c@@h](cc1ccc(cc1)occccc2ccncc2)c(=o)o.cl.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. tirofiban hydrochloride monohydrate. this classification denotes an antiplatelet agent with the molecular formula c22h36n2o5s.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6h925f8o5j, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, hydrochloride, hydrate (1:1:1), but more generally known as tirofiban hydrochloride monohydrate, which bears us nih compound identifier 60946. european medicines agency schedules tirofiban hydrochloride monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11118mig. most nations, for tariff purposes, schedule tirofiban hydrochloride monohydrate under hs 29350090. smiles: ccccs(=o)(=o)n[c@@h](cc1ccc(cc1)occccc2ccncc2)c(=o)o.o.cl.. "
"antihypertensive acrylates and amides and angiotensins and aromatic amino acids. this classification denotes antihypertensives drugs made from or based in part on antihypertensive acrylates, amides, angiotensins, or aromatic amino acids. arginine hydrochloride. this classification denotes a nutritional supplement, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier f7lth1e20y. european medicines agency schedules arginine hcl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00579mig. arginine hydrochloride generally arises in the molecular formula c6h14n4o2.clh. the term arginine hydrochloride is an international nomenclature of cosmetic ingredients designation.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. . "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. anipamil. this classification denotes a calcium channel blocker, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9y54wzv1cj. european medicines agency schedules anipamil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05516mig. anipamil generally arises in the molecular formula c34h52n2o2. the term anipamil is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) anipamil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule anipamil under hs 29269095 and sitc 51484. as of q4 2014, anipamil remains the us fda preferred term for this commodity. anipamil bears us nlm identifiers umls id c0051916 and nci concept code c76578. smiles: o(c1cc(c(cccccccccccc)(cccn(ccc2cc(oc)ccc2)c)c#n)ccc1)c.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. atomoxetine. this classification denotes an antidepressant agent with the molecular formula c17h21no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier asw034s0b8, chemically known as benzenepropanamine, n-methyl-gamma-(2-methylphenoxy)-, (gammar)- but generally known as atomoxetine, which bears us nih compound identifier 54841. atomoxetine most often comes in base and hydrochloride forms. the term atomoxetine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3, 2002, list 48). world health organization schedules atomoxetine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, atomoxetine remains the us fda preferred term for this commodity. atomoxetine bears us nlm identifiers umls id c0076823 and nci concept code c74141. smiles: cc1=cc=cc=c1oc(ccnc)c2=cc=cc=c2.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. devapamil. this classification denotes a calcium channel blocker with the molecular formula c26h36n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m6142ptv7j, chemically known as 2-(3,4-dimethoxyphenyl)-2-isopropyl-5-((m-methoxyphenethyl)methylamino)valeronitrile but generally known as devapamil, which bears us nih compound identifier 65832. european medicines agency schedules devapamil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07015mig. the term devapamil is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). devapamil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule devapamil under hs 29269095 and sitc 51484. as of q4 2014, devapamil remains the us fda preferred term for this commodity. devapamil bears us nlm identifiers umls id c0057583 and nci concept code c77823. smiles: o(c1cc(c(c(c)c)(cccn(ccc2cc(oc)ccc2)c)c#n)ccc1oc)c.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. fendiline. this classification denotes a calcium channel blocker with the molecular formula c23h25n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s253d559a8, chemically known as benzenepropanamine, gamma-phenyl-n-(1-phenylethyl)- but generally known as fendiline, which bears us nih compound identifier 3336. european medicines agency schedules fendiline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07554mig. the term fendiline is an international non-proprietary name. world health organization schedules fendiline in its anatomical therapeutic chemical (atc) classification. fendiline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fendiline under hs 29214980 and sitc 51454. as of q4 2014, fendiline remains the us fda preferred term for this commodity. fendiline bears us nlm identifiers umls id c0015824 and nci concept code c81686. smiles: n(ccc(c1ccccc1)c1ccccc1)c(c1ccccc1)c.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. gallopamil. this classification denotes a calcium channel blocker with the molecular formula c28h40n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 39wpc8jhr8, chemically known as 5-((3,4-dimethoxyphenethyl)methylamino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile but generally known as gallopamil, which bears us nih compound identifier 1234. european medicines agency schedules gallopamil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07874mig. the term gallopamil is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules gallopamil in its anatomical therapeutic chemical (atc) classification. gallopamil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule gallopamil under hs 29269095 and sitc 51484. as of q4 2014, gallopamil remains the us fda preferred term for this commodity. gallopamil bears us nlm identifiers umls id c0016986 and nci concept code c83725. smiles: o(c1cc(c(c(c)c)(cccn(ccc2cc(oc)c(oc)cc2)c)c#n)cc(oc)c1oc)c.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. metirosine or metyrosine. this classification denotes a tyrosine hydroxylase inhibitor with the molecular formula c10h13no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier doq0j0tpf7, chemically known as l-tyrosine, alpha-methyl-, (-)- but generally known as metirosine, which bears us nih compound identifier 12650. european medicines agency schedules metirosine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08894mig. the term metirosine is an international non-proprietary name. world health organization schedules metirosine in its anatomical therapeutic chemical (atc) classification. metirosine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. metirosine or metyrosine bears us nlm identifiers umls id c0886584 and nci concept code c998. smiles: c[c@@](cc1=cc=c(c=c1)o)(c(=o)o)n.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. pargyline. this classification denotes a monoamine oxidase inhibitor and antihypertensive agent with the molecular formula c11h13n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9mv14s8g3e, chemically known as 2-propynylamine, n-benzyl-n-methyl-, hydrochloride but generally known as pargyline, which bears us nih compound identifier 4688. european medicines agency schedules pargyline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09626mig. the term pargyline is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules pargyline in its anatomical therapeutic chemical (atc) classification. pargyline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pargyline under hs 29214980 and sitc 51454. as of q4 2014, pargyline remains the us fda preferred term for this commodity. pargyline bears us nlm identifiers umls id c0030557 and nci concept code c66322. smiles: cn(cc#c)cc1=cc=cc=c1.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. terodiline. this classification denotes a calcium channel blocker and parasympatholytic with the molecular formula c20h27n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70kg06964w, chemically known as propylamine, n-tert-butyl-1-methyl-3,3-diphenyl- but generally known as terodiline, which bears us nih compound identifier 23480. european medicines agency schedules terodiline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10929mig. world health organization schedules terodiline in its anatomical therapeutic chemical (atc) classification. terodiline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terodiline under hs 29214980 and sitc 51454. as of q4 2014, terodiline remains the us fda preferred term for this commodity. smiles: n(c(cc(c1ccccc1)c1ccccc1)c)c(c)(c)c.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. verapamil. this classification denotes a calcium channel blocker with the molecular formula c27h38n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cj0o37ku29, chemically known as 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile but generally known as verapamil, which bears us nih compound identifier 2520. european medicines agency schedules verapamil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00038mig. the term verapamil is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules verapamil in its anatomical therapeutic chemical (atc) classification. verapamil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule verapamil under hs 29269000 and sitc 51484. as of q4 2014, verapamil remains the us fda preferred term for this commodity. verapamil bears us nlm identifiers umls id c0042523 and nci concept code c928. smiles: o(c1cc(c(c(c)c)(cccn(ccc2cc(oc)c(oc)cc2)c)c#n)ccc1oc)c.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. fendiline hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c23h25n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hem3z10iik, chemically known as n-(3,3-diphenylpropyl)-alpha-methylbenzylamine hydrochloride but more generally known as fendiline hydrochloride, which bears us nih compound identifier 26154. european medicines agency schedules fendiline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02113mig. most nations, for tariff and trade purposes, schedule fendiline hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, fendiline hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c1ccccc1)nccc(c2ccccc2)c3ccccc3.cl.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. gallopamil hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c28h40n2o5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vt4vr32a0t, chemically known as 5-((3,4-dimethoxyphenethyl)methylamino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile but more generally known as gallopamil hydrochloride, which bears us nih compound identifier 1234. european medicines agency schedules gallopamil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02309mig. most nations, for tariff and trade purposes, schedule gallopamil hydrochloride under hs 29269095 and sitc 51484. as of q4 2014, gallopamil hydrochloride remains us fdas preferred term for this commodity. gallopamil hydrochloride bears us nlm identifiers umls id c1369325 and nci concept code c83726. smiles: cc(c)c(cccn(c)ccc1ccc(c(c1)oc)oc)(c#n)c2cc(c(c(c2)oc)oc)oc.cl.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. pargyline hydrochloride. this classification denotes a monoamine oxidase inhibitor and antihypertensive agent with the molecular formula c11h13n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w70v6i2omy, chemically known as 2-propynylamine, n-benzyl-n-methyl-, hydrochloride but more generally known as pargyline hydrochloride, which bears us nih compound identifier 4688. european medicines agency schedules pargyline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03653mig. most nations, for tariff and trade purposes, schedule pargyline hydrochloride under hs 29214900 and sitc 51454. as of q4 2014, pargyline hydrochloride remains us fdas preferred term for this commodity. pargyline hydrochloride bears us nlm identifiers umls id c0282289 and nci concept code c66323. smiles: cn(cc#c)cc1ccccc1.cl.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. terodiline hydrochloride. this classification denotes a calcium channel blocker and parasympatholytic c20h27n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k2za89w43f, chemically known as benzenepropanamine, n-(1,1-dimethylethyl)-.alpha.-methyl-.gamma.-phenyl-, hydrochloride, but more generally known as terodiline hydrochloride, which bears us nih compound identifier 23479. european medicines agency schedules terodiline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04728mig. most nations, for tariff and trade purposes, schedule terodiline hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, terodiline hydrochloride remains us fdas preferred term for this commodity. smiles: cc(cc(c1ccccc1)c2ccccc2)nc(c)(c)c.cl.. "
"antihypertensive amines. antihypertensive drugs made from a group of compounds derived from ammonia by substituting organic radicals for the hydrogens.. verapamil hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c27h38n2o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v3888oey5r, chemically known as 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile but more generally known as verapamil hydrochloride, which bears us nih compound identifier 2520. european medicines agency schedules verapamil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05088mig. most nations, for tariff and trade purposes, schedule verapamil hydrochloride under hs 29269000 and sitc 51484. as of q4 2014, verapamil hydrochloride remains us fdas preferred term for this commodity. verapamil hydrochloride bears us nlm identifiers umls id c0700468 and nci concept code c2827. smiles: cc(c)c(cccn(c)ccc1ccc(c(c1)oc)oc)(c#n)c2ccc(c(c2)oc)oc.cl.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. . "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. benazepril. this classification denotes an ace inhibitor with the molecular formula c24h28n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier udm7q7qwp8, chemically known as 1h-1-benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (s-(r*,r*))- but generally known as benazepril, which bears us nih compound identifier 5362124. benazepril most often comes in base and hydrochloride forms. european medicines agency schedules benazepril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05700mig. the term benazepril is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). world health organization schedules benazepril in its anatomical therapeutic chemical (atc) classification. benazepril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benazepril under hs 29337900 and sitc 51561. as of q4 2014, benazepril remains the us fda preferred term for this commodity. benazepril bears us nlm identifiers umls id c0053091 and nci concept code c61645. smiles: o=c1n(c2c(ccc1nc(ccc1ccccc1)c(=o)occ)cccc2)cc(=o)o.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. benazeprilat. this classification denotes an ace inhibitor with the molecular formula c22h24n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jrm708l703, chemically known as 1h-1-benzazepine-1-acetic acid, 3-(((1s)-1-carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (3s)- but generally known as benazeprilat, which bears us nih compound identifier 5463984. european medicines agency schedules benazeprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05701mig. the term benazeprilat is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). benazeprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benazeprilat under hs 29337900 and sitc 51561. as of q4 2014, benazeprilat remains the us fda preferred term for this commodity. benazeprilat bears us nlm identifiers umls id c0105523 and nci concept code c72907. smiles: o=c1n(c2c(ccc1nc(ccc1ccccc1)c(=o)o)cccc2)cc(=o)o.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. libenzapril. this classification denotes an ace inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qd8496wwyk. european medicines agency schedules libenzapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08502mig. libenzapril generally arises in the molecular formula c18h25n3o5. the term libenzapril is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28.) libenzapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule libenzapril under hs 29337900 and sitc 51561. as of q4 2014, libenzapril remains the us fda preferred term for this commodity. libenzapril bears us nlm identifiers umls id c0055225 and nci concept code c81335. smiles: o=c1n(c2c(ccc1nc(ccccn)c(=o)o)cccc2)cc(=o)o.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. diltiazem. this classification denotes a calcium channel blocker with the molecular formula c22h26n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ee92bbp03h, chemically known as 3-acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5h)-one but generally known as diltiazem, which bears us nih compound identifier 3076. european medicines agency schedules diltiazem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07148mig. the term diltiazem is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules diltiazem in its anatomical therapeutic chemical (atc) classification. diltiazem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diltiazem under hs 29349990 and sitc 51579. as of q4 2014, diltiazem remains the us fda preferred term for this commodity. diltiazem bears us nlm identifiers umls id c0012373 and nci concept code c61725. smiles: s1c(c(oc(=o)c)c(=o)n(ccn(c)c)c2c1cccc2)c1ccc(oc)cc1.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. clentiazem. this classification denotes a calcium channel blocker with the molecular formula c22h25cln2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 40dk034drc chemically known as 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-8-chloro-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)- but generally known as clentiazem, which bears us nih compound identifier 57026. european medicines agency schedules clentiazem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06653mig. the term clentiazem is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). most nations schedule clentiazem under hs 29349990 and sitc 51579. as of q4 2014, clentiazem remains the us fda preferred term for this commodity. clentiazem bears us nlm identifiers umls id c0075753 and nci concept code c81679. smiles: cc(=o)oc1c(sc2=c(c=cc(=c2)cl)n(c1=o)ccn(c)c)c3=cc=c(c=c3)oc.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. benazepril hydrochloride. this classification denotes an ace inhibitor with the molecular formula c24h28n2o5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n1sn99t69t, chemically known as 1h-1-benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, (s-(r*,r*))- but more generally known as benazepril hydrochloride, which bears us nih compound identifier 5362123. european medicines agency schedules benazepril hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13003mig. most nations, for tariff and trade purposes, schedule benazepril hydrochloride under hs 29337900 and sitc 51561. as of q4 2014, benazepril hydrochloride remains us fdas preferred term for this commodity. benazepril hydrochloride bears us nlm identifiers umls id c0770917 and nci concept code c28862. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@h]2ccc3ccccc3n(c2=o)cc(=o)o.cl.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. clentiazem maleate. this classification denotes a calcium channel blocker with the molecular formula c22h25cln2o4s.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yn4f0n5qe0, chemically known as 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-8-chloro-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)-, (z)-2-butenedioate (1:1) but more generally known as clentiazem maleate, which bears us nih compound identifier 6435546. most nations, for tariff and trade purposes, schedule clentiazem maleate under hs 29349990 and sitc 51579. as of q4 2014, clentiazem maleate remains us fdas preferred term for this commodity. smiles: cc(=o)o[c@@h]1[c@@h](sc2cc(ccc2n(c1=o)ccn(c)c)cl)c3ccc(cc3)oc.c(=c\\c(=o)o)\\c(=o)o.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. diltiazem hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c22h26n2o4s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier olh94387te, chemically known as 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride, (+)-cis- but more generally known as diltiazem hydrochloride, which bears us nih compound identifier 62920. european medicines agency schedules diltiazem hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13602mig. most nations, for tariff and trade purposes, schedule diltiazem hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, diltiazem hydrochloride remains us fdas preferred term for this commodity. diltiazem hydrochloride bears us nlm identifiers umls id c0700940 and nci concept code c398. smiles: cc(=o)o[c@@h]1[c@@h](sc2ccccc2n(c1=o)ccn(c)c)c3ccc(cc3)oc.cl.. "
"antihypertensive benzazepines. antihypertensive drugs made from compounds with benzene fused to azepines.. diltiazem malate. this classification denotes a calcium channel blocker with the molecular formula c22h26n2o4s.c4h6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 14y6444drp, chemically known as 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-(2-(di-methylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-(2s-cis)-, (s)-hydoxybutanedioate (1:1) but more generally known as diltiazem malate, which bears us nih compound identifier 3037122. european medicines agency schedules diltiazem malate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20629. most nations, for tariff and trade purposes, schedule diltiazem malate under hs 29349990 and sitc 51579. as of q4 2014, diltiazem malate remains us fdas preferred term for this commodity. diltiazem malate bears us nlm identifiers umls id c1165286 and nci concept code c47493. smiles: cc(=o)o[c@@h]1[c@@h](sc2ccccc2n(c1=o)ccn(c)c)c3ccc(cc3)oc.c([c@@h](c(=o)o)o)c(=o)o.. "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. . "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. irbesartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c25h28n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j0e2756z7n, chemically known as 1,3-diazaspiro(4.4)non-1-en-4-one, 2-butyl-3-((2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)- but generally known as irbesartan, which bears us nih compound identifier 3749. european medicines agency schedules irbesartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08293mig. the term irbesartan is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules irbesartan in its anatomical therapeutic chemical (atc) classification. irbesartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule irbesartan under hs 29332990 and sitc 51573. as of q4 2014, irbesartan remains the us fda preferred term for this commodity. irbesartan bears us nlm identifiers umls id c0595301 and nci concept code c29130. smiles: o=c1n(c(=nc21cccc2)cccc)cc1ccc(cc1)c1c(cccc1)c1n[nh]nn1.. "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. diclofurime. this classification denotes a calcium channel blocker with the molecular formula c18h22cl2n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d1fp3k444h, chemically known as 2,3-dichloro-4-methoxyphenyl 2-furyl ketone (e)-o-(2-(diethylamino)ethyl)-oxime. but generally known as diclofurime, which bears us nih compound identifier 9577638. european medicines agency schedules diclofurime in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07095mig. the term diclofurime is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). diclofurime is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diclofurime under hs 29321900 and sitc 51569. as of q4 2014, diclofurime remains the us fda preferred term for this commodity. diclofurime bears us nlm identifiers umls id c0113741 and nci concept code c77824. smiles: clc1c(/c(=n\\occn(cc)cc)c2occc2)ccc(oc)c1cl.. "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. methyldopa. this classification denotes a dopamine agonist and antihypertensive agent with the molecular formula 2c10h13no4.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56lh93261y, chemically known as 3,4-dihydroxy-2-methylphenylalanine but generally known as methyldopa, which bears us nih compound identifier 4138. european medicines agency schedules methyldopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08867mig. world health organization schedules methyldopa in its anatomical therapeutic chemical (atc) classification. methyldopa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methyldopa under hs 29225000 and sitc 51467. as of q4 2014, methyldopa remains the us fda preferred term for this commodity. methyldopa bears us nlm identifiers umls id c0025741 and nci concept code c47616. smiles: cc(cc1=cc(=c(c=c1)o)o)(c(=o)o)n.. "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. azilsartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c25h20n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f9nux55p23, chemically known as 2-ethoxy-3-[[4-[2-(5-oxo-2h-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid but generally known as azilsartan, which bears us nih compound identifier 9825285. european medicines agency schedules azilsartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31561. the term azilsartan is an international non-proprietary name or inn (see who inn reference publication, volume 21, no. 1, 2007, list 57). most nations schedule azilsartan under hs 29349990 and sitc 51579. as of q4 2014, azilsartan remains the us fda preferred term for this commodity. azilsartan bears us nlm identifiers umls id c1958569 and nci concept code c75107. smiles: ccoc1=nc2=cc=cc(=c2n1cc3=cc=c(c=c3)c4=cc=cc=c4c5=nc(=o)on5)c(=o)o.. "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. irbesartan hydrochloride. this classification denotes an angiotensin ii receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3ogc31wumz. european medicines agency schedules irbesartan hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29917. irbesartan hydrochloride generally arises in the molecular formula c25h28n6o.clh. the term irbesartan hydrochloride is a european medicines agency european public assessment report system designation. most nations, for tariff and trade purposes, schedule irbesartan hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, irbesartan hydrochloride remains us fdas preferred term for this commodity. smiles: ccccc1=nc2(cccc2)c(=o)n1cc3ccc(cc3)c4ccccc4c5[nh]nnn5.cl.. "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. methyldopa anhydrous. this classification denotes a dopamine agonist and antihypertensive agent with the molecular formula c10h13no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m4r0h12f6m, chemically known as l-3-(3,4-dihydroxyphenyl)-2-methylalanine, but more generally known as methyldopa anhydrous, which bears us nih compound identifier 4138. european medicines agency schedules methyldopa anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08867mig. most nations, for tariff purposes, schedule methyldopa anhydrous under hs 29225000. smiles: c[c@](cc1ccc(c(c1)o)o)(c(=o)o)n.. "
"antihypertensive benzene derivatives and benzimidazoles and benzofurans and catecholamines. this classification denotes antihypertensives drugs made from or based in part on benzene derivatives, benzimidazoles, benzofurans, or catecholamines. methyldopa sesquihydrate. this classification denotes a dopamine agonist and antihypertensive agent with the molecular formula 2c10h13no4.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56lh93261y, chemically known as l-3-(3,4-dihydroxyphenyl)-2-methylalanine sesquihydrate, but more generally known as methyldopa sesquihydrate, which bears us nih compound identifier 38852. european medicines agency schedules methyldopa sesquihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08867mig. most nations, for tariff purposes, schedule methyldopa sesquihydrate under hs 29225000. smiles: c[c@](cc1ccc(c(c1)o)o)(c(=o)o)n.c[c@](cc1ccc(c(c1)o)o)(c(=o)o)n.o.o.o.. "
"antihypertensive alcohols. antihypertensive drugs made from alkyl compounds containing a hydroxyl group.. . "
"antihypertensive alcohols. antihypertensive drugs made from alkyl compounds containing a hydroxyl group.. candesartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c24h20n6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s8q36md2xx, chemically known as 1h-benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)- but generally known as candesartan, which bears us nih compound identifier 2541. candesartan most often comes in base, celexetil, and hexetil forms. european medicines agency schedules candesartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06070mig. the term candesartan is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules candesartan in its anatomical therapeutic chemical (atc) classification. most nations schedule candesartan under hs 29339990 and sitc 51577. as of q4 2014, candesartan remains the us fda preferred term for this commodity. candesartan bears us nlm identifiers umls id c0717550 and nci concept code c65284. smiles: o(c1n(cc2ccc(cc2)c2c(cccc2)c2n[nh]nn2)c2c(n1)cccc2c(=o)o)cc.. "
"antihypertensive alcohols. antihypertensive drugs made from alkyl compounds containing a hydroxyl group.. telmisartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c33h30n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u5syw473rq, chemically known as (1,1-biphenyl)-2-carboxylic acid, 4-((1,4-dimethyl-2-propyl(2,6-bi-1h-benzimidazol)-1-yl)methyl)- but generally known as telmisartan, which bears us nih compound identifier 65999. european medicines agency schedules telmisartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10874mig. the term telmisartan is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules telmisartan in its anatomical therapeutic chemical (atc) classification. telmisartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule telmisartan under hs 29339990 and sitc 51577. as of q4 2014, telmisartan remains the us fda preferred term for this commodity. telmisartan bears us nlm identifiers umls id c0248719 and nci concept code c47746. smiles: oc(=o)c1c(c2ccc(cn3c4c(nc3ccc)c(cc(c4)c3n(c4c(n3)cccc4)c)c)cc2)cccc1.. "
"antihypertensive alcohols. antihypertensive drugs made from alkyl compounds containing a hydroxyl group.. exaprolol. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h29no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, q4xx54i93r chemically known as 2-propanol, 1-(2-cyclohexylphenoxy)-3-((1-methylethyl)amino)-,(+/-)- but generally known as exaprolol, which bears us nih compound identifier 65485. european medicines agency schedules exaprolol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07491mig. the term exaprolol is an international non-proprietary name or inn. most nations schedule exaprolol under hs 29221980 and sitc 51461. as of q4 2014, exaprolol remains the us fda preferred term for this commodity. exaprolol bears us nlm identifiers umls id c0059928 and nci concept code c65609. smiles: cc(c)ncc(coc1=cc=cc=c1c2ccccc2)o.. "
"antihypertensive alcohols. antihypertensive drugs made from alkyl compounds containing a hydroxyl group.. candesartan cilexetil. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c33h34n6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r85m2x0d68, chemically known as 1h-benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)- but more generally known as candesartan cilexetil, which bears us nih compound identifier 2540. european medicines agency schedules candesartan cilexetil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13222mig. most nations, for tariff and trade purposes, schedule candesartan cilexetil under hs 29339990 and sitc 51577. as of q4 2014, candesartan cilexetil remains us fdas preferred term for this commodity. candesartan cilexetil bears us nlm identifiers umls id c0527379 and nci concept code c28903. smiles: ccoc1nc2cccc(c2n1cc3ccc(cc3)c4ccccc4c5[nh]nnn5)c(=o)oc(c)oc(=o)oc6ccccc6.. "
"antihypertensive alcohols. antihypertensive drugs made from alkyl compounds containing a hydroxyl group.. exaprolol hydrochloride. this classification denotes a beta-adrenergic blocking agent with the molecular formula c18h29no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fgt82hnc7l, chemically known as 2-propanol, 1-(2-cyclohexylphenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)- but more generally known as exaprolol hydrochloride, which bears us nih compound identifier 65484. most nations, for tariff and trade purposes, schedule exaprolol hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, exaprolol hydrochloride remains us fdas preferred term for this commodity. exaprolol hydrochloride bears us nlm identifiers umls id c0952592 and nci concept code c65610. smiles: cc(c)ncc(coc1ccccc1c2ccccc2)o.cl.. "
"antihypertensive alcohols. antihypertensive drugs made from alkyl compounds containing a hydroxyl group.. sapropterin. this classification denotes an antioxidant with the molecular formula c9h15n5o3, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier egx657432i, chemically known as 5,6,7,8-tetrahydrobiopterin but more generally known as sapropterin, which bears u.s. nih compound identifier 1125. european medicines agency schedules sapropterin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10445mig. the term sapropterin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules sapropterin in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. sapropterin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. . "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. sitaxentan. this classification denotes an endothelin-1 protein receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j9qh779mem. european medicines agency schedules sitaxentan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22917. sitaxentan generally arises in the molecular formula c18h15cln2o6s2. the term sitaxentan is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45.) most nations schedule sitaxentan under hs 29350090 and sitc 51580. as of q4 2014, sitaxentan remains the us fda preferred term for this commodity. sitaxentan bears us nlm identifiers umls id c1704271 and nci concept code c73038. smiles: cc1=cc2=c(c=c1cc(=o)c3=c(c=cs3)s(=o)(=o)nc4=c(c(=no4)c)cl)oco2.. "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. bencyclane. this classification denotes a calcium channel blocker with the molecular formula c19h31no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6i97z6s135, chemically known as 3-((1-benzylcycloheptyl)oxy)-n,n-dimethylpropylamin but generally known as bencyclane, which bears us nih compound identifier 2312. bencyclane most often comes in base and fumarate forms. european medicines agency schedules bencyclane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05705mig. the term bencyclane is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules bencyclane in its anatomical therapeutic chemical (atc) classification. bencyclane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bencyclane under hs 29221980 and sitc 51461. as of q4 2014, bencyclane remains the us fda preferred term for this commodity. bencyclane bears us nlm identifiers umls id c0004969 and nci concept code c74226. smiles: o(c1(cccccc1)cc1ccccc1)cccn(c)c.. "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. delapril. this classification denotes an ace inhibitor with the molecular formula c26h32n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w77ual9thi, chemically known as glycine, n-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, (s)- but generally known as delapril, which bears us nih compound identifier 5362116. european medicines agency schedules delapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06948mig. the term delapril is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules delapril in its anatomical therapeutic chemical (atc) classification. delapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule delapril under hs 29242995 and sitc 51479. as of q4 2014, delapril remains the us fda preferred term for this commodity. delapril bears us nlm identifiers umls id c0057301 and nci concept code c75022. smiles: o=c(n(c1cc2c(c1)cccc2)cc(=o)o)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. guggulsterone. this classification denotes an antihypertensive agent with the molecular formula c21h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 34969jx79r, chemically known as (8r,9s,10r,13s,14s,17e)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione, which bears us nih compound identifier 6439929. as of q4 2014, guggulsterone remains the us fda preferred term for this commodity. smiles: cc=c1c(=o)cc2c1(ccc3c2ccc4=cc(=o)ccc34c)c.. "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. bencyclane fumarate. this classification denotes a calcium channel blocker with the molecular structure c19h31no.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, ozn2mg334o chemically known as 3-((1-benzylcycloheptyl)oxy)-n,n-dimethylpropylamine fumarate, but more commonly known as bencyclane fumarate, which bears us nih compound identifier 5282403. european medicines agency schedules bencyclane fumarate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00695mig. most nations, for tariff and trade purposes, schedule bencyclane fumarate under hs 29221980 and sitc 51461. as of q4 2014, bencyclane fumarate remains us fdas preferred term for this commodity. bencyclane fumarate bears us nlm identifiers umls id c0813193 and nci concept code c73828. smiles: cn(c)cccoc1(cccccc1)cc2ccccc2.c(=c/c(=o)o)\\c(=o)o.. "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. delapril hydrochloride. this classification denotes an ace inhibitor with the molecular formula c26h32n2o5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2smm3m5zmh, chemically known as glycine, n-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, monohydrochloride, (s)- but more generally known as delapril hydrochloride, which bears us nih compound identifier 5362115. european medicines agency schedules delapril hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01574mig. most nations, for tariff and trade purposes, schedule delapril hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, delapril hydrochloride remains us fdas preferred term for this commodity. delapril hydrochloride bears us nlm identifiers umls id c2348090 and nci concept code c72734. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@@h](c)c(=o)n(cc(=o)o)c2cc3ccccc3c2.cl.. "
"antihypertensive cycloparaffins and indans and isoxazoles and pregnanes. this classification denotes antihypertensives drugs made from or based in part on cycloparaffins, indans, isoxazoles, or pregnanes. sitaxentan sodium. this classification denotes an endothelin-1 protein receptor antagonist c18h14cln2o6s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6v9jh46e20, chemically known as n-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-(2-(6-methyl-2h-1,3-benzodioxol-5-yl)acetyl)thiophene-3-sulfonamide sodium salt, but more generally known as sitaxentan sodium, which bears us nih compound identifier 11477084. european medicines agency schedules sitaxentan sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22351. most nations, for tariff and trade purposes, schedule sitaxentan sodium under hs 29350090 and sitc 51580. as of q4 2014, sitaxentan sodium remains us fdas preferred term for this commodity. smiles: cc1cc2c(cc1cc(=o)c3c(ccs3)s(=o)(=o)[n-]c4c(c(no4)c)cl)oco2.[na+].. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. . "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guabenxan. this classification denotes an antihypertensive agent with the molecular formula c10h13n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier saw16w26x6, chemically known as (1,4-benzodioxan-6-ylmethyl)guanidine but generally known as guabenxan, which bears us nih compound identifier 28563. european medicines agency schedules guabenxan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07967mig. the term guabenxan is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). guabenxan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule guabenxan under hs 29329985 and sitc 51569. as of q4 2014, guabenxan remains the us fda preferred term for this commodity. guabenxan bears us nlm identifiers umls id c0617438 and nci concept code c65820. smiles: c1coc2=c(o1)c=cc(=c2)cn=c(n)n.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanadrel. this classification denotes an antihypertensive agent with the molecular formula c10h19n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 765c9332t4, chemically known as (1,4-dioxaspiro(4.5)dec-2-ylmethyl)guanidine but generally known as guanadrel, which bears us nih compound identifier 38521. european medicines agency schedules guanadrel in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07980mig. the term guanadrel is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). guanadrel is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule guanadrel under hs 29329970 and sitc 51569. as of q4 2014, guanadrel remains the us fda preferred term for this commodity. guanadrel bears us nlm identifiers umls id c0061938 and nci concept code c65827. smiles: c1ccc2(cc1)occ(o2)cn=c(n)n.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanclofine. this classification denotes an antihypertensive agent with the molecular formula c9h12cl2n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 9d89762n7c chemically known as (2-(2,6-dichloroanilino)ethyl)guanidine but generally known as guanclofine, which bears us nih compound identifier 68754. european medicines agency schedules guanclofine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07983mig. the term guanclofine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16. ). most nations schedule guanclofine under hs 29252900 and sitc 51482. as of q4 2014, guanclofine remains the us fda preferred term for this commodity. guanclofine bears us nlm identifiers umls id c0061941 and nci concept code c65829. smiles: c1=cc(=c(c(=c1)cl)nccn=c(n)n)cl.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanethidine. this classification denotes an antihypertensive agent with the molecular formula c10h22n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zti6c33q2q, chemically known as 2-(1-n,n-heptamethyleneimino)ethylguanidine but generally known as guanethidine, which bears us nih compound identifier 3518. european medicines agency schedules guanethidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07984mig. the term guanethidine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules guanethidine in its anatomical therapeutic chemical (atc) classification. guanethidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule guanethidine under hs 29339990 and sitc 51577. as of q4 2014, guanethidine remains the us fda preferred term for this commodity. guanethidine bears us nlm identifiers umls id c0018318 and nci concept code c65830. smiles: c1cccn(ccc1)ccn=c(n)n.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanfacine. this classification denotes an antihypertensive agent and alpha-adrenergic agonist with the molecular formula c9h9cl2n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30omy4g3mk, chemically known as n-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide but generally known as guanfacine, which bears us nih compound identifier 3519. european medicines agency schedules guanfacine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07985mig. the term guanfacine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules guanfacine in its anatomical therapeutic chemical (atc) classification. guanfacine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule guanfacine under hs 29252900 and sitc 51482. as of q4 2014, guanfacine remains the us fda preferred term for this commodity. guanfacine bears us nlm identifiers umls id c0079466 and nci concept code c61779. smiles: clc1c(cc(=o)/n=c(/n)n)c(cl)ccc1.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanoclor. this classification denotes an antihypertensive agent with the molecular formula c9h12cl2n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m4hbt852yo, chemically known as 2-(2,6-dichlorophenoxy)ethylaminoguanidine sulfate but generally known as guanoclor, which bears us nih compound identifier 71835. european medicines agency schedules guanoclor in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07987mig. world health organization schedules guanoclor in its anatomical therapeutic chemical (atc) classification. guanoclor is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule guanoclor under hs 29280090 and sitc 51486. as of q4 2014, guanoclor remains the us fda preferred term for this commodity. guanoclor bears us nlm identifiers umls id c0061964 and nci concept code c65833. smiles: clc1c(occn/n=c(/n)n)c(cl)ccc1.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanoxyfen. this classification denotes an antihypertensive agent with the molecular formula c10h15n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 03hn50zaf0 chemically known as cn-34,799-5a but generally known as guanoxyfen, which bears us nih compound identifier 6332517. european medicines agency schedules guanoxyfen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07990mig. the term guanoxyfen is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7. ). most nations schedule guanoxyfen under hs 29252900 and sitc 51482. as of q4 2014, guanoxyfen remains the us fda preferred term for this commodity. guanoxyfen bears us nlm identifiers umls id c1881017 and nci concept code c65835. smiles: c1=cc=c(c=c1)occcn=c(n)n.[n+](=o)(o)o.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. pinacidil. this classification denotes an antihypertensive agent with the molecular formula c13h19n5.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7b0zzh8p2w, chemically known as 2-cyano-3-(4-pyridinyl)-1-(1,2,2-trimethylpropyl)guanidine but generally known as pinacidil, which bears us nih compound identifier 4826. european medicines agency schedules pinacidil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09848mig. world health organization schedules pinacidil in its anatomical therapeutic chemical (atc) classification. pinacidil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pinacidil under hs 29333999 and sitc 51574. as of q4 2014, pinacidil remains the us fda preferred term for this commodity. pinacidil bears us nlm identifiers umls id c0071074 and nci concept code c66387. smiles: n(=c(\\nc1ccncc1)nc#n)/c(c(c)(c)c)c.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanadrel sulfate. this classification denotes an antihypertensive agent with the molecular formula 2c10h19n3o2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mt147rmo91, chemically known as (1,4-dioxaspiro(4.5)dec-2-ylmethyl)guanidine but more generally known as guanadrel sulfate, which bears us nih compound identifier 38521. european medicines agency schedules guanadrel sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02424mig. most nations, for tariff and trade purposes, schedule guanadrel sulfate under hs 29329970 and sitc 51569. as of q4 2014, guanadrel sulfate remains us fdas preferred term for this commodity. guanadrel sulfate bears us nlm identifiers umls id c0304525 and nci concept code c65828. smiles: c1ccc2(cc1)occ(o2)cnc(=n)n.c1ccc2(cc1)occ(o2)cnc(=n)n.os(=o)(=o)o.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanethidine monosulfate. this classification denotes an antihypertensive agent with the molecular structure c10h22n4.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 5uby8y002g chemically known as guanidine, (2-(hexahydro-1(2h)-azocinyl)ethyl)-, sulfate (1:1), but more commonly known as guanethidine monosulfate, which bears us nih compound identifier 3518. european medicines agency schedules guanethidine monosulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14033mig. most nations, for tariff and trade purposes, schedule guanethidine monosulfate under hs 29339990 and sitc 51577. as of q4 2014, guanethidine monosulfate remains us fdas preferred term for this commodity. guanethidine monosulfate bears us nlm identifiers umls id c0282190 and nci concept code c65831. smiles: c1cccn(ccc1)ccnc(=n)n.os(=o)(=o)o.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanethidine sulfate. this classification denotes an antihypertensive agent with the molecular formula 2c10h22n4.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8aq60474g9, chemically known as 2-(1-n,n-heptamethyleneimino)ethylguanidine but more generally known as guanethidine sulfate, which bears us nih compound identifier 3518. european medicines agency schedules guanethidine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02426mig. most nations, for tariff and trade purposes, schedule guanethidine sulfate under hs 29339990 and sitc 51577. as of q4 2014, guanethidine sulfate remains us fdas preferred term for this commodity. guanethidine sulfate bears us nlm identifiers umls id c0700538 and nci concept code c80000. smiles: c1cccn(ccc1)ccnc(=n)n.c1cccn(ccc1)ccnc(=n)n.os(=o)(=o)o.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanfacine hydrochloride. this classification denotes an antihypertensive agent and alpha-adrenergic agonist with the molecular formula c9h9cl2n3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pml56a160o, chemically known as n-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide but more generally known as guanfacine hydrochloride, which bears us nih compound identifier 3519. european medicines agency schedules guanfacine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02427mig. most nations, for tariff and trade purposes, schedule guanfacine hydrochloride under hs 29252900 and sitc 51482. as of q4 2014, guanfacine hydrochloride remains us fdas preferred term for this commodity. guanfacine hydrochloride bears us nlm identifiers umls id c0700472 and nci concept code c47550. smiles: c1cc(c(c(c1)cl)cc(=o)nc(=n)n)cl.cl.. "
"antihypertensive guanidines. antihypertensive drugs made from a family of iminourea derivatives.. guanoclor sulfate. this classification denotes an antihypertensive agent with the molecular formula 2c9h12cl2n4o.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q1u97xk18r, chemically known as 2-(2,6-dichlorophenoxy)ethylaminoguanidine sulfate but more generally known as guanoclor sulfate, which bears us nih compound identifier 71835. european medicines agency schedules guanoclor sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14036mig. most nations, for tariff and trade purposes, schedule guanoclor sulfate under hs 29280090 and sitc 51486. as of q4 2014, guanoclor sulfate remains us fdas preferred term for this commodity. guanoclor sulfate bears us nlm identifiers umls id c1881016 and nci concept code c65834. smiles: c1cc(c(c(c1)cl)occnnc(=n)n)cl.c1cc(c(c(c1)cl)occnnc(=n)n)cl.os(=o)(=o)o.. "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. . "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. budralazine. this classification denotes an antihypertensive agent with the molecular formula c14h16n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s0177qhv2b, chemically known as 1(2h)-phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone but generally known as budralazine, which bears us nih compound identifier 6419536. budralazine most often comes in base and hydrochloride forms. european medicines agency schedules budralazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05958mig. the term budralazine is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). budralazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule budralazine under hs 29339990 and sitc 51577. as of q4 2014, budralazine remains the us fda preferred term for this commodity. budralazine bears us nlm identifiers umls id c0054203 and nci concept code c79901. smiles: n(/n=c(/c=c(/c)c)c)c1nncc2c1cccc2.. "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. dihydralazine. this classification denotes an antihypertensive agent and hydrazine with the molecular formula c8h10n6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pcu411f5l6, chemically known as 2,3-dihydro-1,4-phthalazinedione dihydrazone but generally known as dihydralazine, which bears us nih compound identifier 10230. european medicines agency schedules dihydralazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07137mig. world health organization schedules dihydralazine in its anatomical therapeutic chemical (atc) classification. dihydralazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dihydralazine under hs 29339990 and sitc 51577. as of q4 2014, dihydralazine remains the us fda preferred term for this commodity. dihydralazine bears us nlm identifiers umls id c0012271 and nci concept code c97307. smiles: n1nc(nn)c2c(c1nn)cccc2.. "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. dihydralazine hydrochloride. this classification denotes an antihypertensive agent with the molecular formula c8h10n6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ovg1tp7a10, chemically known as 2,3-dihydrophthalazine-1,4-dione dihydrazone monohydrochloride but more generally known as dihydralazine hydrochloride, which bears us nih compound identifier 198456. european medicines agency schedules dihydralazine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01701mig. most nations, for tariff and trade purposes, schedule dihydralazine hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, dihydralazine hydrochloride remains us fdas preferred term for this commodity. dihydralazine hydrochloride bears us nlm identifiers umls id c3273349 and nci concept code c97308. smiles: c1ccc2c(c1)c(nnc2nn)nn.cl.. "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. dihydralazine mesilate. this classification denotes an antihypertensive agent with the molecular formula c8h10n6.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9v8bvp5x5e. european medicines agency schedules dihydralazine mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20331. most nations, for tariff and trade purposes, schedule dihydralazine mesilate under hs 29339990 and sitc 51577. smiles: cs(=o)(=o)o.c1ccc2c(c1)c(nnc2nn)nn.. "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. dihydralazine sulfate. this classification denotes an antihypertensive agent with the molecular formula c8h10n6.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1c2b1w91nk, chemically known as 1,4-dihydrazinophthalazine sulfate but more generally known as dihydralazine sulfate, which bears us nih compound identifier 81764. european medicines agency schedules dihydralazine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01702mig. most nations, for tariff and trade purposes, schedule dihydralazine sulfate under hs 29339990 and sitc 51577. as of q4 2014, dihydralazine sulfate remains us fdas preferred term for this commodity. dihydralazine sulfate bears us nlm identifiers umls id c0011569 and nci concept code c81520. smiles: c1ccc2c(c1)c(nnc2nn)nn.os(=o)(=o)o.. "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. dihydralazine sulphate. this classification denotes an antihypertensive agent and hydrazine with the molecular formula c8h10n6.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1c2b1w91nk, chemically known as 1,4-dihydrazinophthalazine hydrogen sulfate, but more generally known as dihydralazine sulphate, which bears us nih compound identifier 81764. european medicines agency schedules dihydralazine sulphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07137mig. most nations, for tariff purposes, schedule dihydralazine sulphate under hs 29339990. smiles: c1ccc2c(c1)c(nnc2nn)nn.os(=o)(=o)o.. "
"antihypertensive hydralazines. antihypertensive drugs made from a direct-acting vasodilator, pyridazine, phthalazine, and hydrazinophthalazine, hence the name hydra-lazine, hydra-lazines, and hydralazine.. dihydralazine tartrate. this classification denotes an antihypertensive agent and hydrazine c8h10n6.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j9cb6k1n70, chemically known as 1,4-phthalazinedione, 2,3-dihydro-, dihydrazone, (2r,3r)-2,3-dihydroxybutanedioate (1:1), but more generally known as dihydralazine tartrate, which bears us nih compound identifier 56842459. european medicines agency schedules dihydralazine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01703mig. most nations, for tariff and trade purposes, schedule dihydralazine tartrate under hs 29339990 and sitc 51577. as of q4 2014, dihydralazine tartrate remains us fdas preferred term for this commodity. smiles: c1ccc2c(c1)c(nnc2nn)nn.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. . "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. ciprokiren. this classification denotes an antihypertensive agent with the molecular formula c37h55n5o8s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, k259z4o1b3 chemically known as (.alpha.s)-n-((1s,2r,3s)-1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl)-.alpha.-((.alpha.s)-.alpha.-(((1-methyl-1-(morpholinocarbonyl)ethyl)sulfonyl)methyl)hydrocinnamamido)imidazole-4-propionamide but generally known as ciprokiren, which bears us nih compound identifier 64925. european medicines agency schedules ciprokiren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07471mig. the term ciprokiren is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34. ). most nations schedule ciprokiren under hs 29349990 and sitc 51579. as of q4 2014, ciprokiren remains the us fda preferred term for this commodity. ciprokiren bears us nlm identifiers umls id c0251321 and nci concept code c79133. smiles: cc(c)(c(=o)n1ccocc1)s(=o)(=o)cc(cc2=cc=cc=c2)c(=o)nc(cc3=cn=cn3)c(=o)nc(cc4ccccc4)c(c(c5cc5)o)o.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. imidapril. this classification denotes an ace inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bw7h1tjs22. european medicines agency schedules imidapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08143mig. imidapril generally arises in the molecular formula c20h27n3o6. the term imidapril is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29.) imidapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imidapril under hs 29332990 and sitc 51573. as of q4 2014, imidapril remains the us fda preferred term for this commodity. imidapril bears us nlm identifiers umls id c0165703 and nci concept code c72908. smiles: o=c(n1c(cn(c1=o)c)c(=o)o)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. moxonidine. this classification denotes an antihypertensive agent with the molecular formula c9h12cln5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cc6x0l40gw, chemically known as 5-pyrimidinamine, 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl- (9ci) but generally known as moxonidine, which bears us nih compound identifier 4810. european medicines agency schedules moxonidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09092mig. the term moxonidine is an international non-proprietary name. world health organization schedules moxonidine in its anatomical therapeutic chemical (atc) classification. moxonidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moxonidine under hs 29335995 and sitc 51576. as of q4 2014, moxonidine remains the us fda preferred term for this commodity. moxonidine bears us nlm identifiers umls id c0066837 and nci concept code c87629. smiles: clc1nc(nc(oc)c1nc1=nccn1)c.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. imidaprilat. this classification denotes an ace inhibitor with the molecular formula c18h23n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wuu07y30ia, chemically known as 4-imidazolidinecarboxylic acid, 3-((2s)-2-(((1s)-1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, (4s)- but generally known as imidaprilat, which bears us nih compound identifier 5464344. european medicines agency schedules imidaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08144mig. the term imidaprilat is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). imidaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imidaprilat under hs 29332990 and sitc 51573. as of q4 2014, imidaprilat remains the us fda preferred term for this commodity. imidaprilat bears us nlm identifiers umls id c0246977 and nci concept code c65893. smiles: o=c(n1c(cn(c1=o)c)c(=o)o)c(nc(ccc1ccccc1)c(=o)o)c.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. losartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c22h23cln6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jms50mpo89, chemically known as 1h-imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1h-tetrazol-5-yl)(1,1- biphenyl)-4-yl)methyl)- but generally known as losartan, which bears us nih compound identifier 3961. european medicines agency schedules losartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08593mig. the term losartan is an international non-proprietary name. world health organization schedules losartan in its anatomical therapeutic chemical (atc) classification. losartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule losartan under hs 29332990 and sitc 51573. as of q4 2014, losartan remains the us fda preferred term for this commodity. losartan bears us nlm identifiers umls id c0126174 and nci concept code c66869. smiles: clc1nc(n(cc2ccc(cc2)c2c(cccc2)c2n[nh]nn2)c1co)cccc.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. olmesartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c29h30n6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6m97xtv3hd, chemically known as 1h-imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2-(1h-tetrazol-5-yl) (1,1-biphenyl)-4-yl)methyl)- but generally known as olmesartan, which bears us nih compound identifier 158781. european medicines agency schedules olmesartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20707. the term olmesartan is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules olmesartan in its anatomical therapeutic chemical (atc) classification. olmesartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule olmesartan under hs 29332990 and sitc 51573. as of q4 2014, olmesartan remains the us fda preferred term for this commodity. olmesartan bears us nlm identifiers umls id c1098320 and nci concept code c66253. smiles: oc(c1nc(n(c1c(=o)o)cc1ccc(cc1)c1c(cccc1)c1n[nh]nn1)ccc)(c)c.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. pratosartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c25h26n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 66vlq6e6dl. the term pratosartan is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47. ). most nations schedule pratosartan under hs 29339990 and sitc 51577. as of q4 2014, pratosartan remains the us fda preferred term for this commodity. pratosartan bears us nlm identifiers umls id c2347659 and nci concept code c72935. smiles: cccc1=nc2=c(n1cc3=cc=c(c=c3)c4=cc=cc=c4c5=nnn=n5)ccccc2=o.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. remikiren. this classification denotes a protease inhibitor and antihypertensive agent with the molecular formula c33h50n4o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lc7fbl96a4, chemically known as 1h-imidazole-4-propanamide, n-(1-(cyclohexylmethyl)-3-cyclopropyl-2,3-dihydroxypropyl)-alpha-((2-(((1,1-dimethylethyl)sulfonyl)methyl)-1-oxo-3-phenylpropyl)amino)-, (1s-(1r*(r*(r*)),2s*,3r*))- but generally known as remikiren, which bears us nih compound identifier 5462340. european medicines agency schedules remikiren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10273mig. the term remikiren is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules remikiren in its anatomical therapeutic chemical (atc) classification. remikiren is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule remikiren under hs 29332990 and sitc 51573. as of q4 2014, remikiren remains the us fda preferred term for this commodity. remikiren bears us nlm identifiers umls id c0209499 and nci concept code c73099. smiles: s(=o)(=o)(cc(c(=o)nc(c(=o)nc(c(o)c(o)c1cc1)cc1ccccc1)cc1[nh]cnc1)cc1ccccc1)c(c)(c)c.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. trimetaphan camsilate or trimethaphan camsylate. this classification denotes a nicotinic antagonist and antihypertensive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8w556014k9. european medicines agency schedules trimetaphan camsilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11305mig. trimetaphan camsilate generally arises in the molecular formula c22h25n2os.c10h15o4s. the term trimetaphan camsilate is an international non-proprietary name or inn. trimetaphan camsilate or trimethaphan camsylate bears us nlm identifiers umls id c0077158 and nci concept code c66639. smiles: [s]12c(c3n(c(=o)n(c3c1)cc1ccccc1)cc1ccccc1)ccc2.s(=o)(=o)(o)cc12c(c(cc1)cc2=o)(c)c.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. trimetaphan or trimethaphan. this classification denotes a nicotinic antagonist and antihypertensive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8w556014k9. european medicines agency schedules trimetaphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11305mig. trimetaphan camsilate generally arises in the molecular formula c22h25n2os.c10h15o4s. the term trimetaphan is an international non-proprietary name or inn. trimetaphan or trimethaphan bears us nlm identifiers umls id c0041040 and nci concept code c77369. smiles: c1cc2c3c(c[s+]2c1)n(c(=o)n3cc4=cc=cc=c4)cc5=cc=cc=c5.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. imidapril hydrochloride. this classification denotes an ace inhibitor with the molecular formula c20h27n3o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7nsf9gg1nu, chemically known as 4-imidazolidinecarboxylic acid, 3-((2s)-2-(((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, monohydrochloride, (4s)- but more generally known as imidapril hydrochloride, which bears us nih compound identifier 5485193. european medicines agency schedules imidapril hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02642mig. most nations, for tariff and trade purposes, schedule imidapril hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, imidapril hydrochloride remains us fdas preferred term for this commodity. imidapril hydrochloride bears us nlm identifiers umls id c0872994 and nci concept code c99550. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@@h](c)c(=o)n2[c@@h](cn(c2=o)c)c(=o)o.cl.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. imidapril monohydrochloride. this classification denotes an ace inhibitor with the molecular formula c20h27n3o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7nsf9gg1nu, chemically known as 3-((2s)-2-((1s)-n-(1-ethoxycarbonyl-3-phenylpropyl)amino)-propionyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid, hydrochloride-, 4s-, but more generally known as imidapril monohydrochloride, which bears us nih compound identifier 5485193. european medicines agency schedules imidapril monohydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08143mig. most nations, for tariff purposes, schedule imidapril monohydrochloride under hs 29332990. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@@h](c)c(=o)n2[c@@h](cn(c2=o)c)c(=o)o.cl.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. losartan potassium. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c22h22cln6o.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3st302b24a, chemically known as 2-butyl-4-chloro-1-(p-(o-1h-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt but more generally known as losartan potassium, which bears us nih compound identifier 60771. european medicines agency schedules losartan potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02974mig. most nations, for tariff and trade purposes, schedule losartan potassium under hs 29332990 and sitc 51573. as of q4 2014, losartan potassium remains us fdas preferred term for this commodity. losartan potassium bears us nlm identifiers umls id c0700492 and nci concept code c29165. smiles: ccccc1nc(c(n1cc2ccc(cc2)c3ccccc3c4[n-]nnn4)co)cl.[k+].. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. moxonidine hydrochloride. this classification denotes an antihypertensive agent with the molecular formula c9h12cln5o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5ryw07sk5e, chemically known as 4-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine hydrochloride, but more generally known as moxonidine hydrochloride, which bears us nih compound identifier 156339. european medicines agency schedules moxonidine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09092mig. most nations, for tariff purposes, schedule moxonidine hydrochloride under hs 29335995. smiles: cc1nc(c(c(n1)cl)nc2=nccn2)oc.cl.. "
"antihypertensive imidazoles. antihypertensive drugs made from compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons.. olmesartan medoxomil. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c29h30n6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6m97xtv3hd, chemically known as 1h-imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2-(1h-tetrazol-5-yl) (1,1-biphenyl)-4-yl)methyl)- but more generally known as olmesartan, which bears us nih compound identifier 158781. european medicines agency schedules olmesartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20707. the term olmesartan is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules olmesartan in its anatomical therapeutic chemical (atc) classification. olmesartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule olmesartan medoxomil under hs 29349990 and sitc 51579. as of q4 2014, olmesartan medoxomil remains us fdas preferred term for this commodity. olmesartan medoxomil bears us nlm identifiers umls id c0386393 and nci concept code c47640. smiles: cccc1nc(c(n1cc2ccc(cc2)c3ccccc3c4[nh]nnn4)c(=o)occ5c(oc(=o)o5)c)c(c)(c)o.. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. . "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. captopril. this classification denotes an ace inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9g64rsx1xd. european medicines agency schedules captopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06081mig. captopril generally arises in the molecular formula c9h15no3s. the term captopril is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18.) captopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule captopril under hs 29339990 and sitc 51577. as of q4 2014, captopril remains the us fda preferred term for this commodity. captopril bears us nlm identifiers umls id c0006938 and nci concept code c340. smiles: scc(c(=o)n1c(ccc1)c(=o)o)c.. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. moveltipril. this classification denotes an ace inhibitor with the molecular formula c19h30n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lqi0441316, chemically known as (-)-1-((2s)-3-mercapto-2-methylpropionyl)-l-proline, ester with n-(cyclohexyl-carbonyl)thio-d-alanine. but generally known as moveltipril, which bears us nih compound identifier 5745793. european medicines agency schedules moveltipril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09078mig. the term moveltipril is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). moveltipril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule moveltipril under hs 29339990 and sitc 51577. as of q4 2014, moveltipril remains the us fda preferred term for this commodity. moveltipril bears us nlm identifiers umls id c2981287 and nci concept code c87574. smiles: s(cc(c(=o)n1c(ccc1)c(=o)o)c)c(=o)c(nc(=o)c1ccccc1)c.. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. zofenopril. this classification denotes an ace inhibitor with the molecular formula c22h23no4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 290zy759pi chemically known as r-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, (1(r*),2.alpha.,4.alpha.)- but generally known as zofenopril, which bears us nih compound identifier 92400. european medicines agency schedules zofenopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00170mig. the term zofenopril is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24. ). most nations schedule zofenopril under hs 29339990 and sitc 51577. as of q4 2014, zofenopril remains the us fda preferred term for this commodity. zofenopril bears us nlm identifiers umls id c0078836 and nci concept code c82219. smiles: cc(csc(=o)c1=cc=cc=c1)c(=o)n2cc(cc2c(=o)o)sc3=cc=cc=c3.. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. zofenoprilat. this classification denotes an ace inhibitor with the molecular formula c15h19no3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4g4wdk2ybs, chemically known as (2s,4s)-1-[(2s)-2-methyl-3-sulfanylpropanoyl]-4-phenylsulfanylpyrrolidine-2-carboxylic acid but generally known as zofenoprilat, which bears us nih compound identifier 3034048. european medicines agency schedules zofenoprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00171mig. most nations schedule zofenoprilat under hs 29339990 and sitc 51577. as of q4 2014, zofenoprilat remains the us fda preferred term for this commodity. zofenoprilat bears us nlm identifiers umls id c0085065 and nci concept code c95293. smiles: cc(cs)c(=o)n1cc(cc1c(=o)o)sc2=cc=cc=c2.. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. captopril disulfide. this classification denotes an ace inhibitor with the molecular formula c18h28n2o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y21d2c2453, chemically known as l-proline, 1,1-(dithiobis(2-methyl-1-oxo-3,1-propanediyl))bis-, (s-(r*,r*))-, but more generally known as captopril disulfide, which bears us nih compound identifier 163066. european medicines agency schedules captopril disulfide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06081mig. most nations, for tariff purposes, schedule captopril disulfide under hs 29339990. smiles: c[c@h](cssc[c@@h](c)c(=o)n1ccc[c@h]1c(=o)o)c(=o)n2ccc[c@h]2c(=o)o.. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. moveltipril calcium. this classification denotes an ace inhibitor with the molecular formula 2c19h29n2o5s.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sb44s25he5, chemically known as l-proline, n-(cyclohexylcarbonyl)-d-alanyl-(2s)-3-mercapto-2-methylpropanoyl-, calcium salt (2:1), but more generally known as moveltipril calcium, which bears us nih compound identifier 6336573. european medicines agency schedules moveltipril calcium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09078mig. most nations, for tariff purposes, schedule moveltipril calcium under hs 29339990. smiles: c[c@h](csc(=o)[c@@h](c)nc(=o)c1ccccc1)c(=o)n2ccc[c@h]2c(=o)[o-].c[c@h](csc(=o)[c@@h](c)nc(=o)c1ccccc1)c(=o)n2ccc[c@h]2c(=o)[o-].[ca+2].. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. zofenopril calcium. this classification denotes an ace inhibitor with the molecular formula 2c22h22no4s2.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88zq329pu2, chemically known as l-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, calcium salt, (1(r*),2alpha,4alpha)- but more generally known as zofenopril calcium, which bears us nih compound identifier 3033690. european medicines agency schedules zofenopril calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05191mig. most nations, for tariff and trade purposes, schedule zofenopril calcium under hs 29339990 and sitc 51577. as of q4 2014, zofenopril calcium remains us fdas preferred term for this commodity. zofenopril calcium bears us nlm identifiers umls id c0873162 and nci concept code c82220. smiles: c[c@h](csc(=o)c1ccccc1)c(=o)n2c[c@h](c[c@h]2c(=o)[o-])sc3ccccc3.c[c@h](csc(=o)c1ccccc1)c(=o)n2c[c@h](c[c@h]2c(=o)[o-])sc3ccccc3.[ca+2].. "
"antihypertensive imino acids. antihypertensive drugs made from secondary amino acids and carboxylic acids.. zofenoprilat arginine. this classification denotes an ace inhibitor with the molecular formula c15h19no3s2.c6h14n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 36f26zsq0d. the term zofenoprilat arginine is a united states adopted name designation. most nations, for tariff and trade purposes, schedule zofenoprilat arginine under hs 29339990 and sitc 51577. as of q4 2014, zofenoprilat arginine remains us fdas preferred term for this commodity. zofenoprilat arginine bears us nlm identifiers umls id c0646135 and nci concept code c66700. smiles: c[c@h](cs)c(=o)n1c[c@h](c[c@h]1c(=o)o)sc2ccccc2.c(c[c@@h](c(=o)o)n)cnc(=n)n.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. . "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. mecarbinate. this classification denotes an antihypertensive agent with the molecular formula c13h15no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z927x3uj2w, chemically known as 1,2-dimethyl-3-carbethoxy- 5-hydroxyindole but generally known as mecarbinate, which bears us nih compound identifier 616236. european medicines agency schedules mecarbinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08671mig. the term mecarbinate is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8). mecarbinate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mecarbinate under hs 29339990 and sitc 51577. as of q4 2014, mecarbinate remains the us fda preferred term for this commodity. mecarbinate bears us nlm identifiers umls id c0065838 and nci concept code c66065. smiles: o(c(=o)c1c2c(n(c1c)c)ccc(o)c2)cc.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. pentopril. this classification denotes an ace inhibitor with the molecular formula c18h23no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z99269057a, chemically known as 1h-indole-1-pentanoic acid, 2-carboxy-2,3-dihydro-alpha,gamma-dimethyl-delta-oxo-, ethyl ester, (2s-(1(alphas*,gammas*),2r*))- but generally known as pentopril, which bears us nih compound identifier 54938. european medicines agency schedules pentopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09702mig. the term pentopril is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). pentopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pentopril under hs 29339990 and sitc 51577. as of q4 2014, pentopril remains the us fda preferred term for this commodity. pentopril bears us nlm identifiers umls id c0135946 and nci concept code c72909. smiles: o=c(n1c(cc2c1cccc2)c(=o)o)c(cc(c)c(=o)occ)c.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. perindopril. this classification denotes an ace inhibitor with the molecular formula c19h32n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y5gmk36kgy, chemically known as 11h-indole-2-carboxylic acid, octahydro-1-(2-((1-ethoxycarbonyl)butyl)amino)-1-oxopropyl)-, (2s-(1(r*(r*)),2-alpha,3a-beta,7a-beta))- but generally known as perindopril, which bears us nih compound identifier 60184. european medicines agency schedules perindopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09730mig. the term perindopril is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules perindopril in its anatomical therapeutic chemical (atc) classification. perindopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule perindopril under hs 29339990 and sitc 51577. as of q4 2014, perindopril remains the us fda preferred term for this commodity. perindopril bears us nlm identifiers umls id c0136123 and nci concept code c72910. smiles: o=c(n1c2c(cc1c(=o)o)cccc2)c(nc(ccc)c(=o)occ)c.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. perindoprilat. this classification denotes an ace inhibitor with the molecular formula c17h28n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2uv6znq92k, chemically known as 1h-indole-2-carboxylic acid, octahydro-1-(2-((1-carboxybutyl)amino)-1-oxopropyl)-, (2s-(1(r*(r*)),2-alpha,3a-beta,7a-beta))- but generally known as perindoprilat, which bears us nih compound identifier 72022. european medicines agency schedules perindoprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09731mig. the term perindoprilat is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). perindoprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule perindoprilat under hs 29339990 and sitc 51577. as of q4 2014, perindoprilat remains the us fda preferred term for this commodity. perindoprilat bears us nlm identifiers umls id c0070426 and nci concept code c66357. smiles: o=c(n1c2c(cc1c(=o)o)cccc2)c(nc(ccc)c(=o)o)c.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. trandolapril. this classification denotes an ace inhibitor with the molecular formula c24h34n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1t0n3g9crc, chemically known as 1h-indole-2-carboxylic acid, octahydro-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, (2s-(1(r*(r*)),2-alpha,3a-alpha,7a-beta))- but generally known as trandolapril, which bears us nih compound identifier 5484727. european medicines agency schedules trandolapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11212mig. the term trandolapril is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules trandolapril in its anatomical therapeutic chemical (atc) classification. trandolapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trandolapril under hs 29339990 and sitc 51577. as of q4 2014, trandolapril remains the us fda preferred term for this commodity. trandolapril bears us nlm identifiers umls id c0076891 and nci concept code c61978. smiles: o=c(n1c2c(cc1c(=o)o)cccc2)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. trandolaprilat. this classification denotes an ace inhibitor with the molecular formula c22h30n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rr6866vl0o, chemically known as 1h-indol-2-carboxylic acid, 1-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)octahydro- but generally known as trandolaprilat, which bears us nih compound identifier 128549. european medicines agency schedules trandolaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11213mig. the term trandolaprilat is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). trandolaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trandolaprilat under hs 29339990 and sitc 51577. as of q4 2014, trandolaprilat remains the us fda preferred term for this commodity. trandolaprilat bears us nlm identifiers umls id c0165477 and nci concept code c72913. smiles: o=c(n1c2c(cc1c(=o)o)cccc2)c(nc(ccc1ccccc1)c(=o)o)c.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. vintoperol. this classification denotes a calcium channel blocker with the molecular formula c18h24n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier is7c3gtw01, chemically known as 21-nor-1,14-secoeburnamenin-20-ol, 14,15-dihydro-, (3-alpha,16-alpha)- but generally known as vintoperol, which bears us nih compound identifier 65893. european medicines agency schedules vintoperol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00074mig. the term vintoperol is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). vintoperol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vintoperol under hs 29339990 and sitc 51577. as of q4 2014, vintoperol remains the us fda preferred term for this commodity. vintoperol bears us nlm identifiers umls id c0084969 and nci concept code c76585. smiles: occ1(c2n(ccc1)ccc1c2[nh]c2c1cccc2)cc.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. methoserpidine. this classification denotes an antiadrenergic agent with the molecular formula c33h40n2o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8f8c1jqh53, chemically known as (-)-10-methoxydeserpidine but generally known as methoserpidine, which bears us nih compound identifier 297930. the term methoserpidine is an international non-proprietary name or inn. european medicines agency schedules methoserpidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08855mig. most nations schedule methoserpidine under hs 29399900 and sitc 54149. as of q4 2014, methoserpidine remains the us fda preferred term for this commodity. smiles: coc1c(cc2cn3ccc4=c(c3cc2c1c(=o)oc)nc5=c4c=c(c=c5)oc)oc(=o)c6=cc(=c(c(=c6)oc)oc)oc.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. oxprenoate. this classification denotes an antihypertensive agent with the molecular formula c25h38o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2jgy63uvro, chemically known as 3-[(7r,8r,9s,10r,13s,14s,17r)-17-hydroxy-10,\\13-dimethyl-3-oxo-7-propyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl]propanoate but generally known as oxprenoate, which bears us nih compound identifier 23677972. european medicines agency schedules oxprenoate potassium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09554mig. the term oxprenoate is an international non-proprietary name. as of q4 2014, oxprenoate remains the us fda preferred term for this commodity. oxprenoate bears us nlm identifiers umls id c2981339 and nci concept code c87707. smiles: cccc1cc2=cc(=o)ccc2(c3c1c4ccc(c4(cc3)c)(ccc(=o)[o-])o)c.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. perindopril arginine. this classification denotes an ace inhibitor c19h32n2o5.c6h14n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tft5im1kgb, chemically known as l-arginine, (2s,3as,7as)-1-((2s)-2-(((1s)-1-(ethoxycarbonyl)butyl]amino)-1-oxopropyl)octahydro-1h-indole-2-carboxylate (1:1), but more generally known as perindopril arginine, which bears us nih compound identifier 12068809. european medicines agency schedules perindopril arginine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23191. most nations, for tariff and trade purposes, schedule perindopril arginine under hs 29339990 and sitc 51577. as of q4 2014, perindopril arginine remains us fdas preferred term for this commodity. smiles: ccc[c@@h](c(=o)occ)n[c@@h](c)c(=o)n1[c@h]2cccc[c@h]2c[c@h]1c(=o)o.c(c[c@@h](c(=o)o)n)cnc(=n)n.. "
"antihypertensive indoles. antihypertensive drugs made from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to isoindoles which have the nitrogen away from the six-membered ring.. perindopril erbumine. this classification denotes an ace inhibitor with the molecular formula c19h32n2o5.c4h11n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1964x464oj, chemically known as 1h-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-, (2s-(1(r*(r*)),2alpha,3abeta,7abeta))-, compd. with 2-methyl-2-propanamine (1:1) but more generally known as perindopril erbumine, which bears us nih compound identifier 60183. european medicines agency schedules perindopril erbumine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03711mig. most nations, for tariff and trade purposes, schedule perindopril erbumine under hs 29339990 and sitc 51577. as of q4 2014, perindopril erbumine remains us fdas preferred term for this commodity. perindopril erbumine bears us nlm identifiers umls id c0244718 and nci concept code c47666. smiles: ccc[c@@h](c(=o)occ)n[c@@h](c)c(=o)n1[c@h]2cccc[c@h]2c[c@h]1c(=o)o.cc(c)(c)n.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. . "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. lidoflazine. this classification denotes a calcium channel blocker with the molecular formula c30h35f2n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j4zhn3hbte, chemically known as 4-(4,4-bis(p-fluorophenyl)butyl)-1-piperazineaceto-2,6-xylidide but generally known as lidoflazine, which bears us nih compound identifier 3926. european medicines agency schedules lidoflazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08509mig. the term lidoflazine is an international non-proprietary name. world health organization schedules lidoflazine in its anatomical therapeutic chemical (atc) classification. lidoflazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lidoflazine under hs 29335995 and sitc 51576. as of q4 2014, lidoflazine remains the us fda preferred term for this commodity. lidoflazine bears us nlm identifiers umls id c0023665 and nci concept code c81685. smiles: fc1ccc(c(cccn2ccn(cc2)cc(=o)nc2c(cccc2c)c)c2ccc(f)cc2)cc1.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. terciprazine. this classification denotes an antihypertensive agent with the molecular formula c22h29f3n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tce6830h8p, chemically known as (+-)-alpha-(((1-ethynylcyclohexyl)oxy)methyl)-4-(alpha,alpha,alpha-trifluoro-m-tolyl)-1-piperazineethanol but generally known as terciprazine, which bears us nih compound identifier 68763. european medicines agency schedules terciprazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10916mig. the term terciprazine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). terciprazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terciprazine under hs 29335995 and sitc 51576. as of q4 2014, terciprazine remains the us fda preferred term for this commodity. terciprazine bears us nlm identifiers umls id c0610726 and nci concept code c90734. smiles: fc(f)(f)c1cc(n2ccn(cc(o)coc3(ccccc3)c#c)cc2)ccc1.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. zankiren. this classification denotes an antihypertensive agent with the molecular formula c35h55n5o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i36b16a34q, chemically known as 4-thiazolepropanamide, n-((1s,2r,3s)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-alpha-(((2s)-2-(((4-methyl-1-piperazinyl)sulfonyl)methyl)-1-oxo-3-phenylpropyl)amino)-, (alphas)- but generally known as zankiren, which bears us nih compound identifier 3036088. european medicines agency schedules zankiren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00138mig. the term zankiren is an international non-proprietary name. zankiren is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zankiren under hs 29341000 and sitc 51579. as of q4 2014, zankiren remains the us fda preferred term for this commodity. zankiren bears us nlm identifiers umls id c2987041 and nci concept code c95290. smiles: s(=o)(=o)(n1ccn(cc1)c)cc(c(=o)nc(c(=o)nc(cc1ccccc1)c(o)c(o)cc(c)c)cc1ncsc1)cc1ccccc1.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. monatepil. this classification denotes a calcium channel blocker with the molecular formula c28h30fn3os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, n4mmi0j7pw chemically known as 1-piperazinebutanamide, n-(6,11-dihydrodibenzo(b,e)thiepin-11-yl)-4-(4-fluorophenyl) but generally known as monatepil, which bears us nih compound identifier 5282401. european medicines agency schedules monatepil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09047mig. the term monatepil is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). most nations schedule monatepil under hs 29349990 and sitc 51579. as of q4 2014, monatepil remains the us fda preferred term for this commodity. monatepil bears us nlm identifiers umls id cl412665 and nci concept code c83970. smiles: c1cn(ccn1cccc(=o)nc2c3=cc=cc=c3csc4=cc=cc=c24)c5=cc=c(c=c5)f.c(=c\\c(=o)o)\\c(=o)o.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. naftopidil. this classification denotes an antiplatelet agent and alpha-adrenergic blocking agent with the molecular formula c24h28n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r9phw59sfn, chemically known as 1-pioerazineethanol, 4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)- but generally known as naftopidil, which bears us nih compound identifier 4418. european medicines agency schedules naftopidil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09132mig. the term naftopidil is an international non-proprietary name. naftopidil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule naftopidil under hs 29335995 and sitc 51576. as of q4 2014, naftopidil remains the us fda preferred term for this commodity. naftopidil bears us nlm identifiers umls id c0083701 and nci concept code c72927. smiles: oc(cn1ccn(cc1)c1c(oc)cccc1)coc1c2c(ccc1)cccc2.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. eplerenone. this classification denotes a steroid compound and antihypertensive agent with the molecular formula c24h30o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6995v82d0b, chemically known as 9,11alpha-epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, methyl ester but generally known as eplerenone, which bears us nih compound identifier 150310. european medicines agency schedules eplerenone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06574mig. the term eplerenone is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 1 1998, list 39). world health organization schedules eplerenone in its anatomical therapeutic chemical (atc) classification. eplerenone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eplerenone under hs 29372900 and sitc 54153. as of q4 2014, eplerenone remains the us fda preferred term for this commodity. eplerenone bears us nlm identifiers umls id c0961485 and nci concept code c47513. smiles: o1c23c(c4c(cc12)(c1(oc(=o)cc1)cc4)c)c(cc1=cc(=o)ccc31c)c(=o)oc.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. monatepil maleate. this classification denotes a calcium channel blocker with the molecular formula c28h30fn3os.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w456i35skd. the term monatepil maleate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule monatepil maleate under hs 29349990 and sitc 51579. as of q4 2014, monatepil maleate remains us fdas preferred term for this commodity. monatepil maleate bears us nlm identifiers umls id c0246444 and nci concept code c81688. smiles: c1ccc2c(c1)csc3ccccc3c2nc(=o)cccn4ccn(cc4)c5ccc(cc5)f.c(=c\\c(=o)o)\\c(=o)o.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. naftopidil dihydrochloride. this classification denotes an antiplatelet agent and alpha-adrenergic blocking agent with the molecular formula c24h28n2o3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6i80e37jbe, chemically known as naftopidil dihydrochloride, (+/-)-, but more generally known as naftopidil dihydrochloride, which bears us nih compound identifier 6603044. european medicines agency schedules naftopidil dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09132mig. most nations, for tariff purposes, schedule naftopidil dihydrochloride under hs 29335995. smiles: coc1ccccc1n2ccn(cc2)cc(coc3cccc4c3cccc4)o.cl.cl.. "
"antihypertensive piperazines. antihypertensive drugs made from organic compounds composed of a six-membered ring containing two nitrogen atoms at opposite positions (hexa-hydro-pyrazine(s)).. zankiren hydrochloride. this classification denotes the hydrochloride form of an antihypertensive agent with the molecular formula c35h55n5o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i36b16a34q, chemically known as 4-thiazolepropanamide, n-((1s,2r,3s)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-alpha-(((2s)-2-(((4-methyl-1-piperazinyl)sulfonyl)methyl)-1-oxo-3-phenylpropyl)amino)-, (alphas)- but more generally known as zankiren, which bears us nih compound identifier 3036088. european medicines agency schedules zankiren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00138mig. the term zankiren is an international non-proprietary name. zankiren is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule zankiren hydrochloride under hs 29341000 and sitc 51579. as of q4 2014, zankiren hydrochloride remains us fdas preferred term for this commodity. zankiren hydrochloride bears us nlm identifiers umls id c0936138 and nci concept code c95292. smiles: cc(c)c[c@@h]([c@@h]([c@h](cc1ccccc1)nc(=o)[c@h](cc2cscn2)nc(=o)[c@h](cc3ccccc3)cs(=o)(=o)n4ccn(cc4)c)o)o.cl.. "
"antihypertensive bicyclo compounds. antihypertensive drugs made from bridged compounds, two-fused-ring, cyclic hydrocarbons, many of which are -anes, built of cyclohexane and/or cyclopentane, e.g., bicyclo[4.4.0]decane and bicyclo[2.2.1]heptane. . "
"antihypertensive bicyclo compounds. antihypertensive drugs made from bridged compounds, two-fused-ring, cyclic hydrocarbons, many of which are -anes, built of cyclohexane and/or cyclopentane, e.g., bicyclo[4.4.0]decane and bicyclo[2.2.1]heptane. nicaraven. this classification denotes a calcium channel blocker with the molecular formula c15h16n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ud8pev6jbd, chemically known as 1,2-bis(nicotinamido)propane but generally known as nicaraven, which bears us nih compound identifier 71234. european medicines agency schedules nicaraven in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09224mig. the term nicaraven is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). nicaraven is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nicaraven under hs 29333999 and sitc 51574. as of q4 2014, nicaraven remains the us fda preferred term for this commodity. nicaraven bears us nlm identifiers umls id c0043778 and nci concept code c76580. smiles: o=c(nc(cnc(=o)c1cccnc1)c)c1cccnc1.. "
"antihypertensive bicyclo compounds. antihypertensive drugs made from bridged compounds, two-fused-ring, cyclic hydrocarbons, many of which are -anes, built of cyclohexane and/or cyclopentane, e.g., bicyclo[4.4.0]decane and bicyclo[2.2.1]heptane. zabicipril. this classification denotes an ace inhibitor with the molecular formula c23h32n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 475035ss4c, chemically known as (3s)-2-((2s)-n-((1s)-1-carboxy-3-phenylpropyl)alanyl)-2-azabicyclo(2.2.2)octane-3-carboxylic acid, 1-ethyl ester but generally known as zabicipril, which bears us nih compound identifier 71262. european medicines agency schedules zabicipril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00125mig. the term zabicipril is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). zabicipril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zabicipril under hs 29333999 and sitc 51574. as of q4 2014, zabicipril remains the us fda preferred term for this commodity. zabicipril bears us nlm identifiers umls id c0085048 and nci concept code c82218. smiles: oc(=o)c1n(c2ccc1cc2)c(=o)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive bicyclo compounds. antihypertensive drugs made from bridged compounds, two-fused-ring, cyclic hydrocarbons, many of which are -anes, built of cyclohexane and/or cyclopentane, e.g., bicyclo[4.4.0]decane and bicyclo[2.2.1]heptane. zabiciprilat. this classification denotes an ace inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0a2d355316. european medicines agency schedules zabiciprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00126mig. zabiciprilat generally arises in the molecular formula c21h28n2o5. the term zabiciprilat is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31.) zabiciprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zabiciprilat under hs 29333999 and sitc 51574. as of q4 2014, zabiciprilat remains the us fda preferred term for this commodity. zabiciprilat bears us nlm identifiers umls id c0165809 and nci concept code c66678. smiles: oc(=o)c1n(c2ccc1cc2)c(=o)c(nc(ccc1ccccc1)c(=o)o)c.. "
"antihypertensive bicyclo compounds. antihypertensive drugs made from bridged compounds, two-fused-ring, cyclic hydrocarbons, many of which are -anes, built of cyclohexane and/or cyclopentane, e.g., bicyclo[4.4.0]decane and bicyclo[2.2.1]heptane. flordipine. this classification denotes a calcium channel blocker with the molecular formula c26h33f3n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z8ufi7xi7r, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-1-(2-(4-morpholinyl)ethyl)-4-(2-(trifluoromethyl)phenyl)-, diethyl ester but generally known as flordipine, which bears us nih compound identifier 53699. european medicines agency schedules flordipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07649mig. the term flordipine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). flordipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flordipine under hs 29349990 and sitc 51579. as of q4 2014, flordipine remains the us fda preferred term for this commodity. flordipine bears us nlm identifiers umls id c0060464 and nci concept code c81689. smiles: fc(f)(f)c1c(c2c(=c(n(ccn3ccocc3)c(=c2c(=o)occ)c)c)c(=o)occ)cccc1.. "
"antihypertensive bicyclo compounds. antihypertensive drugs made from bridged compounds, two-fused-ring, cyclic hydrocarbons, many of which are -anes, built of cyclohexane and/or cyclopentane, e.g., bicyclo[4.4.0]decane and bicyclo[2.2.1]heptane. ramipril. this classification denotes an ace inhibitor with the molecular formula c23h32n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l35jn3i7sj, chemically known as cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2s-(1(r*(r*)),2alpha,3abeta,6abeta))- but generally known as ramipril, which bears us nih compound identifier 5362129. european medicines agency schedules ramipril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10248mig. the term ramipril is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules ramipril in its anatomical therapeutic chemical (atc) classification. ramipril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ramipril under hs 29339990 and sitc 51577. as of q4 2014, ramipril remains the us fda preferred term for this commodity. ramipril bears us nlm identifiers umls id c0072973 and nci concept code c29411. smiles: o=c(n1c2c(cc1c(=o)o)ccc2)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive bicyclo compounds. antihypertensive drugs made from bridged compounds, two-fused-ring, cyclic hydrocarbons, many of which are -anes, built of cyclohexane and/or cyclopentane, e.g., bicyclo[4.4.0]decane and bicyclo[2.2.1]heptane. ramiprilat. this classification denotes an ace inhibitor with the molecular formula c21h28n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6n5u4qfc3g, chemically known as (2s,3as,6as)-1-((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid but generally known as ramiprilat, which bears us nih compound identifier 5464096. european medicines agency schedules ramiprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10249mig. the term ramiprilat is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). ramiprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ramiprilat under hs 29339990 and sitc 51577. as of q4 2014, ramiprilat remains the us fda preferred term for this commodity. ramiprilat bears us nlm identifiers umls id c0072970 and nci concept code c72911. smiles: o=c(n1c2c(cc1c(=o)o)ccc2)c(nc(ccc1ccccc1)c(=o)o)c.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. . "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. saralasin. this classification denotes an antihypertensive agent with the molecular formula c42h65n13o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h2afv2he66, chemically known as angiotensin ii, 1-(n-methylglycine)-5-l-valine-8-l-alanine- but generally known as saralasin, which bears us nih compound identifier 36736. european medicines agency schedules saralasin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10447mig. the term saralasin is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). saralasin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule saralasin under hs 29371900 and sitc 54154. as of q4 2014, saralasin remains the us fda preferred term for this commodity. saralasin bears us nlm identifiers umls id c0036193 and nci concept code c66527. smiles: o=c(n1c(ccc1)c(=o)nc(c)c(=o)o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)cnc)ccc/n=c(/n)n)c(c)c)cc1ccc(o)cc1)c(c)c)cc1[nh]cnc1.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. ditekiren. this classification denotes an antihypertensive agent with the molecular formula c50h75n9o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5355s3w1is, chemically known as tert-butyl (2s)-2-(((alphas)-alpha-(((1s)-1-(((1s,2s,4s)-2-hydroxy-1-isobutyl-5-methyl-4-(((1s,2s)-2-methyl-1-((2-pyridylmethyl)carbamoyl)butyl)carbamoyl)hexyl)carbamoyl)-2-imidazol-4-ylethyl)methylcarbamoyl)phenethyl)carbamoyl)-1-pyrrolidinecarboxylate but generally known as ditekiren, which bears us nih compound identifier 5464201. european medicines agency schedules ditekiren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06329mig. the term ditekiren is an international non-proprietary name. ditekiren is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ditekiren under hs 29333999 and sitc 51574. as of q4 2014, ditekiren remains the us fda preferred term for this commodity. ditekiren bears us nlm identifiers umls id c0077636 and nci concept code c95291. smiles: oc(c(nc(=o)c(n(c(=o)c(nc(=o)c1n(ccc1)c(=o)oc(c)(c)c)cc1ccccc1)c)cc1[nh]cnc1)cc(c)c)cc(c(c)c)c(=o)nc(c(cc)c)c(=o)ncc1ncccc1.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. enalapril. this classification denotes an ace inhibitor with the molecular formula c20h28n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 69pn84io1a, chemically known as l-proline, n-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl- but generally known as enalapril, which bears us nih compound identifier 5362032. european medicines agency schedules enalapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06514mig. the term enalapril is an international non-proprietary name. world health organization schedules enalapril in its anatomical therapeutic chemical (atc) classification. enalapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enalapril under hs 29339990 and sitc 51577. as of q4 2014, enalapril remains the us fda preferred term for this commodity. enalapril bears us nlm identifiers umls id c0014025 and nci concept code c62027. smiles: o=c(n1c(ccc1)c(=o)o)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. enalaprilat. this classification denotes an ace inhibitor with the molecular formula c18h24n2o5.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gv0o7es0r3, chemically known as l-proline, n-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl- but generally known as enalaprilat, which bears us nih compound identifier 5362032. european medicines agency schedules enalaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06515mig. enalaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enalaprilat under hs 29339990 and sitc 51577. as of q4 2014, enalaprilat remains the us fda preferred term for this commodity. enalaprilat bears us nlm identifiers umls id c0014027 and nci concept code c47510. smiles: o=c(n1c(ccc1)c(=o)o)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. lisinopril. this classification denotes an ace inhibitor with the molecular formula c21h31n3o5.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e7199s1ywr, chemically known as l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-, dihydrate, (s)- but generally known as lisinopril, which bears us nih compound identifier 5362118. european medicines agency schedules lisinopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08533mig. world health organization schedules lisinopril in its anatomical therapeutic chemical (atc) classification. lisinopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lisinopril under hs 29339990 and sitc 51577. as of q4 2014, lisinopril remains the us fda preferred term for this commodity. lisinopril bears us nlm identifiers umls id c0065374 and nci concept code c29159. smiles: o=c(n1c(ccc1)c(=o)o)c(nc(ccc1ccccc1)c(=o)o)ccccn.o.o.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. enalapril maleate. this classification denotes an ace inhibitor with the molecular formula c20h28n2o5.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9o25354epj, chemically known as l-proline, n-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl- but more generally known as enalapril maleate, which bears us nih compound identifier 5362032. european medicines agency schedules enalapril maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01884mig. most nations, for tariff and trade purposes, schedule enalapril maleate under hs 29339990 and sitc 51577. as of q4 2014, enalapril maleate remains us fdas preferred term for this commodity. enalapril maleate bears us nlm identifiers umls id c0600128 and nci concept code c468. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@@h](c)c(=o)n2ccc[c@h]2c(=o)o.c(=c\\c(=o)o)\\c(=o)o.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. enalaprilat anhydrous. this classification denotes an ace inhibitor with the molecular formula c18h24n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q508q118jm, chemically known as l-proline, 1-(n-(1-carboxy-3-phenylpropyl)-l-alanyl)-, (s)-, but more generally known as enalaprilat anhydrous, which bears us nih compound identifier 5362033. european medicines agency schedules enalaprilat anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06515mig. most nations, for tariff purposes, schedule enalaprilat anhydrous under hs 29339990. enalaprilat anhydrous bears us nlm identifiers umls id c0886809 and nci concept code c76135. smiles: c[c@@h](c(=o)n1ccc[c@h]1c(=o)o)n[c@@h](ccc2ccccc2)c(=o)o.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. enalaprilat dihydrate. this classification denotes an ace inhibitor with the molecular formula c18h24n2o5.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gv0o7es0r3, chemically known as l-proline, n-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl- but more generally known as enalaprilat, which bears us nih compound identifier 5362032. european medicines agency schedules enalaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06515mig. enalaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule enalaprilat dihydrate under hs 29339990. smiles: c[c@@h](c(=o)n1ccc[c@h]1c(=o)o)n[c@@h](ccc2ccccc2)c(=o)o.o.o.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. lisinopril anhydrous. this classification denotes an ace inhibitor with the molecular formula c21h31n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7q3p4bs2fd, chemically known as l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-, but more generally known as lisinopril anhydrous, which bears us nih compound identifier 5362119. european medicines agency schedules lisinopril anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08533mig. most nations, for tariff purposes, schedule lisinopril anhydrous under hs 29339990. lisinopril anhydrous bears us nlm identifiers umls id c2827257 and nci concept code c83924. smiles: c1ccc(cc1)cc[c@@h](c(=o)o)n[c@@h](ccccn)c(=o)n2ccc[c@h]2c(=o)o.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. lisinopril dihydrate. this classification denotes an ace inhibitor with the molecular formula c21h31n3o5.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e7199s1ywr, chemically known as l-proline, 1-(n(sup 2)-(1-carboxy-3-phenylpropyl)-l-lysyl)-, dihydrate, (s)- but more generally known as lisinopril, which bears us nih compound identifier 5362118. european medicines agency schedules lisinopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08533mig. world health organization schedules lisinopril in its anatomical therapeutic chemical (atc) classification. lisinopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule lisinopril dihydrate under hs 29339990 and sitc 51577. smiles: c1ccc(cc1)cc[c@@h](c(=o)o)n[c@@h](ccccn)c(=o)n2ccc[c@h]2c(=o)o.o.o.. "
"antihypertensive oligopeptides. antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.. saralasin acetate. this classification denotes an antihypertensive agent with the molecular formula c42h65n13o10.c2h4o2.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fo21z580m4. the term saralasin acetate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule saralasin acetate under hs 29371900 and sitc 54154. as of q4 2014, saralasin acetate remains us fdas preferred term for this commodity. saralasin acetate bears us nlm identifiers umls id c0030114 and nci concept code c66528. smiles: c[c@@h](c(=o)o)nc(=o)[c@@h]1cccn1c(=o)[c@h](cc2c[nh]cn2)nc(=o)[c@h](c(c)c)nc(=o)[c@h](cc3ccc(cc3)o)nc(=o)[c@h](c(c)c)nc(=o)[c@h](cccnc(=n)n)nc(=o)cnc.cc(=o)o.o.. "
"antihypertensive organophosphorus compounds. antihypertensive drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. . "
"antihypertensive organophosphorus compounds. antihypertensive drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. belfosdil. this classification denotes a calcium channel blocker with the molecular formula c27h50o7p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w91cms1v7z, chemically known as phosphonic acid, (2-(2-phenoxyethyl)-1,3-propanediyl)bis-, tetrabutyl ester but generally known as belfosdil, which bears us nih compound identifier 72122. european medicines agency schedules belfosdil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05687mig. the term belfosdil is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). belfosdil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, belfosdil remains the us fda preferred term for this commodity. belfosdil bears us nlm identifiers umls id c0053078 and nci concept code c76023. smiles: p(=o)(occcc)(occcc)cc(cp(=o)(occcc)occcc)ccoc1ccccc1.. "
"antihypertensive organophosphorus compounds. antihypertensive drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. fosinopril. this classification denotes an ace inhibitor with the molecular formula c30h46no7p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r43d2573wo, chemically known as l-proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, (2alpha,4beta)- but generally known as fosinopril, which bears us nih compound identifier 55891. european medicines agency schedules fosinopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13918mig. the term fosinopril is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules fosinopril in its anatomical therapeutic chemical (atc) classification. fosinopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fosinopril under hs 29339990 and sitc 51577. as of q4 2014, fosinopril remains the us fda preferred term for this commodity. fosinopril bears us nlm identifiers umls id c0118168 and nci concept code c65761. smiles: p(=o)(oc(oc(=o)cc)c(c)c)(cc(=o)n1cc(c2ccccc2)cc1c(=o)o)ccccc1ccccc1.. "
"antihypertensive organophosphorus compounds. antihypertensive drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. fosinoprilat. this classification denotes an ace inhibitor with the molecular formula c23h34no5p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s312ey6zt8, chemically known as sq 27,519 but generally known as fosinoprilat, which bears us nih compound identifier 62956. european medicines agency schedules fosinoprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07800mig. the term fosinoprilat is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). fosinoprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fosinoprilat under hs 29339990 and sitc 51577. as of q4 2014, fosinoprilat remains the us fda preferred term for this commodity. fosinoprilat bears us nlm identifiers umls id c0075061 and nci concept code c65762. smiles: p(=o)(o)(cc(=o)n1cc(c2ccccc2)cc1c(=o)o)ccccc1ccccc1.. "
"antihypertensive organophosphorus compounds. antihypertensive drugs made from organic compounds that contain phosphorus as an integral part of the molecule.. fosinopril sodium. this classification denotes an ace inhibitor with the molecular formula c30h45no7p.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nw2rth6t2n, chemically known as l-proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, sodium salt, (1(s*(r*)),2alpha,4beta)- but more generally known as fosinopril sodium, which bears us nih compound identifier 55890. european medicines agency schedules fosinopril sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02265mig. most nations, for tariff and trade purposes, schedule fosinopril sodium under hs 29339990 and sitc 51577. as of q4 2014, fosinopril sodium remains us fdas preferred term for this commodity. fosinopril sodium bears us nlm identifiers umls id c0733440 and nci concept code c47542. smiles: ccc(=o)o[c@h](c(c)c)o[p@@](=o)(ccccc1ccccc1)cc(=o)n2c[c@@h](c[c@h]2c(=o)[o-])c3ccccc3.[na+].. "
"antihypertensive oxazoles. antihypertensive drugs made from five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position.. . "
"antihypertensive oxazoles. antihypertensive drugs made from five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position.. olmidine. this classification denotes an antihypertensive agent with the molecular formula c9h10n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0t3b934y1m, chemically known as 3,4-(methylenedioxy)mandelamidine but generally known as olmidine, which bears us nih compound identifier 31491. european medicines agency schedules olmidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09430mig. the term olmidine is an international non-proprietary name. olmidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule olmidine under hs 29329970 and sitc 51569. as of q4 2014, olmidine remains the us fda preferred term for this commodity. olmidine bears us nlm identifiers umls id c0069453 and nci concept code c90732. smiles: o1c2c(oc1)ccc(c(o)c(=n)n)c2.. "
"antihypertensive oxazoles. antihypertensive drugs made from five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position.. rilmenidine. this classification denotes an antihypertensive agent with the molecular formula c10h16n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p67im25id8, chemically known as 2-oxazolamine, n-(dicyclopropylmethyl)-4,5-dihydro- but generally known as rilmenidine, which bears us nih compound identifier 68712. european medicines agency schedules rilmenidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10316mig. the term rilmenidine is an international non-proprietary name. world health organization schedules rilmenidine in its anatomical therapeutic chemical (atc) classification. rilmenidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rilmenidine under hs 29349990 and sitc 51579. as of q4 2014, rilmenidine remains the us fda preferred term for this commodity. rilmenidine bears us nlm identifiers umls id c0140591 and nci concept code c75240. smiles: c1cc1c(c2cc2)nc3=ncco3.. "
"antihypertensive oxazoles. antihypertensive drugs made from five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position.. rilmenidine dihydrogen phosphate. this classification denotes an antihypertensive agent with the molecular formula c10h16n2o.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 59qd64q32m, chemically known as 4,5-dihydro-n-(dicyclopropylmethyl)-2-oxazolamine phosphate (1:1) but more generally known as rilmenidine dihydrogen phosphate, which bears us nih compound identifier 198614. european medicines agency schedules rilmenidine phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21586. most nations, for tariff and trade purposes, schedule rilmenidine dihydrogen phosphate under hs 29349990. smiles: c1cc1c(c2cc2)nc3=ncco3.op(=o)(o)o.. "
"antihypertensive oxazoles. antihypertensive drugs made from five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position.. rilmenidine phosphate. this classification denotes an antihypertensive agent with the molecular formula c10h16n2o.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 59qd64q32m, chemically known as 4,5-dihydro-n-(dicyclopropylmethyl)-2-oxazolamine phosphate (1:1) but more generally known as rilmenidine dihydrogen phosphate, which bears us nih compound identifier 198614. european medicines agency schedules rilmenidine phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21586. most nations, for tariff and trade purposes, schedule rilmenidine phosphate under hs 29349990 and sitc 51579. as of q4 2014, rilmenidine phosphate remains us fdas preferred term for this commodity. smiles: c1cc1c(c2cc2)nc3=ncco3.op(=o)(o)o.. "
"antihypertensive peptides. antihypertensive drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. oligopeptides are composed of approximately 2-12 amino acids. . "
"antihypertensive peptides. antihypertensive drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. oligopeptides are composed of approximately 2-12 amino acids. enalkiren. this classification denotes an antihypertensive agent with the molecular formula c35h56n6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0u7yz42z47, chemically known as l-histidinamide, n-(3-amino-3-methyl-1-oxobutyl)-o-methyl-l-tyrosyl-n-(1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-, (1s-(1r*,2s*,3r*))- but generally known as enalkiren, which bears us nih compound identifier 60594. european medicines agency schedules enalkiren in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06516mig. the term enalkiren is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). enalkiren is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enalkiren under hs 29332990 and sitc 51573. as of q4 2014, enalkiren remains the us fda preferred term for this commodity. enalkiren bears us nlm identifiers umls id c0059089 and nci concept code c87729. smiles: oc(c(nc(=o)c(nc(=o)c(nc(=o)cc(n)(c)c)cc1ccc(oc)cc1)cc1[nh]cnc1)cc1ccccc1)c(o)cc(c)c.. "
"antihypertensive peptides. antihypertensive drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. oligopeptides are composed of approximately 2-12 amino acids. spirapril. this classification denotes an ace inhibitor with the molecular formula c22h30n2o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 96u2k78i3v, chemically known as 1,4-dithia-7-azaspiro(4,4)nonane-8-carboxylic acid, 7-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, (8s-(7(r*(r*)),8r*))- but generally known as spirapril, which bears us nih compound identifier 91736. european medicines agency schedules spirapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10620mig. the term spirapril is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules spirapril in its anatomical therapeutic chemical (atc) classification. spirapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule spirapril under hs 29349990 and sitc 51579. as of q4 2014, spirapril remains the us fda preferred term for this commodity. spirapril bears us nlm identifiers umls id c0075007 and nci concept code c66560. smiles: s1c2(scc1)cc(n(c2)c(=o)c(nc(ccc1ccccc1)c(=o)occ)c)c(=o)o.. "
"antihypertensive peptides. antihypertensive drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. oligopeptides are composed of approximately 2-12 amino acids. angiotensinamide. this classification denotes a therapeutic hormone with the molecular formula c49h70n14o11, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7wal1x78kv, chemically known as l-phenylalanine, n-(1-(n-(n-(n-(n-(n2-l-asparaginyl-l-arginyl)-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)- but generally known as angiotensin amide, which bears us nih compound identifier 5890. european medicines agency schedules angiotensinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05511mig. the term angiotensinamide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules angiotensin amide in its anatomical therapeutic chemical (atc) classification. most nations schedule angiotensinamide under hs 29332990 and sitc 51573. smiles: o=c(n1c(ccc1)c(=o)nc(cc1ccccc1)c(=o)o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(n)cc(=o)n)ccc/n=c(/n)n)c(c)c)cc1ccc(o)cc1)c(c)c)cc1[nh]cnc1.. "
"antihypertensive peptides. antihypertensive drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. oligopeptides are composed of approximately 2-12 amino acids. spirapril hydrochloride. this classification denotes an ace inhibitor with the molecular formula c22h30n2o5s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier occ25lm897, chemically known as 1,4-dithia-7-azaspiro(4.4)nonane-8-carboxylic acid, 7-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, monohydrochloride, (8s-(7(r*(r*)),8r*))- but more generally known as spirapril hydrochloride, which bears us nih compound identifier 71192. european medicines agency schedules spirapril hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04530mig. most nations, for tariff and trade purposes, schedule spirapril hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, spirapril hydrochloride remains us fdas preferred term for this commodity. spirapril hydrochloride bears us nlm identifiers umls id c1528843 and nci concept code c66561. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@@h](c)c(=o)n2cc3(c[c@h]2c(=o)o)sccs3.cl.. "
"antihypertensive phenylpropionates. antihypertensive drugs made from phenyl-bound propionic acid salts or esters, e.g., (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid.. . "
"antihypertensive phenylpropionates. antihypertensive drugs made from phenyl-bound propionic acid salts or esters, e.g., (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid.. ambrisentan. this classification denotes an endothelin-1 protein receptor antagonist and antihypertensive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hw6nv07qec. european medicines agency schedules ambrisentan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25424. ambrisentan generally arises in the molecular formula c22h22n2o4. the term ambrisentan is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47.) most nations schedule ambrisentan under hs 29335995 and sitc 51576. as of q4 2014, ambrisentan remains the us fda preferred term for this commodity. ambrisentan bears us nlm identifiers umls id c1176329 and nci concept code c72694. smiles: o(c(c(oc1nc(cc(n1)c)c)c(=o)o)(c1ccccc1)c1ccccc1)c.. "
"antihypertensive phenylpropionates. antihypertensive drugs made from phenyl-bound propionic acid salts or esters, e.g., (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid.. darusentan. this classification denotes an endothelin receptor antagonist and antihypertensive agent with the molecular formula c22h22n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 33jd57l6rw, chemically known as benzenepropanoic acid, alpha-((4,6-dimethoxy-2-pyrimidinyl)oxy)-beta-methoxy-beta-phenyl-, (s)- but generally known as darusentan, which bears us nih compound identifier 177236. european medicines agency schedules darusentan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32910. the term darusentan is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule darusentan under hs 29335995 and sitc 51576. as of q4 2014, darusentan remains the us fda preferred term for this commodity. darusentan bears us nlm identifiers umls id c0665087 and nci concept code c75991. smiles: o(c(c(oc1nc(oc)cc(oc)n1)c(=o)o)(c1ccccc1)c1ccccc1)c.. "
"antihypertensive phthalazines. antihypertensive drugs made from benzopyridazines.. . "
"antihypertensive phthalazines. antihypertensive drugs made from benzopyridazines.. cromakalim or levcromakalim. this classification denotes an antihypertensive agent with the molecular formula c16h18n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0g4x367wa3, chemically known as 2h-1-benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-, trans-(+-)- but generally known as cromakalim, which bears us nih compound identifier 71191. european medicines agency schedules cromakalim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06822mig. the term cromakalim is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). cromakalim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cromakalim or levcromakalim bears us nlm identifiers umls id c0056506 and nci concept code c79109. smiles: o1c(c(o)c(n2cccc2=o)c2c1ccc(c2)c#n)(c)c.. "
"antihypertensive phthalazines. antihypertensive drugs made from benzopyridazines.. flavodilol. this classification denotes an antihypertensive agent with the molecular formula c21h23no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, m8fr1kl85j chemically known as 4h-1-benzopyran-4-one, 7-(2-hydroxy-3-(propylamino)propoxy)-2-phenyl-, (+/-)- but generally known as flavodilol, which bears us nih compound identifier 54410. european medicines agency schedules flavodilol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07634mig. the term flavodilol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23. ). most nations schedule flavodilol under hs 29329985 and sitc 51569. as of q4 2014, flavodilol remains the us fda preferred term for this commodity. flavodilol bears us nlm identifiers umls id c0060436 and nci concept code c72783. smiles: cccncc(coc1=cc2=c(c=c1)c(=o)c=c(o2)c3=cc=cc=c3)o.. "
"antihypertensive phthalazines. antihypertensive drugs made from benzopyridazines.. hydralazine. this classification denotes an antihypertensive agent with the molecular formula c8h8n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 26nak24ls8, chemically known as 1 (2h)-phthalazinone, hydrazone, monohydrochloride but generally known as hydralazine, which bears us nih compound identifier 3637. european medicines agency schedules hydralazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08059mig. the term hydralazine is an international non-proprietary name. world health organization schedules hydralazine in its anatomical therapeutic chemical (atc) classification. hydralazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule hydralazine under hs 29339990 and sitc 51577. as of q4 2014, hydralazine remains the us fda preferred term for this commodity. hydralazine bears us nlm identifiers umls id c0020223 and nci concept code c62032. smiles: n(n)c1nncc2c1cccc2.. "
"antihypertensive phthalazines. antihypertensive drugs made from benzopyridazines.. flavodilol maleate. this classification denotes an antihypertensive agent with the molecular formula c21h23no4.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y0dfc0d3q8, chemically known as 4h-1-benzopyran-4-one, 7-(2-hydroxy-3-(propylamino)propoxy)-2-phenyl-, (+-)-, (z)-2-butenedioate (1:1) (salt) but generally known as flavodilol maleate, which bears us nih compound identifier 6435382. most nations schedule flavodilol maleate under hs 29329985 and sitc 51569. as of q4 2014, flavodilol maleate remains the us fda preferred term for this commodity. smiles: cccncc(coc1=cc2=c(c=c1)c(=o)c=c(o2)c3=cc=cc=c3)o.c(=cc(=o)o)c(=o)o.. "
"antihypertensive phthalazines. antihypertensive drugs made from benzopyridazines.. hydralazine hydrochloride. this classification denotes an antihypertensive agent with the molecular formula c8h8n4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fd171b778y, chemically known as 1 (2h)-phthalazinone, hydrazone, monohydrochloride but more generally known as hydralazine hydrochloride, which bears us nih compound identifier 3637. european medicines agency schedules hydralazine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02553mig. most nations, for tariff and trade purposes, schedule hydralazine hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, hydralazine hydrochloride remains us fdas preferred term for this commodity. hydralazine hydrochloride bears us nlm identifiers umls id c0699178 and nci concept code c551. smiles: c1ccc2c(c1)cnnc2nn.cl.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. . "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. diproteverine. this classification denotes a calcium channel blocker with the molecular formula c26h35no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8a5oia91gt, chemically known as 1-(3,4-diethoxybenzyl)-3,4-dihydro-6,7-diisopropoxyisoquinoline but generally known as diproteverine, which bears us nih compound identifier 50463. european medicines agency schedules diproteverine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07227mig. the term diproteverine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). diproteverine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diproteverine under hs 29391900 and sitc 54141. as of q4 2014, diproteverine remains the us fda preferred term for this commodity. diproteverine bears us nlm identifiers umls id c0114311 and nci concept code c73025. smiles: o(c1cc2c(c(=ncc2)cc2cc(occ)c(occ)cc2)cc1oc(c)c)c(c)c.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. moexipril. this classification denotes an ace inhibitor with the molecular formula c27h34n2o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wt87c52tjz, chemically known as (3s)-2-((2s)-n-((1s)-1-carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester but generally known as moexipril, which bears us nih compound identifier 91270. european medicines agency schedules moexipril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09030mig. the term moexipril is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules moexipril in its anatomical therapeutic chemical (atc) classification. most nations schedule moexipril under hs 29334990 and sitc 51575. as of q4 2014, moexipril remains the us fda preferred term for this commodity. moexipril bears us nlm identifiers umls id c0066685 and nci concept code c83967. smiles: o=c(n1c(cc2c(c1)cc(oc)c(oc)c2)c(=o)o)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. quinapril. this classification denotes an ace inhibitor with the molecular formula c25h30n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rj84y44811, chemically known as 3-isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3s-(2(r*(r*)),3r*))- but generally known as quinapril, which bears us nih compound identifier 54892. european medicines agency schedules quinapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10201mig. the term quinapril is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules quinapril in its anatomical therapeutic chemical (atc) classification. quinapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinapril under hs 29334990 and sitc 51575. as of q4 2014, quinapril remains the us fda preferred term for this commodity. quinapril bears us nlm identifiers umls id c0072857 and nci concept code c62074. smiles: o=c(n1c(cc2c(c1)cccc2)c(=o)o)c(nc(ccc1ccccc1)c(=o)occ)c.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. quinaprilat. this classification denotes an ace inhibitor with the molecular formula c23h26n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 34ssx5lde5, chemically known as 3-isoquinolinecarboxylic acid, 2-((2s)-2-(((1s)-1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3s)- but generally known as quinaprilat, which bears us nih compound identifier 107994. european medicines agency schedules quinaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10202mig. the term quinaprilat is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). quinaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule quinaprilat under hs 29334990 and sitc 51575. as of q4 2014, quinaprilat remains the us fda preferred term for this commodity. quinaprilat bears us nlm identifiers umls id c0072858 and nci concept code c95129. smiles: o=c(n1c(cc2c(c1)cccc2)c(=o)o)c(nc(ccc1ccccc1)c(=o)o)c.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. falipamil. this classification denotes a calcium channel blocker with the molecular formula c24h32n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n6a93zmn7u, chemically known as 2-(3-((3,4-dimethoxyphenetyl)methylamino)propyl)-5,6-dimethoxyphthalimidine but generally known as falipamil, which bears us nih compound identifier 71222. european medicines agency schedules falipamil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07500mig. the term falipamil is an international non-proprietary name. falipamil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule falipamil under hs 29337900 and sitc 51561. as of q4 2014, falipamil remains the us fda preferred term for this commodity. falipamil bears us nlm identifiers umls id c0117251 and nci concept code c65614. smiles: o=c1n(cccn(ccc2cc(oc)c(oc)cc2)c)cc2c1cc(oc)c(oc)c2.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. diproteverine hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c26h35no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t587zfv6um, chemically known as 1-(3,4-diethoxybenzyl)-3,4-dihydro-6,7-diisopropoxyisoquinoline but more generally known as diproteverine hydrochloride, which bears us nih compound identifier 50463. most nations, for tariff and trade purposes, schedule diproteverine hydrochloride under hs 29391900. as of q4 2014, diproteverine hydrochloride remains us fdas preferred term for this commodity. diproteverine hydrochloride bears us nlm identifiers umls id c0107185 and nci concept code c97979. smiles: ccoc1ccc(cc1occ)cc2=nccc3c2cc(c(c3)oc(c)c)oc(c)c.cl.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. moexipril hydrochloride. this classification denotes an ace inhibitor with the molecular formula c27h34n2o7.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q1umg3uh45, chemically known as 3-isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-, monohydrochloride, (3s-(2(r*(r*)),3r*))- but more generally known as moexipril hydrochloride, which bears us nih compound identifier 54889. european medicines agency schedules moexipril hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03312mig. most nations, for tariff and trade purposes, schedule moexipril hydrochloride under hs 29334990 and sitc 51575. as of q4 2014, moexipril hydrochloride remains us fdas preferred term for this commodity. moexipril hydrochloride bears us nlm identifiers umls id c0771294 and nci concept code c29267. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@@h](c)c(=o)n2cc3cc(c(cc3c[c@h]2c(=o)o)oc)oc.cl.. "
"antihypertensive nicotinic acids. antihypertensive drugs made from 2-, 3-, or 4-pyridinecarboxylic acids, pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position.. quinapril hydrochloride. this classification denotes a tetrahydroisoquinoline, angiotensin-converting enzyme inhibitor, and antihypertensive agent with the molecular formula c25h30n2o5.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 33067b3n2m, chemically known as 3-isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, monohydrochloride, (3s-(2(r*(r*)),3r*)) but more generally known as quinapril hydrochloride, which bears us nih compound identifier 54891. european medicines agency schedules quinapril hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04164mig. most nations, for tariff and trade purposes, schedule quinapril hydrochloride under hs 29334990 and sitc 51575. as of q4 2014, quinapril hydrochloride remains us fdas preferred term for this commodity. quinapril hydrochloride bears us nlm identifiers umls id c0770920 and nci concept code c29398. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@@h](c)c(=o)n2cc3ccccc3c[c@h]2c(=o)o.cl.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. . "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. quinuclium bromide. this classification denotes an antihypertensive agent with the molecular formula 2c14h18no.2br.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 502h53wmm0, chemically known as 1-methyl-3-oxo-4-phenyl-1-azoniabicyclo(2.2.2)octane, bromide but generally known as quinuclium bromide, which bears us nih compound identifier 47458. european medicines agency schedules quinuclium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10224mig. most nations schedule quinuclium bromide under hs 29333999 and sitc 51574. as of q4 2014, quinuclium bromide remains the us fda preferred term for this commodity. quinuclium bromide bears us nlm identifiers umls id c2825666 and nci concept code c81522. smiles: c[n+]12ccc(cc1)(c(=o)c2)c3=cc=cc=c3.[br-].. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. amiquinsin. this classification denotes an antihypertensive agent with the molecular formula c11h12n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 85hk85c137, chemically known as 4-amino-6,7-dimethoxyquinoline but generally known as amiquinsin, which bears us nih compound identifier 23510. amiquinsin most often comes in base and hydrochloride forms. european medicines agency schedules amiquinsin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05456mig. the term amiquinsin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). amiquinsin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amiquinsin under hs 29334990 and sitc 51575. as of q4 2014, amiquinsin remains the us fda preferred term for this commodity. amiquinsin bears us nlm identifiers umls id c0610917 and nci concept code c79900. smiles: coc1=cc2=c(c=cn=c2c=c1oc)n.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. mibefradil. this classification denotes a calcium channel blocker with the molecular formula c29h38fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 27b90x776a, chemically known as acetic acid, methoxy-, 2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1s-cis)- but generally known as mibefradil, which bears us nih compound identifier 60662. european medicines agency schedules mibefradil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08940mig. the term mibefradil is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules mibefradil in its anatomical therapeutic chemical (atc) classification. mibefradil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mibefradil under hs 29339990 and sitc 51577. as of q4 2014, mibefradil remains the us fda preferred term for this commodity. mibefradil bears us nlm identifiers umls id c0286185 and nci concept code c87686. smiles: cl.cl.fc1cc2c(c(c(oc(=o)coc)(cc2)ccn(cccc2[nh]c3c(n2)cccc3)c)c(c)c)cc1.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. phenactropinium. this classification denotes a nicotinic antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43p9q83uff. european medicines agency schedules phenactropinium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09746mig. phenactropinium generally arises in the molecular formula c24h28no4.cl. the term phenactropinium is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4.) as of q4 2014, phenactropinium remains the us fda preferred term for this commodity. smiles: c[n+]1(c2ccc1cc(c2)oc(=o)c(c3=cc=cc=c3)o)cc(=o)c4=cc=cc=c4.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. cryptenamine. this classification denotes an antihypertensive mixture of closely related hypotensive alkaloids from veratrum album. european medicines agency schedules cryptenamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13498mig.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. amiquinsin hydrochloride. this classification denotes an antihypertensive agent with the molecular formula c11h12n2o2.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ez270u8z9w, chemically known as 4-quinolinamine, 6,7-dimethoxy-, monohydrochloride, monohydrate but more generally known as amiquinsin hydrochloride, which bears us nih compound identifier 23509. most nations, for tariff and trade purposes, schedule amiquinsin hydrochloride under hs 29334990 and sitc 51575. as of q4 2014, amiquinsin hydrochloride remains us fdas preferred term for this commodity. amiquinsin hydrochloride bears us nlm identifiers umls id c0953995 and nci concept code c75237. smiles: coc1cc2c(ccnc2cc1oc)n.o.cl.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. mibefradil dihydrochloride. this classification denotes a calcium channel blocker with the molecular formula c29h38fn3o3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 842tup3pq8, chemically known as acetic acid, methoxy-, 2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1s-cis)-, but more generally known as mibefradil dihydrochloride, which bears us nih compound identifier 60662. european medicines agency schedules mibefradil dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08940mig. most nations, for tariff purposes, schedule mibefradil dihydrochloride under hs 29339990. as of q4 2014, mibefradil dihydrochloride remains us fdas preferred term for this commodity. mibefradil dihydrochloride bears us nlm identifiers umls id c0286186 and nci concept code c87687. smiles: cc(c)[c@h]1c2ccc(cc2cc[c@@]1(ccn(c)cccc3[nh]c4ccccc4n3)oc(=o)coc)f.cl.cl.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. mibefradil hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c29h38fn3o3.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 842tup3pq8, chemically known as acetic acid, methoxy-, 2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1s-cis)- but more generally known as mibefradil dihydrochloride, which bears us nih compound identifier 60662. european medicines agency schedules mibefradil dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20668. most nations, for tariff and trade purposes, schedule mibefradil hydrochloride under hs 29339990 and sitc 51577. smiles: cc(c)[c@h]1c2ccc(cc2cc[c@@]1(ccn(c)cccc3[nh]c4ccccc4n3)oc(=o)coc)f.cl.cl.. "
"antihypertensive quinolines and quinuclidines and tetrahydronaphthalenes and tropanes and veratrum alkaloids. this classification denotes antihypertensives drugs made from or based in part on quinolines, quinuclidines, tetrahydronaphthalenes, or tropanes. phenactropinium chloride. this classification denotes a nicotinic antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43p9q83uff. european medicines agency schedules phenactropinium chloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09746mig. phenactropinium chloride generally arises in the molecular formula c24h28no4.cl. the term phenactropinium chloride is an international non-proprietary name or inn (see world health organization inn reference publication, volume 16, no. 3 1962, list 4.) most nations, for tariff and trade purposes, schedule phenactropinium chloride under hs 29399900 and sitc 54149. as of q4 2014, phenactropinium chloride remains us fdas preferred term for this commodity. phenactropinium chloride bears us nlm identifiers umls id c0604633 and nci concept code c90898. smiles: c[n+]1(c2ccc1cc(c2)oc(=o)c(c3ccccc3)o)cc(=o)c4ccccc4.[cl-].. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. . "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. ketanserin. this classification denotes a serotonin antagonist with the molecular formula c22h22fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 97f9de4ct4, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)- but generally known as ketanserin, which bears us nih compound identifier 3822. european medicines agency schedules ketanserin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08366mig. the term ketanserin is an international non-proprietary name. world health organization schedules ketanserin in its anatomical therapeutic chemical (atc) classification. ketanserin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ketanserin under hs 29335995 and sitc 51576. as of q4 2014, ketanserin remains the us fda preferred term for this commodity. ketanserin bears us nlm identifiers umls id c0022616 and nci concept code c604. smiles: fc1ccc(c(=o)c2ccn(cc2)ccn2c(=o)c3c([nh]c2=o)cccc3)cc1.. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. minoxidil. this classification denotes a vasodilating agent and antihypertensive agent with the molecular formula c9h15n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5965120sh1, chemically known as 2,6-diamino-4-piperidinopyrimidin-1-oxid but generally known as minoxidil, which bears us nih compound identifier 4201. european medicines agency schedules minoxidil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08982mig. the term minoxidil is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules minoxidil in its anatomical therapeutic chemical (atc) classification. minoxidil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule minoxidil under hs 29335995 and sitc 51576. as of q4 2014, minoxidil remains the us fda preferred term for this commodity. minoxidil bears us nlm identifiers umls id c0730881 and nci concept code c47623. smiles: on1c(n)cc(n2ccccc2)nc1=n.. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. pempidine. this classification denotes a nicotinic antagonist and antihypertensive agent with the molecular formula c10h21n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n5i18ji9d6, chemically known as 1,2,2,6,6-pentamethylpiperidine but generally known as pempidine, which bears us nih compound identifier 6603. european medicines agency schedules pempidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09658mig. the term pempidine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). pempidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pempidine under hs 29333999 and sitc 51574. as of q4 2014, pempidine remains the us fda preferred term for this commodity. pempidine bears us nlm identifiers umls id c0030810 and nci concept code c66335. smiles: cc1(cccc(n1c)(c)c)c.. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. perhexiline. this classification denotes a calcium channel blocker, cardiovascular agent, and vasodilator agent with the molecular formula c19h35n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ku65374x44, chemically known as 2-(2,2-dicyclohexylethyl)piperidine but generally known as perhexiline, which bears us nih compound identifier 4746. european medicines agency schedules perhexiline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09726mig. world health organization schedules perhexiline in its anatomical therapeutic chemical (atc) classification. perhexiline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule perhexiline under hs 29333999 and sitc 51574. as of q4 2014, perhexiline remains the us fda preferred term for this commodity. smiles: n1c(cc(c2ccccc2)c2ccccc2)cccc1.. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. ketanserin tartrate. this classification denotes a serotonin antagonist with the molecular formula c22h22fn3o3.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 645498qk7h, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) but more generally known as ketanserin tartrate, which bears us nih compound identifier 135348. european medicines agency schedules ketanserin tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02831mig. most nations, for tariff and trade purposes, schedule ketanserin tartrate under hs 29335995 and sitc 51576. as of q4 2014, ketanserin tartrate remains us fdas preferred term for this commodity. ketanserin tartrate bears us nlm identifiers umls id c1517662 and nci concept code c2036. smiles: c1ccc2c(c1)c(=o)n(c(=o)[nh]2)ccn3ccc(cc3)c(=o)c4ccc(cc4)f.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. minoxidil sulfate ester. this classification denotes a vasodilating agent and antihypertensive agent with the molecular formula c9h15n5o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2h6k6y231j, chemically known as 2-pyrimidinamine, 1,6-dihydro-6-imino-4-(1-piperidinyl)-1-(sulfooxy)-, but more generally known as minoxidil sulfate ester, which bears us nih compound identifier 4202. european medicines agency schedules minoxidil sulfate ester or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08982mig. most nations, for tariff purposes, schedule minoxidil sulfate ester under hs 29335995. smiles: c1c([n+](c(nc1n2ccccc2)n)os(=o)(=o)[o-])n.. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. pempidine tartrate. this classification denotes a nicotinic antagonist and antihypertensive agent c10h21n.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier thi82m7n4m, chemically known as 1,2,2,6,6-pentamethylpiperidine tartrate, but more generally known as pempidine tartrate, which bears us nih compound identifier 120729. european medicines agency schedules pempidine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03672mig. most nations, for tariff and trade purposes, schedule pempidine tartrate under hs 29333999 and sitc 51574. as of q4 2014, pempidine tartrate remains us fdas preferred term for this commodity. smiles: cc1(cccc(n1c)(c)c)c.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antihypertensive piperidines. antihypertensive drugs made from a family of hexahydropyridines.. perhexiline maleate. this classification denotes a calcium channel blocker with the molecular formula c19h35n.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k7v8y90g0h, chemically known as 2-(2,2-dicyclohexylethyl)piperidinium hydrogen maleate but more generally known as perhexiline maleate, which bears us nih compound identifier 5284439. european medicines agency schedules perhexiline maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03710mig. most nations, for tariff and trade purposes, schedule perhexiline maleate under hs 29333999 and sitc 51574. as of q4 2014, perhexiline maleate remains us fdas preferred term for this commodity. perhexiline maleate bears us nlm identifiers umls id c0070413 and nci concept code c90822. smiles: c1ccc(cc1)c(cc2ccccn2)c3ccccc3.c(=c\\c(=o)o)\\c(=o)o.. "
"antihypertensive prostaglandins and pyrazoles and pyrimidines and quinazolines. this classification denotes antihypertensives drugs made from or based in part on prostaglandins, pyrazoles, pyrimidines, or quinazolines. . "
"antihypertensive prostaglandins and pyrazoles and pyrimidines and quinazolines. this classification denotes antihypertensives drugs made from or based in part on prostaglandins, pyrazoles, pyrimidines, or quinazolines. treprostinil. this classification denotes a prostaglandin analogue and antihypertensive agent with the molecular formula c23h34o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rum6k67esg, chemically known as u-62,840 but generally known as treprostinil, which bears us nih compound identifier 54786. european medicines agency schedules treprostinil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21168. the term treprostinil is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 2, 2003, list 49). world health organization schedules treprostinil in its anatomical therapeutic chemical (atc) classification. most nations schedule treprostinil under hs 29375000 and sitc 54156. as of q4 2014, treprostinil remains the us fda preferred term for this commodity. treprostinil bears us nlm identifiers umls id c1145760 and nci concept code c61983. smiles: oc1c(c2c(c1)cc1c(c2)cccc1occ(=o)o)ccc(o)ccccc.. "
"antihypertensive prostaglandins and pyrazoles and pyrimidines and quinazolines. this classification denotes antihypertensives drugs made from or based in part on prostaglandins, pyrazoles, pyrimidines, or quinazolines. muzolimine. this classification denotes an antihypertensive agent and diuretic with the molecular formula c11h11cl2n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 07z36289zx, chemically known as 5-amino-2-(1-(3,4-dichlorophenyl)-ethyl)-2,4-dihydro-3h-pyrazol-3-one but generally known as muzolimine, which bears us nih compound identifier 41386. european medicines agency schedules muzolimine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09097mig. world health organization schedules muzolimine in its anatomical therapeutic chemical (atc) classification. muzolimine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule muzolimine under hs 29331990 and sitc 51571. as of q4 2014, muzolimine remains the us fda preferred term for this commodity. smiles: cc(c1=cc(=c(c=c1)cl)cl)n2c(=o)cc(=n2)n.. "
"antihypertensive prostaglandins and pyrazoles and pyrimidines and quinazolines. this classification denotes antihypertensives drugs made from or based in part on prostaglandins, pyrazoles, pyrimidines, or quinazolines. tasosartan. this classification denotes an angiotensin ii type 1 receptor blocker with the molecular formula c23h21n7o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 48g92v856h, chemically known as 5,8-dihydro-2,4-dimethyl-8-(p-(o-1h-tetrazol-5-ylphenyl)benzyl)pyrido(2,3-d)pyrimidin-7(6h)-one but generally known as tasosartan, which bears us nih compound identifier 60919. european medicines agency schedules tasosartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10834mig. world health organization schedules tasosartan in its anatomical therapeutic chemical (atc) classification. tasosartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tasosartan under hs 29337900 and sitc 51561. as of q4 2014, tasosartan remains the us fda preferred term for this commodity. smiles: o=c1n(c2nc(nc(c2cc1)c)c)cc1ccc(cc1)c1c(cccc1)c1n[nh]nn1.. "
"antihypertensive prostaglandins and pyrazoles and pyrimidines and quinazolines. this classification denotes antihypertensives drugs made from or based in part on prostaglandins, pyrazoles, pyrimidines, or quinazolines. pelanserin. this classification denotes a serotonin antagonist with the molecular formula c21h24n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6snr96e409, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(3-(4-phenyl-1-piperazinyl)propyl)- but generally known as pelanserin, which bears us nih compound identifier 65435. european medicines agency schedules pelanserin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09648mig. the term pelanserin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). pelanserin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pelanserin under hs 29335995 and sitc 51576. as of q4 2014, pelanserin remains the us fda preferred term for this commodity. pelanserin bears us nlm identifiers umls id c0070209 and nci concept code c76965. smiles: c1ccc(cc1)n2ccn(cc2)cccn3c(=o)c4ccccc4[nh]c3=o.. "
"antihypertensive prostaglandins and pyrazoles and pyrimidines and quinazolines. this classification denotes antihypertensives drugs made from or based in part on prostaglandins, pyrazoles, pyrimidines, or quinazolines. pelanserin hydrochloride. this classification denotes a serotonin antagonist c21h24n4o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4j8i18zp0a, chemically known as 3-(3-(4-phenyl-1-piperazinyl)propyl)-2,4(1h,3h)-quinazolinedione monohydrochloride, but more generally known as pelanserin hydrochloride, which bears us nih compound identifier 65436. most nations, for tariff and trade purposes, schedule pelanserin hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, pelanserin hydrochloride remains us fdas preferred term for this commodity. pelanserin hydrochloride bears us nlm identifiers umls id c2698754 and nci concept code c76966. smiles: c1ccc(cc1)n2ccn(cc2)cccn3c(=o)c4ccccc4[nh]c3=o.cl.. "
"antihypertensive prostaglandins and pyrazoles and pyrimidines and quinazolines. this classification denotes antihypertensives drugs made from or based in part on prostaglandins, pyrazoles, pyrimidines, or quinazolines. treprostinil sodium. this classification denotes a prostaglandin analogue and antihypertensive agent with the molecular formula c23h33o5.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7jz75n2nt6, chemically known as acetic acid, (((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)-3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-, monosodium salt but more generally known as treprostinil sodium, which bears us nih compound identifier 130880. european medicines agency schedules treprostinil sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22911. most nations, for tariff and trade purposes, schedule treprostinil sodium under hs 29375000 and sitc 54156. as of q4 2014, treprostinil sodium remains us fdas preferred term for this commodity. treprostinil sodium bears us nlm identifiers umls id c1101501 and nci concept code c61984. smiles: ccccc[c@@h](cc[c@@h]1[c@h]2cc3cccc(c3c[c@h]2c[c@h]1o)occ(=o)[o-])o.[na+].. "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. . "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. cadralazine. this classification denotes an antihypertensive agent with the molecular formula c12h21n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8t96i3u713, chemically known as hydrazinecarboxylic acid, 2-(6-(ethyl(2-hydroxypropyl)amino)-3-pyridazinyl)-, ethyl ester but generally known as cadralazine, which bears us nih compound identifier 2515. european medicines agency schedules cadralazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06042mig. the term cadralazine is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules cadralazine in its anatomical therapeutic chemical (atc) classification. cadralazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cadralazine under hs 29339990 and sitc 51577. as of q4 2014, cadralazine remains the us fda preferred term for this commodity. cadralazine bears us nlm identifiers umls id c0054422 and nci concept code c81527. smiles: oc(cn(cc)c1nnc(nnc(=o)occ)cc1)c.. "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. cilazapril. this classification denotes an ace inhibitor with the molecular formula c22h31n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8q9454114q, chemically known as 6h-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, octahydro-9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-10-oxo-, hydrate, (1s-(1-alpha,9-alpha(r*)))- but generally known as cilazapril, which bears us nih compound identifier 56329. european medicines agency schedules cilazapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06265mig. the term cilazapril is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules cilazapril in its anatomical therapeutic chemical (atc) classification. cilazapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cilazapril under hs 29339940 and sitc 51577. smiles: o=c1n2n(cccc2c(=o)o)cccc1nc(ccc1ccccc1)c(=o)occ.o.. "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. cilazaprilat. this classification denotes an ace inhibitor with the molecular formula c20h27n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wbl76fh528, chemically known as n-((1s,9s)-1-carboxy-10-oxoperhydropyridazino-(1,2-alpha)(1,2)diazepin-9-yl)-4-phenyl-l-homoalanine but generally known as cilazaprilat, which bears us nih compound identifier 64766. european medicines agency schedules cilazaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06266mig. the term cilazaprilat is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). cilazaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cilazaprilat under hs 29339940 and sitc 51577. as of q4 2014, cilazaprilat remains the us fda preferred term for this commodity. cilazaprilat bears us nlm identifiers umls id c0055724 and nci concept code c75927. smiles: o=c1n2n(cccc2c(=o)o)cccc1nc(ccc1ccccc1)c(=o)o.. "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. levosimendan. this classification denotes an anti-arrhythmia agent, cardiotonic agent, and vasodilator agent with the molecular formula c14h12n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c6t4514l4e, chemically known as (r)-((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile but generally known as levosimendan, which bears us nih compound identifier 3033825. european medicines agency schedules levosimendan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08493mig. world health organization schedules levosimendan in its anatomical therapeutic chemical (atc) classification. most nations schedule levosimendan under hs 29339990 and sitc 51577. as of q4 2014, levosimendan remains the us fda preferred term for this commodity. smiles: o=c1nn=c(c(c1)c)c1ccc(n/n=c(/c#n)c#n)cc1.. "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. mopidralazine. this classification denotes an antihypertensive agent with the molecular formula c14h19n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 96600s6glk, chemically known as 4-(6-((2,5-dimethylpyrrol-1-yl)amino)-3-pyridazinyl)morpholine but generally known as mopidralazine, which bears us nih compound identifier 71143. european medicines agency schedules mopidralazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09059mig. the term mopidralazine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). mopidralazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mopidralazine under hs 29349990 and sitc 51579. as of q4 2014, mopidralazine remains the us fda preferred term for this commodity. mopidralazine bears us nlm identifiers umls id c0066788 and nci concept code c66191. smiles: o1ccn(cc1)c1nnc(nn2c(ccc2c)c)cc1.. "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. cilazapril anhydrous. this classification denotes an ace inhibitor with the molecular formula c22h31n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8q9454114q, chemically known as 6h-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-, monohydrate, (1s-(1.alpha.,9.alpha.(r*))), but more generally known as cilazapril anhydrous, which bears us nih compound identifier 56330. european medicines agency schedules cilazapril anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06265mig. most nations, for tariff purposes, schedule cilazapril anhydrous under hs 29339940. as of q4 2014, cilazapril anhydrous remains us fdas preferred term for this commodity. cilazapril anhydrous bears us nlm identifiers umls id c0886706 and nci concept code c76134. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@h]2cccn3ccc[c@h](n3c2=o)c(=o)o.. "
"antihypertensive pyridazines. antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.. cilazapril monohydrate. this classification denotes an ace inhibitor with the molecular structure c22h31n3o5.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 19kw7pi29f chemically known as (1s,9s)-9-(((s)-1-carboxy-3-phenylpropyl)amino)octahydro-10-oxo-6h-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid 9-ethyl ester monohydrate, but more commonly known as cilazapril, which bears us nih compound identifier 56329. european medicines agency schedules cilazapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06265mig. the term cilazapril is an international non-proprietary name or inn (see world health organization inn reference publication, volume 39, no. 5, 1985, list 25. ). most nations, for tariff and trade purposes, schedule cilazapril monohydrate under hs 29339940 and sitc 51577. as of q4 2014, cilazapril monohydrate remains us fdas preferred term for this commodity. cilazapril monohydrate bears us nlm identifiers umls id c0055723 and nci concept code c76133. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@h]2cccn3ccc[c@h](n3c2=o)c(=o)o.o.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. . "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. efonidipine. this classification denotes a calcium channel blocker with the molecular formula c34h38n3o7p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40ztp2t37q, chemically known as 2-(n-benzylanilino)ethyl (- )-1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-5-phosphononicotinate, cyclic 2,2-dimethyltrimethylene ester. but generally known as efonidipine, which bears us nih compound identifier 119171. european medicines agency schedules efonidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06471mig. the term efonidipine is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). efonidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule efonidipine under hs 29349990 and sitc 51579. as of q4 2014, efonidipine remains the us fda preferred term for this commodity. efonidipine bears us nlm identifiers umls id c0286819 and nci concept code c73026. smiles: p1(=o)(occ(co1)(c)c)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)occn(cc1ccccc1)c1ccccc1)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. amlodipine. this classification denotes a calcium channel blocker with the molecular formula c20h25cln2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1j444qc288, chemically known as 3,5-pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester but generally known as amlodipine, which bears us nih compound identifier 2162. amlodipine most often comes in base, benzenesulfonate, besilate, besylate, and maleate forms. european medicines agency schedules amlodipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05467mig. the term amlodipine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules amlodipine in its anatomical therapeutic chemical (atc) classification. amlodipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amlodipine under hs 29333999 and sitc 51574. as of q4 2014, amlodipine remains the us fda preferred term for this commodity. amlodipine bears us nlm identifiers umls id c0051696 and nci concept code c61635. smiles: clc1c(c2c(=c(nc(=c2c(=o)oc)c)coccn)c(=o)occ)cccc1.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. nifedipine. this classification denotes a calcium channel blocker with the molecular formula c17h18n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i9zf7l6g2l, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-, dimethyl ester (8ci) but generally known as nifedipine, which bears us nih compound identifier 4485. european medicines agency schedules nifedipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09253mig. the term nifedipine is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules nifedipine in its anatomical therapeutic chemical (atc) classification. nifedipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nifedipine under hs 29333999 and sitc 51574. as of q4 2014, nifedipine remains the us fda preferred term for this commodity. nifedipine bears us nlm identifiers umls id c0028066 and nci concept code c29290. smiles: o(c(=o)c1=c(nc(=c(c1c1c([n](=o)o)cccc1)c(=o)oc)c)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. niguldipine. this classification denotes a calcium channel blocker with the molecular formula c36h39n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z81n45o25z, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(4,4-diphenyl-1-piperidinyl)propyl methyl ester but generally known as niguldipine, which bears us nih compound identifier 1236. european medicines agency schedules niguldipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09284mig. the term niguldipine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). most nations schedule niguldipine under hs 29333999 and sitc 51574. as of q4 2014, niguldipine remains the us fda preferred term for this commodity. niguldipine bears us nlm identifiers umls id c0068753 and nci concept code c84018. smiles: o(cccn1ccc(cc1)(c1ccccc1)c1ccccc1)c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. nilvadipine. this classification denotes a calcium channel blocker with the molecular formula c19h19n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0214fut37j, chemically known as 3,5-pyridinedicarboxylic acid, 2-cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-, 3-methyl 5-(1-methylethyl) ester but generally known as nilvadipine, which bears us nih compound identifier 4494. european medicines agency schedules nilvadipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09292mig. the term nilvadipine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules nilvadipine in its anatomical therapeutic chemical (atc) classification. nilvadipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nilvadipine under hs 29333999 and sitc 51574. as of q4 2014, nilvadipine remains the us fda preferred term for this commodity. nilvadipine bears us nlm identifiers umls id c0132512 and nci concept code c84019. smiles: o(c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc)c#n)c)c(c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. aprikalim. this classification denotes an antihypertensive agent with the molecular formula c12h16n2os2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 374bh4kvrg, chemically known as 2h-thiopyran-2-carbothioamide, tetrahydro-n-methyl-2-(3-pyridinyl)-, 1-oxide but generally known as aprikalim, which bears us nih compound identifier 3034038. european medicines agency schedules aprikalim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05541mig. the term aprikalim is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). aprikalim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aprikalim under hs 29349990 and sitc 51579. as of q4 2014, aprikalim remains the us fda preferred term for this commodity. aprikalim bears us nlm identifiers umls id c0209261 and nci concept code c77145. smiles: cnc(=s)[c@@]1(ccccs1=o)c2=cn=cc=c2.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. nisoldipine. this classification denotes a calcium channel blocker with the molecular formula c20h24n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4i8hab65sz, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester but generally known as nisoldipine, which bears us nih compound identifier 4499. european medicines agency schedules nisoldipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09307mig. the term nisoldipine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules nisoldipine in its anatomical therapeutic chemical (atc) classification. nisoldipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nisoldipine under hs 29333999 and sitc 51574. as of q4 2014, nisoldipine remains the us fda preferred term for this commodity. nisoldipine bears us nlm identifiers umls id c0028116 and nci concept code c29291. smiles: o(c(=o)c1=c(nc(=c(c1c1c([n](=o)o)cccc1)c(=o)oc)c)c)cc(c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. barnidipine. this classification denotes a calcium channel blocker with the molecular formula c27h29n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2vby96aswj, chemically known as (+)-(3s,4s)-1-benzyl-3-pyrrolidinyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate but generally known as barnidipine, which bears us nih compound identifier 65884. barnidipine most often comes in base and hydrochloride forms. european medicines agency schedules barnidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06105mig. the term barnidipine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules barnidipine in its anatomical therapeutic chemical (atc) classification. barnidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule barnidipine under hs 29333999 and sitc 51574. as of q4 2014, barnidipine remains the us fda preferred term for this commodity. barnidipine bears us nlm identifiers umls id c0078703 and nci concept code c73024. smiles: o(c1ccn(c1)cc1ccccc1)c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. omapatrilat. this classification denotes an ace inhibitor with the molecular formula c19h24n2o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 36nli90e7t, chemically known as 7h-pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid, octahydro-4-(((2s)-2-mercapto-1-oxo-3-phenylpropyl)amino)-5-oxo-, (4s,7s,10as)- but generally known as omapatrilat, which bears us nih compound identifier 126046. european medicines agency schedules omapatrilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12450mig. the term omapatrilat is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). omapatrilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule omapatrilat under hs 29349990 and sitc 51579. as of q4 2014, omapatrilat remains the us fda preferred term for this commodity. omapatrilat bears us nlm identifiers umls id c0663645 and nci concept code c1782. smiles: s1c2n(c(ccc2)c(=o)o)c(=o)c(nc(=o)c(s)cc2ccccc2)cc1.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. palonidipine. this classification denotes a calcium channel blocker with the molecular formula c29h34fn3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fms4x67q96, chemically known as (- )-3-(benzylmethyl-amino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate. but generally known as palonidipine, which bears us nih compound identifier 119154. european medicines agency schedules palonidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09592mig. the term palonidipine is an international non-proprietary name. palonidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule palonidipine under hs 29333999 and sitc 51574. as of q4 2014, palonidipine remains the us fda preferred term for this commodity. palonidipine bears us nlm identifiers umls id c1882274 and nci concept code c66297. smiles: fc1c(c2c(=c(nc(=c2c(=o)oc)c)c)c(=o)occ(cn(cc2ccccc2)c)(c)c)cc([n](=o)o)cc1.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. teludipine. this classification denotes a calcium channel blocker with the molecular formula c28h38n2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z9oj72bm3o, chemically known as 3,5-pyridinedicarboxylic acid, 2-((dimethylamino)methyl)-4-(2-(3-(1,1-dimethylethoxy)-3-oxo-1-propenyl)phenyl)-1,4-dihydro-6-methyl-, diethyl ester, (e)- but generally known as teludipine, which bears us nih compound identifier 6436165. european medicines agency schedules teludipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10876mig. the term teludipine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). teludipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule teludipine under hs 29333999 and sitc 51574. as of q4 2014, teludipine remains the us fda preferred term for this commodity. teludipine bears us nlm identifiers umls id c0292596 and nci concept code c84196. smiles: o(c(=o)c1=c(nc(=c(c1c1c(cccc1)/c=c/c(=o)oc(c)(c)c)c(=o)occ)c)cn(c)c)cc.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. cilnidipine. this classification denotes a calcium channel blocker with the molecular formula c27h28n2o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 97t5az1jip, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 3-phenyl-2-propenyl ester, (e)-(+-)- but generally known as cilnidipine, which bears us nih compound identifier 5282138. european medicines agency schedules cilnidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06268mig. world health organization schedules cilnidipine in its anatomical therapeutic chemical (atc) classification. most nations schedule cilnidipine under hs 29333999 and sitc 51574. as of q4 2014, cilnidipine remains the us fda preferred term for this commodity. smiles: o(c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc/c=c/c1ccccc1)c)c)ccoc.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. clevidipine. this classification denotes a calcium channel blocker with the molecular formula c21h23cl2no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19o2gp3b7q, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester but generally known as clevidipine, which bears us nih compound identifier 153994. european medicines agency schedules clevidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06655mig. the term clevidipine is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). world health organization schedules clevidipine in its anatomical therapeutic chemical (atc) classification. clevidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule clevidipine under hs 29333999 and sitc 51574. as of q4 2014, clevidipine remains the us fda preferred term for this commodity. clevidipine bears us nlm identifiers umls id c0766108 and nci concept code c72727. smiles: clc1c(c2c(=c(nc(=c2c(=o)oc)c)c)c(=o)ococ(=o)ccc)cccc1cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. elgodipine. this classification denotes a calcium channel blocker with the molecular formula c29h33fn2o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3ji11z5ref, chemically known as 3,5-pyridinedicarboxylic acid, 4-(1,3-benzodioxol-4-yl)-1,4-dihydro-2,6-dimethyl-, 2-(((4-fluorophenyl)methyl)methylamino)ethyl 1-methylethyl ester, (+-)- but generally known as elgodipine, which bears us nih compound identifier 60701. european medicines agency schedules elgodipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06484mig. the term elgodipine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). elgodipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule elgodipine under hs 29349990 and sitc 51579. as of q4 2014, elgodipine remains the us fda preferred term for this commodity. elgodipine bears us nlm identifiers umls id c0082382 and nci concept code c76579. smiles: fc1ccc(cn(ccoc(=o)c2=c(nc(=c(c2c2c3ococ3ccc2)c(=o)oc(c)c)c)c)c)cc1.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. felodipine. this classification denotes a calcium channel blocker with the molecular formula c18h19cl2no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ol961r6o2c, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, ethyl methyl ester but generally known as felodipine, which bears us nih compound identifier 3333. european medicines agency schedules felodipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11963mig. the term felodipine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules felodipine in its anatomical therapeutic chemical (atc) classification. felodipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule felodipine under hs 29333999 and sitc 51574. as of q4 2014, felodipine remains the us fda preferred term for this commodity. felodipine bears us nlm identifiers umls id c0015772 and nci concept code c29046. smiles: clc1c(c2c(=c(nc(=c2c(=o)oc)c)c)c(=o)occ)cccc1cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. forasartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c23h28n8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 065f7wpt0b, chemically known as 5-((3,5-dibutyl-1h-1,2,4-triazol-1-yl)methyl)-2-(2-(1h-tetrazol-5-ylphenyl))pyridine but generally known as forasartan, which bears us nih compound identifier 132706. european medicines agency schedules forasartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07781mig. the term forasartan is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). forasartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule forasartan under hs 29333999 and sitc 51574. as of q4 2014, forasartan remains the us fda preferred term for this commodity. forasartan bears us nlm identifiers umls id c0250070 and nci concept code c65749. smiles: n1(nc(nc1cccc)cccc)cc1ccc(nc1)c1c(cccc1)c1n[nh]nn1.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. isradipine. this classification denotes a calcium channel blocker with the molecular formula c19h21n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yo1uk1s598, chemically known as 2,1,3-benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv. but generally known as isradipine, which bears us nih compound identifier 3784. european medicines agency schedules isradipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08346mig. the term isradipine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules isradipine in its anatomical therapeutic chemical (atc) classification. isradipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule isradipine under hs 29349990 and sitc 51579. as of q4 2014, isradipine remains the us fda preferred term for this commodity. isradipine bears us nlm identifiers umls id c0071304 and nci concept code c47577. smiles: o(c(=o)c1=c(nc(=c(c1c1c2nonc2ccc1)c(=o)oc)c)c)c(c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. tiadenol. this classification denotes a fatty alcohol and hypolipidemic agent with the molecular formula c14h30o2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 22251270cx, chemically known as 1,10-bis(hydroxyethylthio)decane but generally known as tiadenol, which bears us nih compound identifier 23403. european medicines agency schedules tiadenol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10998mig. world health organization schedules tiadenol in its anatomical therapeutic chemical (atc) classification. tiadenol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tiadenol under hs 29309085 and sitc 51549. as of q4 2014, tiadenol remains the us fda preferred term for this commodity. smiles: s(ccccccccccscco)cco.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. lercanidipine. this classification denotes a calcium channel blocker with the molecular formula c36h41n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v7xtj4r0bh, chemically known as (+-)-2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate but generally known as lercanidipine, which bears us nih compound identifier 65866. european medicines agency schedules lercanidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08437mig. the term lercanidipine is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules lercanidipine in its anatomical therapeutic chemical (atc) classification. most nations schedule lercanidipine under hs 29333999 and sitc 51574. as of q4 2014, lercanidipine remains the us fda preferred term for this commodity. lercanidipine bears us nlm identifiers umls id c0526399 and nci concept code c81687. smiles: o(c(cn(ccc(c1ccccc1)c1ccccc1)c)(c)c)c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. manidipine. this classification denotes a calcium channel blocker with the molecular formula c35h38n4o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6o4754us88, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(4-(diphenylmethyl)-1-piperazinyl)ethyl methyl ester but generally known as manidipine, which bears us nih compound identifier 4008. european medicines agency schedules manidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08641mig. world health organization schedules manidipine in its anatomical therapeutic chemical (atc) classification. manidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule manidipine under hs 29335995 and sitc 51576. as of q4 2014, manidipine remains the us fda preferred term for this commodity. manidipine bears us nlm identifiers umls id c0065656 and nci concept code c81682. smiles: o(ccn1ccn(cc1)c(c1ccccc1)c1ccccc1)c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. nicardipine. this classification denotes a calcium channel blocker with the molecular formula c26h29n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cz5312222s, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester but generally known as nicardipine, which bears us nih compound identifier 4474. european medicines agency schedules nicardipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09225mig. the term nicardipine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules nicardipine in its anatomical therapeutic chemical (atc) classification. nicardipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nicardipine under hs 29333999 and sitc 51574. as of q4 2014, nicardipine remains the us fda preferred term for this commodity. nicardipine bears us nlm identifiers umls id c0028005 and nci concept code c66879. smiles: o(c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc)c)c)ccn(cc1ccccc1)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. benidipine. this classification denotes a calcium channel blocker with the molecular formula c28h31n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4g9t91js7e, chemically known as (+-)-(r*)-3-((r*)-1-benzyl-3-piperidyl) methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate but generally known as benidipine, which bears us nih compound identifier 60065. benidipine most often comes in base and hydrochloride forms. european medicines agency schedules benidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05719mig. the term benidipine is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). world health organization schedules benidipine in its anatomical therapeutic chemical (atc) classification. benidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benidipine under hs 29333999 and sitc 51574. as of q4 2014, benidipine remains the us fda preferred term for this commodity. benidipine bears us nlm identifiers umls id c0053108 and nci concept code c81680. smiles: o(c1cccn(c1)cc1ccccc1)c(=o)c1=c(nc(=c(c1c1cc([n](=o)o)ccc1)c(=o)oc)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. lacidipine. this classification denotes a calcium channel blocker with the molecular formula c26h33no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 260080034n, chemically known as 1h-imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1h-tetrazol-5-yl)(1,1- biphenyl)-4-yl)methyl)- but generally known as lacidipine, which bears us nih compound identifier 3961. european medicines agency schedules lacidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08383mig. the term lacidipine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules lacidipine in its anatomical therapeutic chemical (atc) classification. lacidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lacidipine under hs 29333999 and sitc 51574. as of q4 2014, lacidipine remains the us fda preferred term for this commodity. lacidipine bears us nlm identifiers umls id c0064568 and nci concept code c80881. smiles: clc1nc(n(cc2ccc(cc2)c2c(cccc2)c2n[nh]nn2)c1co)cccc.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. amlodipine besilate. this classification denotes a calcium channel blocker with the molecular formula c20h25cln2o5.c6h6o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 864v2q084h, chemically known as 3,5-pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester but more generally known as amlodipine besilate, which bears us nih compound identifier 2162. european medicines agency schedules amlodipine besilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12864mig. most nations, for tariff and trade purposes, schedule amlodipine besilate under hs 29333999 and sitc 51574. smiles: ccoc(=o)c1=c(nc(=c(c1c2ccccc2cl)c(=o)oc)c)coccn.c1ccc(cc1)s(=o)(=o)o.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. amlodipine maleate. this classification denotes a calcium channel blocker with the molecular formula c20h25cln2o5.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cq27g2bzjm, chemically known as 3,5-pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, (+-)-, (z)-2-butenedioate (1:1) but more generally known as amlodipine maleate, which bears us nih compound identifier 6435922. european medicines agency schedules amlodipine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00476mig. most nations, for tariff and trade purposes, schedule amlodipine maleate under hs 29333999 and sitc 51574. as of q4 2014, amlodipine maleate remains us fdas preferred term for this commodity. amlodipine maleate bears us nlm identifiers umls id c0886700 and nci concept code c65230. smiles: ccoc(=o)c1=c(nc(=c(c1c2ccccc2cl)c(=o)oc)c)coccn.c(=c\\c(=o)o)\\c(=o)o.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. amlodipine mesilate hydrate. this classification denotes the hydrate form of a calcium channel blocker with the molecular formula c20h25cln2o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 291y33ezha. european medicines agency schedules amlodipine mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22129. most nations, for tariff and trade purposes, schedule amlodipine mesilate hydrate under hs 29333999. smiles: ccoc(=o)c1=c(nc(=c(c1c2ccccc2cl)c(=o)oc)c)coccn.cs(=o)(=o)o.o.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. amlodipine mesylate hydrate. this classification denotes the hydrate form of a calcium channel blocker with the molecular formula c20h25cln2o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 291y33ezha. european medicines agency schedules amlodipine mesylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22129. most nations, for tariff and trade purposes, schedule amlodipine mesylate hydrate under hs 29333999. smiles: ccoc(=o)c1=c(nc(=c(c1c2ccccc2cl)c(=o)oc)c)coccn.cs(=o)(=o)o.o.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. barnidipine hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c27h29n3o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7lz6r3aem1, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 1-(phenylmethyl)-3-pyrrolidinyl ester, monohydrochloride, (s-(r*,r*))- but more generally known as barnidipine hydrochloride, which bears us nih compound identifier 163733. european medicines agency schedules barnidipine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00671mig. most nations, for tariff and trade purposes, schedule barnidipine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, barnidipine hydrochloride remains us fdas preferred term for this commodity. smiles: cc1=c([c@@h](c(=c(n1)c)c(=o)o[c@h]2ccn(c2)cc3ccccc3)c4cccc(c4)[n+](=o)[o-])c(=o)oc.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. benidipine hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c28h31n3o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0a6746fwdl. european medicines agency schedules benidipine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13004mig. the term benidipine hydrochloride is a u.s. fda designation. most nations, for tariff and trade purposes, schedule benidipine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, benidipine hydrochloride remains us fdas preferred term for this commodity. benidipine hydrochloride bears us nlm identifiers umls id c0088341 and nci concept code c81677. smiles: cc1=c([c@h](c(=c(n1)c)c(=o)o[c@@h]2cccn(c2)cc3ccccc3)c4cccc(c4)[n+](=o)[o-])c(=o)oc.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. clevidipine butyrate. this classification denotes a calcium channel blocker with the molecular formula c21h23cl2no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19o2gp3b7q, chemically known as 3,5-pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester but more generally known as clevidipine, which bears us nih compound identifier 153994. european medicines agency schedules clevidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06655mig. the term clevidipine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 11, no. 11997, list 37). world health organization schedules clevidipine in its anatomical therapeutic chemical (atc) classification. clevidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule clevidipine butyrate under hs 29333999. smiles: cccc(=o)ococ(=o)c1=c(nc(=c(c1c2cccc(c2cl)cl)c(=o)oc)c)c.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. efonidipine hydrochloride ethanolate. this classification denotes a calcium channel blocker with the molecular formula c34h38n3o7p.c2h6o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84hj0q6tmn, chemically known as (+/-)-efonidipine hydrochloride ethanolate, but more generally known as efonidipine hydrochloride ethanolate, which bears us nih compound identifier 163838. european medicines agency schedules efonidipine hydrochloride ethanolate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06471mig. most nations, for tariff purposes, schedule efonidipine hydrochloride ethanolate under hs 29349990. smiles: cco.cc1=c(c(c(=c(n1)c)p2(=o)occ(co2)(c)c)c3cccc(c3)[n+](=o)[o-])c(=o)occn(cc4ccccc4)c5ccccc5.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. elgodipine hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c29h33fn2o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mir106h7si, chemically known as 2-((p-fluorobenzyl)methylamino)ethyl isopropyl (+/-)- 1,4-dihydro-2,6-dimethyl-4-(2,3-(methylenedioxy)phenyl)-3,5-pyridinedicarboxylate hydrochloride, but more generally known as elgodipine hydrochloride, which bears us nih compound identifier 60701. european medicines agency schedules elgodipine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06484mig. most nations, for tariff purposes, schedule elgodipine hydrochloride under hs 29349990. smiles: cc1=c(c(c(=c(n1)c)c(=o)oc(c)c)c2cccc3c2oco3)c(=o)occn(c)cc4ccc(cc4)f.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. lercanidipine hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c36h41n3o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oa8tfx68pe, chemically known as 2-((3,3-diphenylpropyl)methylamino)-1,1-dimethylethyl methyl (4rs)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate monohydrochloride but more generally known as lercanidipine hydrochloride, which bears us nih compound identifier 157917. european medicines agency schedules lercanidipine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02894mig. most nations, for tariff and trade purposes, schedule lercanidipine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, lercanidipine hydrochloride remains us fdas preferred term for this commodity. lercanidipine hydrochloride bears us nlm identifiers umls id c0595331 and nci concept code c87685. smiles: cc1=c(c(c(=c(n1)c)c(=o)oc(c)(c)cn(c)ccc(c2ccccc2)c3ccccc3)c4cccc(c4)[n+](=o)[o-])c(=o)oc.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. manidipine dihydrochloride. this classification denotes a calcium channel blocker with the molecular formula c35h38n4o6.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zl507uz6ql, chemically known as 2-(4-(diphenylmethyl)-1-piperazinyl)ethyl methyl (+/-)-1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinecarboxylate dihydrochloride, but more generally known as manidipine dihydrochloride, which bears us nih compound identifier 150762. european medicines agency schedules manidipine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08641mig. most nations, for tariff purposes, schedule manidipine dihydrochloride under hs 29335995. smiles: cc1=c(c(c(=c(n1)c)c(=o)occn2ccn(cc2)c(c3ccccc3)c4ccccc4)c5cccc(c5)[n+](=o)[o-])c(=o)oc.cl.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. manidipine hydrochloride. this classification denotes a calcium channel blocker with the molecular structure c35h38n4o6.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, zl507uz6ql chemically known as 2-(4-(diphenylmethyl)-1-piperazinyl)ethyl methyl (+/-)-1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinecarboxylate dihydrochloride, but more commonly known as manidipine hydrochloride, which bears us nih compound identifier 150762. european medicines agency schedules manidipine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03085mig. most nations, for tariff and trade purposes, schedule manidipine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, manidipine hydrochloride remains us fdas preferred term for this commodity. smiles: cc1=c(c(c(=c(n1)c)c(=o)occn2ccn(cc2)c(c3ccccc3)c4ccccc4)c5cccc(c5)[n+](=o)[o-])c(=o)oc.cl.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. nicardipine hydrochloride. this classification denotes a calcium channel blockader, antihypertensive agent, and vasodilator agent with the molecular formula c26h29n3o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k5bc5011k3, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester, monohydrochloride but more generally known as nicardipine hydrochloride, which bears us nih compound identifier 41114. european medicines agency schedules nicardipine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03420mig. most nations, for tariff and trade purposes, schedule nicardipine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, nicardipine hydrochloride remains us fdas preferred term for this commodity. nicardipine hydrochloride bears us nlm identifiers umls id c0770150 and nci concept code c29840. smiles: cc1=c(c(c(=c(n1)c)c(=o)occn(c)cc2ccccc2)c3cccc(c3)[n+](=o)[o-])c(=o)oc.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. nifedipine hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c17h18n2o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9626v3kspm, chemically known as 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3,5-dimethyl ester, hydrochloride (1:1), but more generally known as nifedipine hydrochloride, which bears us nih compound identifier 63011. european medicines agency schedules nifedipine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09253mig. most nations, for tariff purposes, schedule nifedipine hydrochloride under hs 29333999. smiles: cc1=c(c(c(=c(n1)c)c(=o)oc)c2ccccc2[n+](=o)[o-])c(=o)oc.cl.. "
"antihypertensive pyridines. antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.. teludipine hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c28h38n2o6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7p6b96qlkn, chemically known as 3,5-pyridinedicarboxylic acid, 2-((dimethylamino)methyl)-4-(2-(3-(1,1-dimethylethoxy)-3-oxo-1-propenyl)phenyl)-1,4-dihydro-6-methyl-, diethyl ester, (e)- but more generally known as teludipine hydrochloride, which bears us nih compound identifier 6436165. most nations, for tariff and trade purposes, schedule teludipine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, teludipine hydrochloride remains us fdas preferred term for this commodity. teludipine hydrochloride bears us nlm identifiers umls id c0292595 and nci concept code c66585. smiles: ccoc(=o)c1=c(nc(=c(c1c2ccccc2/c=c/c(=o)oc(c)(c)c)c(=o)occ)cn(c)c)c.cl.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. . "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. bepridil. this classification denotes a calcium channel blocker with the molecular formula c24h34n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 755bo701ma, chemically known as 1-pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-n-phenyl-n-(phenylmethyl)- but generally known as bepridil, which bears us nih compound identifier 2351. bepridil most often comes in base and hydrochloride forms. european medicines agency schedules bepridil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13041mig. the term bepridil is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules bepridil in its anatomical therapeutic chemical (atc) classification. bepridil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bepridil under hs 29339990 and sitc 51577. as of q4 2014, bepridil remains the us fda preferred term for this commodity. bepridil bears us nlm identifiers umls id c0005116 and nci concept code c87448. smiles: o(cc(n1cccc1)cn(cc1ccccc1)c1ccccc1)cc(c)c.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. enalpril. this classification denotes an antihypertensive agent with the molecular formula c20h28n2o5.c4h4o4 , a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9o25354epj, chemically known as (z)-but-2-enedioicacid;(2s)-1-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid, which bears us nih compound identifier 5388961. smiles: ccoc(=o)c(ccc1=cc=cc=c1)nc(c)c(=o)n2cccc2c(=o)o.c(=cc(=o)o)c(=o)o.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. pentolinium or pentolonium. this classification denotes a nicotinic antagonist with the molecular formula c15h32n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ull76wpu5x, chemically known as pyrrolidinium, 1,1-(1,5-pentanediyl)bis(1-methyl- but generally known as pentolinium, which bears us nih compound identifier 5850. pentolinium or pentolonium bears us nlm identifiers umls id c0030885 and nci concept code c77367. smiles: c[n+]1(cccc1)ccccc[n+]2(cccc2)c.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. rilmakalim. this classification denotes an antihypertensive agent with the molecular formula c21h23no5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 47y56t6lei, chemically known as 2-pyrrolidinone, 1-(3,4-dihydro-3-hydroxy-2,2-dimethyl-6-(phenylsulfonyl)-2h-1-benzopyran-4-yl)-, (3s-trans)- but generally known as rilmakalim, which bears us nih compound identifier 65966. european medicines agency schedules rilmakalim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10314mig. the term rilmakalim is an international non-proprietary name. most nations schedule rilmakalim under hs 29349990 and sitc 51579. as of q4 2014, rilmakalim remains the us fda preferred term for this commodity. rilmakalim bears us nlm identifiers umls id c0652011 and nci concept code c75239. smiles: s(=o)(=o)(c1cc2c(n3cccc3=o)c(o)c(oc2cc1)(c)c)c1ccccc1.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. vernakalant. this classification denotes a mixed ion channel blocker with the molecular formula c20h31no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9g468c8b13, chemically known as (3r)-1-[(1r,2r)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol but generally known as vernakalant, which bears us nih compound identifier 9930049. vernakalant most often comes in base and hydrochloride forms. european medicines agency schedules vernakalant in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30707. the term vernakalant is an international non-proprietary name or inn (see who inn reference publication, volume 21, no. 3, 2007, list 58). world health organization schedules vernakalant in its anatomical therapeutic chemical (atc) classification. as of q4 2014, vernakalant remains the us fda preferred term for this commodity. smiles: coc1=c(c=c(c=c1)ccoc2ccccc2n3ccc(c3)o)oc.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. bepridil hydrochloride. this classification denotes a calcium channel blocker with the molecular formula c24h34n2o.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4w2p15d93m, chemically known as 1-pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-n-phenyl-n-(phenylmethyl)-, monohydrochloride but more generally known as bepridil hydrochloride, which bears us nih compound identifier 50088. european medicines agency schedules bepridil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13042mig. most nations, for tariff and trade purposes, schedule bepridil hydrochloride under hs 29339990. as of q4 2014, bepridil hydrochloride remains us fdas preferred term for this commodity. bepridil hydrochloride bears us nlm identifiers umls id c0770909 and nci concept code c47412. smiles: cc(c)cocc(cn(cc1ccccc1)c2ccccc2)n3cccc3.o.cl.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. bepridil hydrochloride monohydrate. this classification denotes a calcium channel blocker with the molecular formula c24h34n2o.clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4w2p15d93m, chemically known as 1-(2-(n-benzylanilino)-1-(isobutoxymethyl)ethyl)-pyrrolidine monohydrochloride monohydrate, but more generally known as bepridil hydrochloride monohydrate, which bears us nih compound identifier 91725. european medicines agency schedules bepridil hydrochloride monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13041mig. most nations, for tariff purposes, schedule bepridil hydrochloride monohydrate under hs 29339990. smiles: cc(c)cocc(cn(cc1ccccc1)c2ccccc2)n3cccc3.o.cl.. "
"antihypertensive pyrrolidines. antihypertensive drugs made from tetrahydropyrroles.. pentolonium tartrate. this classification denotes a nicotinic antagonist and antihypertensive agent with the molecular formula c15h32n2.2c4h5o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 953357gacy, chemically known as 1,1-pentamethylenebis(1-methylpyrrolidinium tartrate) but more generally known as pentolinium tartrate, which bears us nih compound identifier 5849. european medicines agency schedules pentolonium tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09700mig. the term pentolinium tartrate is an international non-proprietary name. most nations, for tariff and trade purposes, schedule pentolonium tartrate under hs 29339990. smiles: c[n+]1(cccc1)ccccc[n+]2(cccc2)c.[c@@h]([c@h](c(=o)[o-])o)(c(=o)o)o.[c@@h]([c@h](c(=o)[o-])o)(c(=o)o)o.. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. . "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. azamethonium. this classification denotes an antihypertensive agent with the molecular formula c13h33n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43xk6aw58d, chemically known as ((methylimino)diethylene)bis(ethyldimethylammonium) but generally known as azamethonium, which bears us nih compound identifier 9383. european medicines agency schedules azamethonium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21910. the term azamethonium is an international non-proprietary name. as of q4 2014, azamethonium remains the us fda preferred term for this commodity. azamethonium bears us nlm identifiers umls id c2346893 and nci concept code c73610. smiles: cc[n+](c)(c)ccn(c)cc[n+](c)(c)cc.. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. chlorisondamine. this classification denotes a nicotinic antagonist with the molecular formula c14h20cl4n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jd3m24f66i, chemically known as 1h-isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2- (trimethylammonio)ethyl)- but generally known as chlorisondamine, which bears us nih compound identifier 6243. european medicines agency schedules chlorisondamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06182mig. the term chlorisondamine is an international non-proprietary name. as of q4 2014, chlorisondamine remains the us fda preferred term for this commodity. chlorisondamine bears us nlm identifiers umls id c0008211 and nci concept code c83619. smiles: c[n+]1(cc2=c(c1)c(=c(c(=c2cl)cl)cl)cl)cc[n+](c)(c)c.[cl-].. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. hexamethonium. this classification denotes a nicotinic antagonist with the molecular formula c12h30n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3c9psp36z2, chemically known as ammonium, hexamethylenebis(trimethyl- or trimethyl-[6-(trimethylazaniumyl)hexyl]azanium but generally known as hexamethonium, which bears us nih compound identifier 3604. european medicines agency schedules hexamethonium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02506mig. the term hexamethonium is an international non-proprietary name. as of q4 2014, hexamethonium remains the us fda preferred term for this commodity. hexamethonium bears us nlm identifiers umls id c0062637 and nci concept code c75979. smiles: c[n+](c)(c)cccccc[n+](c)(c)c.. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. pentamethonium. this classification denotes a nicotinic antagonist with the molecular formula c11h28n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 521ds2d2hb, chemically known as 1,5-pentanediaminium, n,n,n,n,n,n-hexamethyl-, dibromide (9ci) but generally known as pentamethonium bromide, which bears us nih compound identifier 10919. european medicines agency schedules pentamethonium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09681mig. the term pentamethonium is an international non-proprietary name. as of q4 2014, pentamethonium remains the us fda preferred term for this commodity. pentamethonium bears us nlm identifiers umls id c0070299 and nci concept code c84044. smiles: c[n+](c)(c)ccccc[n+](c)(c)c.. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. azamethonium bromide. this classification denotes an antihypertensive agent with the molecular formula c13h33n3.2br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4k6nei0msr, chemically known as 3,3,6,9,9-pentamethyl-6-aza-3,9-diazoniaundecan dibromid but more generally known as azamethonium bromide, which bears us nih compound identifier 9382. european medicines agency schedules azamethonium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05632mig. the term azamethonium bromide is an international non-proprietary name. most nations, for tariff and trade purposes, schedule azamethonium bromide under hs 29239000 and sitc 51481. as of q4 2014, azamethonium bromide remains us fdas preferred term for this commodity. azamethonium bromide bears us nlm identifiers umls id c0104798 and nci concept code c72971. smiles: cc[n+](c)(c)ccn(c)cc[n+](c)(c)cc.[br-].[br-].. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. chlorisondamine chloride. this classification denotes a nicotinic antagonist with the molecular formula c14h20cl4n2.2cl, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7b58w7756g, chemically known as 4,5,6,7-tetrachloro-2-(2-dimethylaminoethyl)-isoindoline dimethochloride but more generally known as chlorisondamine chloride, which bears us nih compound identifier 6243. european medicines agency schedules chlorisondamine chloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06182mig. the term chlorisondamine chloride is an international non-proprietary name. most nations, for tariff and trade purposes, schedule chlorisondamine chloride under hs 29339990 and sitc 51577. as of q4 2014, chlorisondamine chloride remains us fdas preferred term for this commodity. chlorisondamine chloride bears us nlm identifiers umls id c0282099 and nci concept code c76788. smiles: c[n+]1(cc2c(c(c(c(c2cl)cl)cl)cl)c1)cc[n+](c)(c)c.[cl-].[cl-].. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. hexamethonium bromide. this classification denotes a nicotinic antagonist with the molecular formula c12h30n2.2br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8j77x3s603, chemically known as 1,6-hexanediaminium, n,n,n,n,n,n-hexamethyl-, dichloride but more generally known as hexamethonium bromide, which bears us nih compound identifier 3604. european medicines agency schedules hexamethonium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08028mig. the term hexamethonium bromide is an international non-proprietary name. most nations, for tariff and trade purposes, schedule hexamethonium bromide under hs 29239000 and sitc 51481. as of q4 2014, hexamethonium bromide remains us fdas preferred term for this commodity. hexamethonium bromide bears us nlm identifiers umls id c0121631 and nci concept code c80001. smiles: c[n+](c)(c)cccccc[n+](c)(c)c.[br-].[br-].. "
"antihypertensive quaternary ammonium compounds. antihypertensive drugs made from derivatives of ammonium compounds, nh4+ y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups.. pentamethonium bromide. this classification denotes a nicotinic antagonist with the molecular formula c11h28n2.2br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0ux03a6jjc, chemically known as 1,5-pentanediaminium, n,n,n,n,n,n-hexamethyl-, dibromide (9ci) but more generally known as pentamethonium bromide, which bears us nih compound identifier 10919. european medicines agency schedules pentamethonium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09681mig. the term pentamethonium bromide is an international non-proprietary name. most nations, for tariff and trade purposes, schedule pentamethonium bromide under hs 29239000 and sitc 51481. as of q4 2014, pentamethonium bromide remains us fdas preferred term for this commodity. pentamethonium bromide bears us nlm identifiers umls id c0304528 and nci concept code c80532. smiles: c[n+](c)(c)ccccc[n+](c)(c)c.[br-].[br-].. "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. . "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. bietaserpine. this classification denotes an antihypertensive agent with the molecular formula c39h53n3o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0p5b94fvd5, chemically known as 3-beta,20-alpha-yohimban-16-beta-carboxylic acid, 1-(2-(diethylamino)ethyl)-18-beta-hydroxy-11,17-alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) but generally known as bietaserpine, which bears us nih compound identifier 65518. bietaserpine most often comes in base and bitartrate forms. european medicines agency schedules bietaserpine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05826mig. the term bietaserpine is an international non-proprietary name. world health organization schedules bietaserpine in its anatomical therapeutic chemical (atc) classification. bietaserpine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bietaserpine under hs 29399900 and sitc 54149. as of q4 2014, bietaserpine remains the us fda preferred term for this commodity. bietaserpine bears us nlm identifiers umls id c0053565 and nci concept code c72973. smiles: o(c1c(c2c(cn3c(c2)c2n(c4c(c2cc3)ccc(oc)c4)ccn(cc)cc)cc1oc(=o)c1cc(oc)c(oc)c(oc)c1)c(=o)oc)c.. "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. deserpidine. this classification denotes an antihypertensive agent with the molecular formula c32h38n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9016e3vb47, chemically known as 3-beta,20-alpha-yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-17-alpha-methoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) but generally known as deserpidine, which bears us nih compound identifier 8550. european medicines agency schedules deserpidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06992mig. the term deserpidine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules deserpidine in its anatomical therapeutic chemical (atc) classification. deserpidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule deserpidine under hs 29399900 and sitc 54149. as of q4 2014, deserpidine remains the us fda preferred term for this commodity. deserpidine bears us nlm identifiers umls id c0175158 and nci concept code c61699. smiles: o(c1c(c2c(cn3c(c2)c2[nh]c4c(c2cc3)cccc4)cc1oc(=o)c1cc(oc)c(oc)c(oc)c1)c(=o)oc)c.. "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. mefeserpine. this classification denotes an antihypertensive agent with the molecular formula c32h38n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42el4l295a, chemically known as 3beta,20alpha-yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy-, methyl ester, (p-methoxyphenoxy)acetate (ester) but generally known as mefeserpine, which bears us nih compound identifier 3045407. european medicines agency schedules mefeserpine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08707mig. the term mefeserpine is an international non-proprietary name. mefeserpine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mefeserpine under hs 29399900 and sitc 54149. as of q4 2014, mefeserpine remains the us fda preferred term for this commodity. mefeserpine bears us nlm identifiers umls id c2981312 and nci concept code c87628. smiles: o(c1c(c2c(cn3c(c2)c2[nh]c4c(c2cc3)ccc(oc)c4)cc1oc(=o)coc1ccc(oc)cc1)c(=o)oc)c.. "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. rescinnamine. this classification denotes an antihypertensive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q6w1f7dj2d. european medicines agency schedules rescinnamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10285mig. rescinnamine generally arises in the molecular formula c35h42n2o9. the term rescinnamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3.) rescinnamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rescinnamine under hs 29399900 and sitc 54149. as of q4 2014, rescinnamine remains the us fda preferred term for this commodity. rescinnamine bears us nlm identifiers umls id c0035167 and nci concept code c61923. smiles: o(c1c(c2c(cn3c(c2)c2[nh]c4c(c2cc3)ccc(oc)c4)cc1oc(=o)/c=c/c1cc(oc)c(oc)c(oc)c1)c(=o)oc)c.. "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. reserpine. this classification denotes a multidrug resistance modulator and adrenergic agent with the molecular formula c33h40n2o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8b1qwr724a, chemically known as 20alpha-yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) (8ci) but generally known as reserpine, which bears us nih compound identifier 5052. european medicines agency schedules reserpine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10286mig. the term reserpine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules reserpine in its anatomical therapeutic chemical (atc) classification. reserpine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule reserpine under hs 29399900 and sitc 54149. as of q4 2014, reserpine remains the us fda preferred term for this commodity. reserpine bears us nlm identifiers umls id c0035179 and nci concept code c803. smiles: o(c1c(c2c(cn3c(c2)c2[nh]c4c(c2cc3)ccc(oc)c4)cc1oc(=o)c1cc(oc)c(oc)c(oc)c1)c(=o)oc)c.. "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. vincamine. this classification denotes a cns stimulant with the molecular formula c21h26n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 996xvd0jht, chemically known as methyl (3alpha,14alpha,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylate but generally known as vincamine, which bears us nih compound identifier 5668. european medicines agency schedules vincamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00054mig. the term vincamine is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules vincamine in its anatomical therapeutic chemical (atc) classification. vincamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vincamine under hs 29399900 and sitc 54149. as of q4 2014, vincamine remains the us fda preferred term for this commodity. vincamine bears us nlm identifiers umls id c0042674 and nci concept code c87697. smiles: oc1(n2c3c4n(cccc4(c1)cc)ccc3c1c2cccc1)c(=o)oc.. "
"antihypertensive secologanin tryptamine alkaloids. antihypertensive drugs made from compounds formed by condensation of secologanin with tryptamine resulting in a tetrahydro-beta-carboline which is processed further to a number of bioactive compounds.. vincamine hydrochloride. this classification denotes a cns stimulant c21h26n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x9xm85r7qq, chemically known as (3.alpha.,14.beta.,16.alpha.)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester hydrochloride, but more generally known as vincamine hydrochloride, which bears us nih compound identifier 165895. european medicines agency schedules vincamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05099mig. most nations, for tariff and trade purposes, schedule vincamine hydrochloride under hs 29399900 and sitc 54149. as of q4 2014, vincamine hydrochloride remains us fdas preferred term for this commodity. smiles: cc[c@@]12cccn3[c@@h]1c4c(c5ccccc5n4[c@](c2)(c(=o)oc)o)cc3.cl.. "
"antihypertensive sulfonamides. antihypertensive drugs made from a group of compounds that contain the structure so2nh2.. . "
"antihypertensive sulfonamides. antihypertensive drugs made from a group of compounds that contain the structure so2nh2.. piretanide. this classification denotes a loop diuretic with the molecular formula c17h18n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dq6kk6gv93, chemically known as benzoic acid, 3-(aminosulfonyl)-4-phenoxy-5-(pyrrolidinyl)- but generally known as piretanide, which bears us nih compound identifier 4849. european medicines agency schedules piretanide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09906mig. the term piretanide is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules piretanide in its anatomical therapeutic chemical (atc) classification. piretanide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piretanide under hs 29350090 and sitc 51580. as of q4 2014, piretanide remains the us fda preferred term for this commodity. piretanide bears us nlm identifiers umls id c0071132 and nci concept code c66419. smiles: s(=o)(=o)(n)c1c(oc2ccccc2)c(n2cccc2)cc(c1)c(=o)o.. "
"antihypertensive sulfonamides. antihypertensive drugs made from a group of compounds that contain the structure so2nh2.. diazoxide. this classification denotes a vasodilating agent with the molecular formula c8h7cln2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o5cb12l4fn, chemically known as 7-chloro-3-methyl-2h-1,2,4-benzothiadiazine 1,1-dioxide but generally known as diazoxide, which bears us nih compound identifier 3019. european medicines agency schedules diazoxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07071mig. the term diazoxide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules diazoxide in its anatomical therapeutic chemical (atc) classification. diazoxide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diazoxide under hs 29349990 and sitc 51579. as of q4 2014, diazoxide remains the us fda preferred term for this commodity. diazoxide bears us nlm identifiers umls id c0012022 and nci concept code c428. smiles: clc1cc2s(=o)(=o)n=c(nc2cc1)c.. "
"antihypertensive sulfonamides. antihypertensive drugs made from a group of compounds that contain the structure so2nh2.. bendroflumethiazide. this classification denotes a thiazide diuretic with the molecular formula c15h14f3n3o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5q52x6icji, chemically known as 3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide but generally known as bendroflumethiazide, which bears us nih compound identifier 2315. european medicines agency schedules bendroflumethiazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05711mig. the term bendroflumethiazide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules bendroflumethiazide in its anatomical therapeutic chemical (atc) classification. bendroflumethiazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bendroflumethiazide under hs 29350090 and sitc 51580. as of q4 2014, bendroflumethiazide remains the us fda preferred term for this commodity. bendroflumethiazide bears us nlm identifiers umls id c0701080 and nci concept code c47410. smiles: s1(=o)(=o)nc(nc2c1cc(s(=o)(=o)n)c(c2)c(f)(f)f)cc1ccccc1.. "
"antihypertensive sulfonamides. antihypertensive drugs made from a group of compounds that contain the structure so2nh2.. piretanide sodium. this classification denotes a loop diuretic c17h17n2o5s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4757j7s0v0, chemically known as benzoic acid, 3-(aminosulfonyl)-4-phenoxy-5-(1-pyrrolidinyl)-, sodium salt (1:1), but more generally known as piretanide sodium, which bears us nih compound identifier 73425479. european medicines agency schedules piretanide sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03870mig. most nations, for tariff and trade purposes, schedule piretanide sodium under hs 29350090 and sitc 51580. as of q4 2014, piretanide sodium remains us fdas preferred term for this commodity. smiles: c1ccc(cc1)oc2c(cc(cc2s(=o)(=o)n)c(=o)[o-])n3cccc3.[na+].. "
"antihypertensive sulfonamides. antihypertensive drugs made from a group of compounds that contain the structure so2nh2.. torasemide. this classification denotes a loop diuretic with the molecular formula c16h20n4o3s, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier w31x2h97fb, chemically known as 3-pyridinesulfonamide, n-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)- but more generally known as torasemide, which bears u.s. national institutes of health compound identifier 41781. european medicines agency schedules torasemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11195mig. the term torasemide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules torasemide in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. torasemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"antihypertensive terpenes. antihypertensive drugs made from a class of compounds composed of repeating 5-carbon units of hemiterpenes.. . "
"antihypertensive terpenes. antihypertensive drugs made from a class of compounds composed of repeating 5-carbon units of hemiterpenes.. mecamylamine. this classification denotes a nicotinic antagonist with the molecular formula c11h21n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6ee945d3ok, chemically known as 3-beta-methylamino-2,2,3-trimethylbicyclo(2.2.1)heptane but generally known as mecamylamine, which bears us nih compound identifier 4032. european medicines agency schedules mecamylamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08670mig. the term mecamylamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules mecamylamine in its anatomical therapeutic chemical (atc) classification. mecamylamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mecamylamine under hs 29213099 and sitc 51453. as of q4 2014, mecamylamine remains the us fda preferred term for this commodity. mecamylamine bears us nlm identifiers umls id c0025029 and nci concept code c66063. smiles: cc1(c2ccc(c2)c1(c)nc)c.. "
"antihypertensive terpenes. antihypertensive drugs made from a class of compounds composed of repeating 5-carbon units of hemiterpenes.. tinabinol. this classification denotes an antihypertensive agent with the molecular formula c23h34o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 455y914akk, chemically known as 1,2,3,5-tetrahydro-5,5-dimethyl-8-(1,2-dimethylheptyl)thiopyrano(2,3-c)(1)benzopyran-10-ol but generally known as tinabinol, which bears us nih compound identifier 65443. european medicines agency schedules tinabinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11072mig. the term tinabinol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). tinabinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tinabinol under hs 29349990 and sitc 51579. as of q4 2014, tinabinol remains the us fda preferred term for this commodity. tinabinol bears us nlm identifiers umls id c2699948 and nci concept code c75242. smiles: s1c2=c(c3c(oc2(c)c)cc(c(c(ccccc)c)c)cc3o)ccc1.. "
"antihypertensive terpenes. antihypertensive drugs made from a class of compounds composed of repeating 5-carbon units of hemiterpenes.. mecamylamine hydrochloride. this classification denotes a nicotinic antagonist with the molecular formula c11h21n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4956djr58o, chemically known as 3-beta-methylamino-2,2,3-trimethylbicyclo(2.2.1)heptane but more generally known as mecamylamine hydrochloride, which bears us nih compound identifier 4032. european medicines agency schedules mecamylamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03104mig. most nations, for tariff and trade purposes, schedule mecamylamine hydrochloride under hs 29213099 and sitc 51453. as of q4 2014, mecamylamine hydrochloride remains us fdas preferred term for this commodity. mecamylamine hydrochloride bears us nlm identifiers umls id c0304526 and nci concept code c66064. smiles: cc1(c2ccc(c2)c1(c)nc)c.cl.. "
"antihypertensive tetrazoles. antihypertensive drugs made from 5-member ring of four nitrogen atom and one carbon atom, based on cn4h2.. . "
"antihypertensive tetrazoles. antihypertensive drugs made from 5-member ring of four nitrogen atom and one carbon atom, based on cn4h2.. valsartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c24h29n5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 80m03yxj7i, chemically known as l-valine, n-(1-oxopentyl)-n-((2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)- but generally known as valsartan, which bears us nih compound identifier 60846. european medicines agency schedules valsartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00017mig. the term valsartan is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). world health organization schedules valsartan in its anatomical therapeutic chemical (atc) classification. valsartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule valsartan under hs 29339990 and sitc 51577. as of q4 2014, valsartan remains the us fda preferred term for this commodity. valsartan bears us nlm identifiers umls id c0216784 and nci concept code c47781. smiles: oc(=o)c(n(cc1ccc(cc1)c1c(cccc1)c1n[nh]nn1)c(=o)cccc)c(c)c.. "
"antihypertensive thiazoles. antihypertensive drugs made from sulfur compounds with nitrogen, based on c3h3ns.. . "
"antihypertensive thiazoles. antihypertensive drugs made from sulfur compounds with nitrogen, based on c3h3ns.. etozolin. this classification denotes a loop diuretic and antihypertensive agent with the molecular formula c13h20n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ueo8uw9v1z, chemically known as 3-methyl-4-oxo-5-piperidino-.delta.(sup2,a)-thiazolidineacetic acid ethyl ester but generally known as etozolin, which bears us nih compound identifier 5384145. european medicines agency schedules etozolin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07344mig. the term etozolin is an international non-proprietary name. world health organization schedules etozolin in its anatomical therapeutic chemical (atc) classification. etozolin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule etozolin under hs 29341000 and sitc 51579. as of q4 2014, etozolin remains the us fda preferred term for this commodity. etozolin bears us nlm identifiers umls id c0059877 and nci concept code c65600. smiles: s1c(n2ccccc2)c(=o)n(c\\1=c/c(=o)occ)c.. "
"antihypertensive thiazoles. antihypertensive drugs made from sulfur compounds with nitrogen, based on c3h3ns.. rentiapril. this classification denotes an ace inhibitor with the molecular formula c13h15no4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d0tam1017b, chemically known as 4-thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2r-cis)- but generally known as rentiapril, which bears us nih compound identifier 71244. european medicines agency schedules rentiapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10277mig. the term rentiapril is an international non-proprietary name. rentiapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rentiapril under hs 29341000 and sitc 51579. as of q4 2014, rentiapril remains the us fda preferred term for this commodity. rentiapril bears us nlm identifiers umls id c0073061 and nci concept code c72912. smiles: s1c(n(c(c1)c(=o)o)c(=o)ccs)c1c(o)cccc1.. "
"antihypertensive thiazoles. antihypertensive drugs made from sulfur compounds with nitrogen, based on c3h3ns.. semotiadil. this classification denotes a calcium channel blocker, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dgn08qz30g. european medicines agency schedules semotiadil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10481mig. semotiadil generally arises in the molecular formula c29h32n2o6s. the term semotiadil is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31.) semotiadil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule semotiadil under hs 29349990 and sitc 51579. as of q4 2014, semotiadil remains the us fda preferred term for this commodity. semotiadil bears us nlm identifiers umls id c0084530 and nci concept code c72624. smiles: s1c(c2c(occcn(ccoc3cc4ococ4cc3)c)ccc(oc)c2)c(=o)n(c2c1cccc2)c.. "
"antihypertensive thiazoles. antihypertensive drugs made from sulfur compounds with nitrogen, based on c3h3ns.. utibapril. this classification denotes an antihypertensive agent with the molecular formula c22h31n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 87i5h747bc, chemically known as 1,3,4-thiadiazole-2-carboxylic acid, 5-(1,1-dimethylethyl)-3-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-2,3-dihydro-, (2s-(2r*,3(r*(r*))))- but generally known as utibapril, which bears us nih compound identifier 60359. european medicines agency schedules utibapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11391mig. the term utibapril is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). utibapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule utibapril under hs 29349990 and sitc 51579. as of q4 2014, utibapril remains the us fda preferred term for this commodity. utibapril bears us nlm identifiers umls id c0082621 and nci concept code c81524. smiles: s1c(=nn(c1c(=o)o)c(=o)c(nc(ccc1ccccc1)c(=o)occ)c)c(c)(c)c.. "
"antihypertensive thiazoles. antihypertensive drugs made from sulfur compounds with nitrogen, based on c3h3ns.. semotiadil fumarate. this classification denotes a calcium channel blocker with the molecular formula c29h32n2o6s.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 48e2q389vx, chemically known as 2h-1,4-benzothiazin-3(4h)-one, 2-(2-(3-((2-(1,3-benzodioxol-5-yloxy)ethyl)methylamino)propoxy)-5-methoxyphenyl)-4-methyl-, (2r)-, (2e)-2-butenedioate (1:1), but more generally known as semotiadil fumarate, which bears us nih compound identifier 6437846. european medicines agency schedules semotiadil fumarate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10481mig. most nations, for tariff purposes, schedule semotiadil fumarate under hs 29349990. smiles: cn1c2ccccc2s[c@@h](c1=o)c3cc(ccc3occcn(c)ccoc4ccc5c(c4)oco5)oc.c(=c/c(=o)o)\\c(=o)o.. "
"antihypertensive thiepins. antihypertensive drugs made from seven-membered sulfur compounds with six carbon atoms and one sulfur atom.. . "
"antihypertensive thiepins. antihypertensive drugs made from seven-membered sulfur compounds with six carbon atoms and one sulfur atom.. temocapril. this classification denotes an angiotensin-converting enzyme inhibitor and antihypertensive agent with the molecular formula c23h28n2o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 18iz008eu6, chemically known as 1,4-thiazepine-4(5h)-acetic acid, 6-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-, (2s-(2alpha,6beta(r*)))- but generally known as temocapril, which bears us nih compound identifier 71323. european medicines agency schedules temocapril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10884mig. world health organization schedules temocapril in its anatomical therapeutic chemical (atc) classification. temocapril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule temocapril under hs 29349990 and sitc 51579. as of q4 2014, temocapril remains the us fda preferred term for this commodity. temocapril bears us nlm identifiers umls id c0753183 and nci concept code c99555. smiles: s1c(cn(c(=o)c(nc(ccc2ccccc2)c(=o)occ)c1)cc(=o)o)c1sccc1.. "
"antihypertensive thiepins. antihypertensive drugs made from seven-membered sulfur compounds with six carbon atoms and one sulfur atom.. temocaprilat. this classification denotes an ace inhibitor with the molecular formula c21h24n2o5s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2d6a12q12r, chemically known as 1,4-thiazepine-4(5h)-acetic acid, 6-((1-carboxy-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-, (2s-(2alpha,6beta(r*)))- but generally known as temocaprilat, which bears us nih compound identifier 71324. european medicines agency schedules temocaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10885mig. the term temocaprilat is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). temocaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule temocaprilat under hs 29349990 and sitc 51579. as of q4 2014, temocaprilat remains the us fda preferred term for this commodity. temocaprilat bears us nlm identifiers umls id c0646101 and nci concept code c75023. smiles: s1c(cn(c(=o)c(nc(ccc2ccccc2)c(=o)o)c1)cc(=o)o)c1sccc1.. "
"antihypertensive thiepins. antihypertensive drugs made from seven-membered sulfur compounds with six carbon atoms and one sulfur atom.. temocapril hydrochloride. this classification denotes an ace inhibitor with the molecular formula c23h28n2o5s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8g820i95vp, chemically known as 1,4-thiazepine-4-(5h)-acetic acid, 6-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, (2s-(2alpha,6beta(r*)))- but more generally known as temocapril hydrochloride, which bears us nih compound identifier 71322. european medicines agency schedules temocapril hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04716mig. most nations, for tariff and trade purposes, schedule temocapril hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, temocapril hydrochloride remains us fdas preferred term for this commodity. temocapril hydrochloride bears us nlm identifiers umls id c0208801 and nci concept code c99556. smiles: ccoc(=o)[c@h](ccc1ccccc1)n[c@h]2cs[c@@h](cn(c2=o)cc(=o)o)c3cccs3.cl.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. . "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. neldazosin. this classification denotes an antihypertensive agent with the molecular formula c18h25n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g3e7ro42mb, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(3-hydroxybutyryl)piperazine but generally known as neldazosin, which bears us nih compound identifier 65908. european medicines agency schedules neldazosin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09184mig. the term neldazosin is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). neldazosin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule neldazosin under hs 29335995 and sitc 51576. as of q4 2014, neldazosin remains the us fda preferred term for this commodity. neldazosin bears us nlm identifiers umls id c1882042 and nci concept code c66226. smiles: o=c(n1ccn(cc1)c1nc2c(c(n1)n)cc(oc)c(oc)c2)cc(o)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. benclonidine. this classification denotes an antihypertensive agent with the molecular formula c16h13cl2n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1999398a3p, chemically known as 4,5-dihydro-1-benzoyl-n-(2,6-dichlorophenyl)-1h-imidazol-2-amine but generally known as benclonidine, which bears us nih compound identifier 68774. european medicines agency schedules benclonidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05704mig. the term benclonidine is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). benclonidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benclonidine under hs 29332990 and sitc 51573. as of q4 2014, benclonidine remains the us fda preferred term for this commodity. benclonidine bears us nlm identifiers umls id c2346992 and nci concept code c72972. smiles: clc1c(nc2=nccn2c(=o)c2ccccc2)c(cl)ccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. ciheptolane. this classification denotes an antihypertensive agent and analgesic agent with the molecular formula c20h23no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nld2x0vd2u, chemically known as 10,11-dihydro-n,n-dimethylspiro(5h-dibenzo(a,d)cycloheptene-5,2-(1,3)dioxolane)-4-methylamine. but generally known as ciheptolane, which bears us nih compound identifier 115697. european medicines agency schedules ciheptolane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06261mig. the term ciheptolane is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). ciheptolane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ciheptolane under hs 29329970 and sitc 51569. as of q4 2014, ciheptolane remains the us fda preferred term for this commodity. ciheptolane bears us nlm identifiers umls id c2699211 and nci concept code c77318. smiles: o1c2(occ1cn(c)c)c1c(ccc3c2cccc3)cccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. cronidipine. this classification denotes a calcium channel blocker with the molecular formula c30h32cln3o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7txj9my5v9, chemically known as (8-(p-chlorophenyl)-1,4-dioxa-8-azaspiro(4,5)dec-2-yl)methyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate but generally known as cronidipine, which bears us nih compound identifier 65918. european medicines agency schedules cronidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06826mig. the term cronidipine is an international non-proprietary name. most nations schedule cronidipine under hs 29349990 and sitc 51579. as of q4 2014, cronidipine remains the us fda preferred term for this commodity. cronidipine bears us nlm identifiers umls id c2825728 and nci concept code c81683. smiles: clc1ccc(n2ccc3(oc(co3)coc(=o)c3=c(nc(=c(c3c3cc([n](=o)o)ccc3)c(=o)oc)c)c)cc2)cc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. dagapamil. this classification denotes a calcium channel blocker with the molecular formula c36h56n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 64o87u613h, chemically known as 2-(3-((m-methoxyphenethyl)methylamino)propyl)-2-(3,4,5-trimethoxyphenyl)tetradecanenitrile. but generally known as dagapamil, which bears us nih compound identifier 205957. european medicines agency schedules dagapamil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06888mig. the term dagapamil is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). dagapamil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dagapamil under hs 29269095 and sitc 51484. as of q4 2014, dagapamil remains the us fda preferred term for this commodity. dagapamil bears us nlm identifiers umls id c2825727 and nci concept code c81681. smiles: o(c1cc(c(cccccccccccc)(cccn(ccc2cc(oc)ccc2)c)c#n)cc(oc)c1oc)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. elisartan. this classification denotes an angiotensin ii receptor antagonist with the molecular formula c27h29cln6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wcc8z95027, chemically known as 1h-imidazole-5-carboxylic acid, 2-butyl-4-chloro-1-((2-(1h-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)-, 1-((ethoxycarbonyl)oxy)ethyl ester but generally known as elisartan, which bears us nih compound identifier 183766. european medicines agency schedules elisartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06487mig. the term elisartan is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). elisartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule elisartan under hs 29332990 and sitc 51573. as of q4 2014, elisartan remains the us fda preferred term for this commodity. elisartan bears us nlm identifiers umls id c2348398 and nci concept code c72933. smiles: clc1nc(n(cc2ccc(cc2)c2c(cccc2)c2n[nh]nn2)c1c(=o)oc(oc(=o)occ)c)cccc.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. fenperate. this classification denotes an antihypertensive agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1nj4dg390g. european medicines agency schedules fenperate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07586mig. fenperate generally arises in the molecular formula c25h31no4. the term fenperate is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15.) fenperate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fenperate under hs 29333999 and sitc 51574. as of q4 2014, fenperate remains the us fda preferred term for this commodity. fenperate bears us nlm identifiers umls id c1880759 and nci concept code c65665. smiles: o(ccn1ccccc1)c(=o)c(oc(=o)c)(cc1ccccc1)cc1ccccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. iprotiazem. this classification denotes a calcium channel blocker with the molecular formula c37h49n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3vpx99q2d7, chemically known as ( )-(r)-2-isopropyl-4-methyl-2-(o-(4-(4-(3,4,5-trimethoxyphenethyl)-1-piperazinyl)butoxy)phenyl)-2h-1,4-benzothiazin-3(4h)-one. but generally known as iprotiazem, which bears us nih compound identifier 195131. european medicines agency schedules iprotiazem in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08286mig. the term iprotiazem is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). iprotiazem is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule iprotiazem under hs 29349990 and sitc 51579. as of q4 2014, iprotiazem remains the us fda preferred term for this commodity. iprotiazem bears us nlm identifiers umls id c2825726 and nci concept code c81678. smiles: s1c(c(c)c)(c2c(occccn3ccn(cc3)ccc3cc(oc)c(oc)c(oc)c3)cccc2)c(=o)n(c2c1cccc2)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. leptacline. this classification denotes an antihypertensive agent with the molecular formula c12h23n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5dxm29256p, chemically known as piperidine, 1-(cyclohexylmethyl)- but generally known as leptacline, which bears us nih compound identifier 71660. european medicines agency schedules leptacline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08436mig. the term leptacline is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). leptacline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule leptacline under hs 29333999 and sitc 51574. as of q4 2014, leptacline remains the us fda preferred term for this commodity. leptacline bears us nlm identifiers umls id c2825667 and nci concept code c81523. smiles: n1(cc2ccccc2)ccccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. mazokalim. this classification denotes an antihypertensive agent with the molecular formula c23h28n6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k3n608ec7l, chemically known as ethyl 5-((3s,4r)-4-((1,6-dihydro-6-oxo-3-pyridazinyl)oxy)-3-hydroxy-2,2,3-trimethyl-6-chromanyl)-1h-tetrazole-1-butyrate. but generally known as mazokalim, which bears us nih compound identifier 3045404. european medicines agency schedules mazokalim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08658mig. the term mazokalim is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). mazokalim is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mazokalim under hs 29349990 and sitc 51579. as of q4 2014, mazokalim remains the us fda preferred term for this commodity. mazokalim bears us nlm identifiers umls id c2827250 and nci concept code c83907. smiles: o1c(c(o)(c(oc2n[nh]c(=o)cc2)c2c1ccc(c2)c1n(nnn1)cccc(=o)occ)c)(c)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. utibaprilat. this classification denotes an ace inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kn82541nhv. european medicines agency schedules utibaprilat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00001mig. utibaprilat generally arises in the molecular formula c20h27n3o5s. the term utibaprilat is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32.) utibaprilat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule utibaprilat under hs 29349990 and sitc 51579. as of q4 2014, utibaprilat remains the us fda preferred term for this commodity. utibaprilat bears us nlm identifiers umls id c0950771 and nci concept code c72914. smiles: s1c(=nn(c1c(=o)o)c(=o)c(nc(ccc1ccccc1)c(=o)o)c)c(c)(c)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. orbutopril. this classification denotes an ace inhibitor with the molecular formula c20h34n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gfj8659tqp, chemically known as (2s,3as,7as)-1-((s)-n-((s)-1-carboxypentyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester but generally known as orbutopril, which bears us nih compound identifier 5745795. european medicines agency schedules orbutopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09456mig. the term orbutopril is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). orbutopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule orbutopril under hs 29339990 and sitc 51577. as of q4 2014, orbutopril remains the us fda preferred term for this commodity. orbutopril bears us nlm identifiers umls id c2983809 and nci concept code c90629. smiles: o(c(=o)c1n(c2c(c1)cccc2)c(=o)c(nc(cccc)c(=o)o)c)cc.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. peraquinsin. this classification denotes an antihypertensive agent with the molecular formula c23h28n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5726cf21ky, chemically known as 6,7-dimethoxy-2-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)-4-(3h)-quinazolinone but generally known as peraquinsin, which bears us nih compound identifier 3047831. european medicines agency schedules peraquinsin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09714mig. the term peraquinsin is an international non-proprietary name. peraquinsin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule peraquinsin under hs 29335995 and sitc 51576. as of q4 2014, peraquinsin remains the us fda preferred term for this commodity. peraquinsin bears us nlm identifiers umls id c1882322 and nci concept code c66351. smiles: o(c1c(n2ccn(cc2)ccc2[nh]c3c(c(=o)n2)cc(oc)c(oc)c3)cccc1)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. piclonidine. this classification denotes an antihypertensive agent with the molecular formula c14h17cl2n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r7p4d56j1z, chemically known as (+-)-2-(2,6-dichloro-n-(tetrahydro-2h-pyran-2-yl)anilino)-2-imidazoline but generally known as piclonidine, which bears us nih compound identifier 68914. european medicines agency schedules piclonidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09811mig. the term piclonidine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). piclonidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piclonidine under hs 29349990 and sitc 51579. as of q4 2014, piclonidine remains the us fda preferred term for this commodity. piclonidine bears us nlm identifiers umls id c1882374 and nci concept code c66381. smiles: clc1c(n(c2occcc2)c2=nccn2)c(cl)ccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. pivopril. this classification denotes an ace inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3v6i5962em. european medicines agency schedules pivopril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09952mig. pivopril generally arises in the molecular formula c16h27no4s. the term pivopril is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) pivopril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pivopril under hs 29309085 and sitc 51549. as of q4 2014, pivopril remains the us fda preferred term for this commodity. pivopril bears us nlm identifiers umls id c1882404 and nci concept code c66443. smiles: s(cc(c(=o)n(c1cccc1)cc(=o)o)c)c(=o)c(c)(c)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. rescimetol. this classification denotes an antihypertensive agent with the molecular formula c33h38n2o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 25yf317r6s, chemically known as yohimban-16-carboxylic acid, 18-((3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl)oxy)-11,17-dimethoxy-, methyl ester, (3-beta,16-beta,17-alpha,18-beta,20-alpha)- but generally known as rescimetol, which bears us nih compound identifier 5282209. european medicines agency schedules rescimetol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10284mig. the term rescimetol is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). rescimetol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rescimetol under hs 29399900 and sitc 54149. as of q4 2014, rescimetol remains the us fda preferred term for this commodity. rescimetol bears us nlm identifiers umls id c2347955 and nci concept code c72977. smiles: o(c1c(c2c(cn3c(c2)c2[nh]c4c(c2cc3)ccc(oc)c4)cc1oc(=o)/c=c/c1cc(oc)c(o)cc1)c(=o)oc)c.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. sagandipine. this classification denotes a calcium channel blocker with the molecular formula c27h31fn2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 20o65j0b72, chemically known as methyl (5-piperidinomethyl)furfuryl 4-(o-fluorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate. but generally known as sagandipine, which bears us nih compound identifier 3058740. european medicines agency schedules sagandipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10414mig. the term sagandipine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). sagandipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sagandipine under hs 29349990 and sitc 51579. as of q4 2014, sagandipine remains the us fda preferred term for this commodity. sagandipine bears us nlm identifiers umls id c2348129 and nci concept code c73028. smiles: fc1c(c2c(=c(nc(=c2c(=o)oc)c)c)c(=o)occ2oc(cn3ccccc3)cc2)cccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. sornidipine. this classification denotes a calcium channel blocker, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z82yp691v7. european medicines agency schedules sornidipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10606mig. sornidipine generally arises in the molecular formula c22h24n2o9. the term sornidipine is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28.) sornidipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sornidipine under hs 29349990 and sitc 51579. as of q4 2014, sornidipine remains the us fda preferred term for this commodity. sornidipine bears us nlm identifiers umls id c2699493 and nci concept code c74227. smiles: o1c2c(occ2o)c(oc(=o)c2=c(nc(=c(c2c2c([n](=o)o)cccc2)c(=o)oc)c)c)c1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. tefenperate. this classification denotes an antihypertensive agent with the molecular formula c29h37cl2no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w5p145l26t, chemically known as 2-(2,2,6,6-tetramethylpiperidino)ethyl 2-chlor-alpha-(2-chlorbenzyl)-alpha-hydroxyhydrocinnamat acetat but generally known as tefenperate, which bears us nih compound identifier 163310. european medicines agency schedules tefenperate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10866mig. the term tefenperate is an international non-proprietary name. tefenperate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tefenperate under hs 29333999 and sitc 51574. as of q4 2014, tefenperate remains the us fda preferred term for this commodity. tefenperate bears us nlm identifiers umls id c2699907 and nci concept code c75241. smiles: clc1c(cc(oc(=o)c)(c(=o)occn2c(cccc2(c)c)(c)c)cc2c(cl)cccc2)cccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. tenosal. this classification denotes a calcium channel blocker with the molecular formula c12h8o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier eek88k197t, chemically known as 2-thiophenecarboxylic acid, ester with salicylic acid but generally known as tenosal, which bears us nih compound identifier 65838. european medicines agency schedules tenosal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10898mig. the term tenosal is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). tenosal is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tenosal under hs 29349990 and sitc 51579. as of q4 2014, tenosal remains the us fda preferred term for this commodity. tenosal bears us nlm identifiers umls id c2699913 and nci concept code c76584. smiles: s1c(c(=o)oc2c(cccc2)c(=o)o)ccc1.. "
"antihypertensive drugs, synthesized. this classification denotes antihypertensive drugs composed of multiple constituents, with no dominant constituent.. zolasartan. this classification denotes an angiotensin ii receptor antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6na6uhb9sw. european medicines agency schedules zolasartan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00174mig. zolasartan generally arises in the molecular formula c24h20brcln6o3. the term zolasartan is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34.) zolasartan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zolasartan under hs 29349990 and sitc 51579. as of q4 2014, zolasartan remains the us fda preferred term for this commodity. zolasartan bears us nlm identifiers umls id c0211676 and nci concept code c66702. smiles: ccccc1=nc(=c(n1cc2=cc3=c(c=c2)oc(=c3br)c4=cc=cc=c4c5=nnn=n5)c(=o)o)cl.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. . "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. amlodipine/valsartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. aliskiren/amlodipine/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. aliskiren/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. aliskiren/valsartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. alskiren/amlodipine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. amlodipine/benazepril. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. amlodipine/hydrochlorothiazide/olmesartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. amlodipine/hydrochlorothiazide/valsartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. amlodipine/olmesartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. amlodipine/telmisartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. chlorothiazide/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. atenolol/chlorthalidone. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. benazepril/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. bendroflumethiazide/nadolol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. bendroflumethiazide/potassium chloride/rauwolfia serpentina. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. bendroflumethiazide/rauwolfia serpentina. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. bisoprolol/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. candesartan/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. captopril/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. chlorothiazide/methyldopa. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. flumethiazide/potassium chloride/rauwolfia serpentina. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. chlorthalidone/clonidine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. chlorthalidone/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. cryptenamine/methyclothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. deserpidine/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. deserpidine/methyclothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. diltiazem/enalapril. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. enalapril/felodipine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. enalapril/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. eprosartan/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/losartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. fosinopril/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. guanethidine/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydralazine/hydrochlorothiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydralazine/hydrochlorothiazide/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydralazine/isosorbide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydralazine/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/irbesartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/labetalol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/lisinopril. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/valsartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/methyldopa. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/metoprolol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/moexipril. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/olmesartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/propranolol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/quinapril. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/telmisartan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydrochlorothiazide/timolol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. hydroflumethiazide/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. methyclothiazide/pargyline. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. methyclothiazide/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. polythiazide/prazosin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. polythiazide/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. quinethazone/reserpine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination antihypertensives. this classification denotes combination drugs that treat acute or chronic, persistently-high, systemic arterial blood pressure, or vascular hypertension, hence the term antihypertensives. typical combination antihypertensive constituents are aliskiren, benazepril, candesartan, deserpidine, diltiazem, eprosartan, fosinopril, guanethidine, and hydralazine.. reserpine/trichlormethiazide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv400. this va drug class (cv400) classifies this compound as belonging to the group antihypertensive combinations.. "
"combination calcium channel blockers. this classification denotes combination drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools, hence the term calcium channel blockers. typical combination calcium channel blocker constituents are amlodipine and sodium chloride.. . "
"combination calcium channel blockers. this classification denotes combination drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools, hence the term calcium channel blockers. typical combination calcium channel blocker constituents are amlodipine and sodium chloride.. amlodipine/atorvastatin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv200. this va drug class (cv200) classifies this compound as belonging to the group calcium channel blockers.. "
"combination calcium channel blockers. this classification denotes combination drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools, hence the term calcium channel blockers. typical combination calcium channel blocker constituents are amlodipine and sodium chloride.. sodium chloride/verapamil. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cv200. this va drug class (cv200) classifies this compound as belonging to the group calcium channel blockers.. "
